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ABSTRACT
Caliciviruses are single-stranded positive-sense RNA viruses. The viral 
genome is polyadenylated and 7-8 kb in length. Non-structural polypeptide coding 
sequences are located in the 5 s region of the genome whereas structural polypeptide 
coding sequences are located at the 3’end. In addition the replication cycle involves 
the synthesis of at least one 3 s co-terminal subgenomic RNA. The most important 
feature of calicivirus mRNA is the lack of a “cap” structure at the 5’ end. The viral 
mRNA bears a 10-15 kDa YPg protein linked to both genomic and sub-genomic 
RNAs. The lack of a ‘cap’ structure suggests that calicivirus mRNA is translated by a 
cap-independent mechanism. The aim of this project was to investigate the 
mechanism of translation initiation on feline calicivirus (FCV) mRNA. This was 
achieved by examining (i) the proposed role for the 15 kDa VPg protein, as a ‘cap 
analogue’, and (ii) the interactions of cellular proteins to the 5’ and 3’ ends of the 
FCV genome.
Firstly, expressed FCV VPg was purified and used to raise antisera in rabbits. 
The antisera were subsequently used to analyse proteins from FCV-infected CRFK 
cells. Secondly, pull-down and ELISA-based binding assays suggested interaction of 
recombinant FCV VPg with the canonical initiation factor eIF4E. Thirdly, studies of 
the interactions between cellular proteins and the 5’ and 3’ terminal ends of the FCV 
genome by UV cross-linking and oligo(dT) RNA-protein binding assays were 
conducted. Results suggested interaction o f the 5’ end of the FCV genome with 
proteins eIF4A, polypyrimidine tract-binding protein (PTB) and La, and eIF4A with 
the 3’ end of the FCV genome. Based on the results of this work, this thesis proposes 
a model of the interactions between the FCV genome, VPg and cellular proteins in 
translation initiation.
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Chapter 1
Introduction
1.1 The Caliciviruses: an introduction
The International Committee on Taxonomy of Viruses (ICTV) has approved 
the proposal submitted by the present Caliciviridae Study Group (CSG) [Mayo, 2002] 
to divide the family of Caliciviridae into four genera designated Lagovirus, Vesivirus, 
Norovirus, and Sapovirus. The genera have been further divided into the following 
species: Rabbit hemorrhagic disease virus and European brown hare syndrome virus 
(genus Lagovirus); Vesicular exanthema of swine virus and Feline calicivirus (genus 
Vesivirus); Norwalk virus (genus Norovirus); and Sapporo virus (genus Sapovirus). 
Table 1.1 summarises the present classification of the Caliciviridae family along with 
the species of each genus.
1.1.1 Vesicular exanthema of swine virus (VESV)
The prototype species of the caliciviruses is considered to be vesicular 
exanthema of swine virus (VESV), which caused an epidemic in the USA in 1932 
[reviewed in Cubitt, 1987]. The epidemic observed in swine was traced to the feeding 
of meat from sea mammals, resulting in a pig-to-pig infection. VESV causes an acute, 
febrile, contagious disease in swine, characterized by the formation of vesicles 
predominantly on the snout, oral mucosa and the feet, with the main cause of 
mortality being late abortions. At the time of the outbreak, the disease symptoms were 
indistinguishable from those of foot-and-mouth disease, leading to immediate actions
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Chapter 1 Introduction
for its eradication [reviewed in Carter et a l ,  1991; Thiel and Konig, 1999]. In 1972 
closely related viruses were found to be infecting sea lions on the island of San 
Miguel off the Californian coast, hence the name San Miguel sea lion virus (SMSV). 
The symptoms to pinnipeds were similar to those caused by VESV, with vesicular 
lesions on the flippers often being associated with the disease. Since then, similar 
viruses have been isolated from a variety of marine animals including fish, pinnipeds 
and whales and also scavengers such as foxes and primates. At least twelve serotypes 
of SMSV have been isolated, several o f which cause disease in pigs, suggesting that 
VESV spread to pigs through feed contaminated with viruses from marine sources 
[reviewed in Carter et a l ,  1991; Thiel and Konig, 1999].
1.1.2 Rabbit heamorrhagic disease virus (RHDV)
In the spring and summer of 1984 an outbreak of an apparently new viral 
disease in rabbits was observed in China. The disease resulted in pronounced 
enlargement of the liver and necrotising hepatitis. Additional symptoms included 
haemorrhages in the respiratory system, cardiac muscle, and spleen. The disease 
incubation in rabbits was 2-3 days with morbidity approaching 100 % and mortality 
over 90 % [reviewed in Thiel and Konig, 1999; Green et a l ,  2000]. Virus isolated 
from infected livers was initially described as a picornavirus and a parvovirus until 
the causative agent, rabbit haemorrhagic disease virus (RHDV) was identified as a 
calicivirus in 1990 [Ohlinger et a l ,  1990; Parra and Prieto, 1990]. In 1995 escape of 
RHDV from experiments conducted on Wardang Island off the coast of South 
Australia led to dramatic reductions in the rabbit populations [Kaiser, 1995; Holden, 
1995; Lawson, 1995]. A close relative of RHDV is the European brown hare
3
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syndrome virus (EBHSV) usually causing disease only in hares [Wirblich et al.,
1994].
1.1.3 Feline calicivirus (FCV)
Feline calicivirus (FCV) was first isolated in 1957 [reviewed in Cubitt, 1987 
and Carter et al., 1991] when a cytopathic virus was recovered from cats dying from 
panleukopenia. FCV is a major agent of respiratory disease in cats, with mortality up 
to 30%. Infection is associated mainly with ulceration of the epithelium of the oral 
cavity (stomatitis), lethargy and polyarthritis (limping syndrome) although additional 
symptoms include conjunctivitis, rhinitis, tracheitis, pneumonia, and fever [reviewed 
in Carter et al., 1991]. A live attenuated vaccine has been developed based on the F9 
strain, which only promotes immunity to a sub-population (approximately 50% of 
field strains). There is evidence suggesting this restricted immunity has led to the 
emergence of several strains [Knowles et al., 1990].
Other animal caliciviruses whose genome sequences have been recently 
identified include the primate calicivirus Pan 1 [Rinehart-Kim et a l 1999] and the 
bovine enteric calicivirus, Jena virus (JV) [Liu et al., 1999].
1.1.4 Human caliciviruses (HuCVs)
The classification of animal caliciviruses was based on their characteristic 
morphology determined by negative contrast electron microscopy (EM), revealing 
surfaces covered in a regular array of dark spots [reviewed in Carter et a l ,  1991]. 
Particles of this characteristic morphology were observed by direct EM in 1976 in the 
stools of infants suffering from diarrhoea [Flewett & Davies, 1976; Madeley &
4
Chapter 1 Introduction
Cosgrove, 1976]. H u m a n  caliciviruses (HuCVs) or human enteric caliciviruses have 
been linked with outbreaks of mild diarrhoea in children and infants worldwide and 
shown to induce illness in volunteer studies [reviewed in Carter et al, 1991].
The h um an  prototype of caliciviruses is the Norwalk virus (NV) first described during 
an epidemic of gastroenteritis in a school in Norwalk, Ohio, in 1968. Symptoms 
include acute diarrhoea and projectile vomiting (gastroenteritis), myalgias, and 
abdominal cramps [reviewed in Green et al, 2000]. It too was initially described as a 
picornavirus or parvovirus based on its appearance under E M  [Kapikian et al., 1972]. 
Greenberg and colleagues’ [1981] demonstration of the presence of a single major 
structural protein in Norwalk virions purified from human faeces proved to be a 
characteristic consistent with that of the Caliciviridae. The inability of N V  to grow in 
cell culture prevented the detailed characterization of the virus until cloning of the N V  
genome by Jiang et al. in 1990 led to the recognition of N V  and other related ‘small 
round structured viruses’ (SRSV) as members of the Caliciviridae [Lambden et al, 
1993].
Another caliciviras described as causing gastroenteritis was later isolated from an 
outbreak in an orphanage in Sapporo, Japan [reviewed in Clarke &  Lambden, 2000; 
Green et al., 2000], thus named Sapporo virus (SV). S V  demonstrated the classical 
morphology of H u C V  and was one of the first viruses to be characterized as 
antigenically distinct from N V  [Nakata et al, 1985]. Classic caliciviruses or 
Sapoviruses include the Plymouth virus and the Manchester virus (MV). Analysis of 
full-length genomic sequences of the Plymouth virus and Manchester virus [Liu et al.,
1995] unveiled a major difference in the reading frame usage between classic H u C V s  
and SRSVs, thus establishing the two groups as distinct.
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1.2 C alic iv irus m orphology
As  mentioned above (Section 1.1.4), Kapikian and colleagues [1972] first 
visualized a 27 n m  particle w he n  preparations of Norwalk virus were subjected to 
immune E M .  Under E M ,  negatively stained calicivirus particles are approximately 
33-40 n m  in diameter, non-enveloped, and have a distinctive morphology; a series of 
characteristic cup-shaped depressions on the surface of each virion is apparent when 
viewed by negative stain electron microscopy. The surface structure comprises an 
icosahedral capsid, constructed from only one type of structural protein. The capsid is 
often characterized by space occupying subunits, usually visible as knob-like 
capsomeres, which displace stain and thus appear white in micrographs. Thus, 
calicivirus virions have a ‘lacy’ appearance, which is attributed to the array of dark 
stain-filled hollows (cup-shaped depressions) on its surface (Figure 1.1). There are 32 
such cup-shaped depressions located at each apex and face of the icosahedron and 
each is separated from its neighbours by an unstained ridge. This characteristic 
morphology provided the name of this n e w  family of viruses and is derived from the 
Latin calyx, which means cup or chalice. W h e n  viruses are viewed along their two-, 
three-, and five-fold axes of symmetry they have a characteristic appearance; four 
hollows arranged as a cross, a ‘star of David’ and a ten-pointed sphere, respectively 
[reviewed in Cubitt, 1987; Carter et al, 1991]. However, this is n o w  considered to be 
a generalisation as caliciviruses with an ill-defined surface morphology and a fuzzy 
edge have been identified. Prasad et al [1994a] demonstrated using cryoelectron 
microscopy and three-dimensional image reconstruction, that virions from a primate 
calicivirus (of the V E S V / S M S V  genetic group) are 40.5 n m  in diameter with 32-cup 
shaped surface structures comprising 90 arch-like capsomeres arranged in T  =  3 
icosahedral symmetry. Each capsomere is a dimer of the viral capsid protein and bears
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Figure 1.1: C r y o - E M  of baculovirus-expressed Norwalk virus capsid.
Taken from Prasad et al. [1994b].
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three domains comprising an upper bi-lobed structure, a central stem and a lower 
shell. The three-dimensional structure of baculovirus-expressed Norwalk virus capsid 
protein has also been determined using electron cryomicroscopy and computer image 
processing techniques. Although the N V  capsid protein was found to have a 
distinctive architecture, it also shared several similarities with the structure of T=3 
primate calicivirus [Prasad et al, 1994b]. Recently, Chen et al [2003] have reported 
the crystallization of S M S V  serotype 4 ( S M S Y 4 )  and the results of the preliminary X- 
ray crystallographic analysis of the crystals. The crystallography results showed that 
S M S V 4  comprises of five icosahedral assymetric units, each consisting of three 
capsid protein subunits.
1.3 C alicivirus genome structure
The viral genome comprises a single-stranded polyadenylated R N A  of 
positive polarity and 7-8kb in length. A n  important feature of calicivirus R N A  is the 
lack of a 5’ “cap” structure - m 7G(5’)ppp(5’)Nmp - found on most eukaryotic m R N A  
molecules. Instead, the viral m R N A  bears a 10-15 k D a  covalently attached viral 
protein (genome-linked -VPg) at the 5’end [Burroughs &  Brown, 1978; Schaffer et 
al, 1980; Wimmer, 1982; Meyers et al, 1991], The non-structural polypeptide coding 
sequences are located in the 5’ region of the genome whereas the structural 
polypeptide coding sequences are located at the 3’end. The replication cycle involves 
the synthesis of at least one 3 ’ co-terminal subgenomic R N A  [Carter, 1990; Herbert et 
al, 1996]. Sub-genomic viral R N A s  are also VPg-linked [Meyers et al, 1991, Herbert 
et al, 1996]. The family Caliciviridae is clearly distinct from that of the well-defined 
family of Picornaviridae as they show different genome arrangements. Figure 1.2
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shows a diagrammatic representation of the genome organization of picoma- and 
caliciviruses.
1.3.1 G e n o m e  structure of Vesivirus and Norovirus genera
Sequence analyses have revealed that within the family of Caliciviridae there 
are two fundamentally different arrangements of the open reading frames (ORFs) in 
their genome [reviewed in Clarke &  Lambden, 1997] (Figure 1.3). A  characteristic 
feature of F C V  is the separate reading frames for the capsid and non-structural 
polyprotein. Complete genome sequences are available for four different F C V  isolates 
[Neill, 1990; Neill et al, 1991; Carter et al, 1992a; Sosnovtsev &  Green, 1995] all 
showing a high level of similarity. The F C V  genome encodes three O R F s  with the 
first potential initiation codon for O R F 1  located at nucleotide 20, encoding a long 
polyprotein of 1763 amino acids [Carter et al, 1992a]. The nucleotide sequence at the 
junction between the polyprotein termination codon and the O R F 2  initiation codon is 
absolutely conserved. T w o  bases follow the termination codon for O R F 1  and the first 
base of the initiation codon for O R F 2  does not overlap but is frameshifted -1 relative 
to O R F 1  ( G T T  T G A  G C  A T G  TGC). The small 3 ’-end O R F  (ORF3) is similarly 
frameshifted (-1) relative to O R F  2 (therefore, +1 relative to O RF 1)  but in this case 
the termination codon of O R F 2  overlaps the start codon of O R F 3  by four nucleotides 
( A A G  T T A  T G  A TT) [Carter et al, 1992a; reviewed in Clarke &  Lambden, 1997]. 
Although no complete genome sequence is available for the V E S V / S M S V  group of 
viruses, partial sequences of two S M S V  serotypes [Neill, 1992] indicate a genome 
organization similar to F C V  as it bears three ORFs. The genome arrangenment of 
S R S V s  O R F s  is also very similar to that of F C V  with three distinct ORFs. Detailed 
sequence comparison of several isolates has resulted in the subdivision of S R S V s  into
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two genetic groups [Lambden &  Clarke, 1994]. Complete genome sequences are 
available for seven group I isolates [Jiang et al, 1990; Lambden et al, 1993; Hardy &  
Estes, 1996; Liu et al, 1999b; Schreier et al, 2000; Someya et al., 2000; Katayama et 
al., 2002] and twelve group II isolates [Lew et al., 1994; Dingle et al., 1995; Seah et 
al., 1999; Green et al, 2002b; Katayama et al, 2002].
1.3.2 G e n o m e  structure of Lagovirus and Sapovirus genera
The arrangement of O R F s  in R H D V ,  E B H S V  and Sapovirus or ‘classic’ 
H u C V s  is different to the genome organization of FCV. In the case of R H D V  and the 
closely related E B H S V ,  O R F 1  (encoding the non-structural proteins) is fused to the 
capsid sequence as a contiguous coding sequence creating a single, large polyprotein 
occupying the majority (up to 94%) of the viral genome. The R H D V  genome is 7437 
nucleotides in length (without the poly(A) tail) and has a predicted translational start 
codon for the polyprotein (ORF1) at nucleotide 10. O R F 1  extends to position 7041, 
giving a product of 2344 amino acids encoding a polyprotein of predicted molecular 
mass of 257 kDa. O R F 2  of the R H D V  genome, which corresponds in size and 
genome location to the small 3 ’-terminal O R F 3  of FCV, is located at nucleotide 7025 
and has a 17 nucleotide overlap with O R F 1  but is nevertheless frameshifted -1 
relative to the capsid-encoding O R F  ( A T G  G C T  T T T  C T T  A T G  T C T G A A ) .  O R F 2  
of R H D V  encodes a polypeptide of 117 amino acids and shares only 2 9 %  amino acid 
sequence identity with F C V  O R F 3  [Meyers et al, 1991a], Sequence analysis of the 
E B H S V  genome revealed a similar genome organization to R H D V ,  sharing 7 5 %  
amino acid sequence identity in the capsid [Wirblich et al, 1994; Le Gall et al,
1996]. In the case of the H u C V  Manchester genome, the region encoding the capsid 
protein is in the same frame and contiguous with the coding region of non-structural
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proteins forming one large polyprotein of 2208 amino acids. Although H u C V  has a 
small 3 ’-terminal O R F  in c o m m o n  with the other caliciviruses, computer analyses 
predicted an additional O R F  (ORF3), encoding a polypeptide of 161 amino acids, in a 
different frame overlapping with the N  terminus of the capsid [reviewed in Clarke and 
Lambden, 1997].
1.4 Subgenomic m RN A s
1.4.1 Vesivirus R N A
Early studies on S M S V  and V E S V  [Ehresmann &  Schaffer, 1977, 1979; Black 
et al, 1978] showed that caliciviruses synthesize two polyadenylated single-stranded 
R N A s  (ssRNA), which lack the typical 5 ’-methylated cap structure, in infected cells. 
The first one, equivalent in size to positive-stranded genomic R N A  (36S), had a 
molecular weight of 2.6 x 106. The other (22S), which represented about half the 
intracellular viral s s R N A  molecules, had a molecular weight of 1.1 x 106. The 
presence of a poly(A) tail [Ehresmann &  Schaffer, 1977] and results of in vitro 
translation experiments [Black ei al, 1978] indicated that the smaller s s R N A  was a 
subgenomic m R N A .  In addition to the two ssRNAs found in S M S V -  and VESV-cells 
infected, double-stranded (dsRNA) polyadenylated R N A  exhibiting characteristics of 
replicative form and replicative intermediate R N A  sedimenting in the region of 18-22 
S and resistant to ribonuclease treatment were found [Ehresmann &  Schaffer, 1979; 
Black et al, 1978].
The genomic length R N A  molecule was also observed in SDS-disrupted 
virions of S M S V  but not subgenomic R N A  [Ehresmann &  Schaffer, 1977]. Recently, 
Neill [2002] reported the presence of subgenomic m R N A  in low density F C V  virion
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particles (CFI/68 strain) during infection in vitro. The significance of the presence of 
low density virion particles containing subgenomic m R N A  during infection as well as 
whether this occurs in vivo is still unknown. Analysis of FCV-infected cells by 
Northern blot with c D N A  probes gave some conflicting data on the number and size 
of FCV-specific transcripts [Neill &  Mengeling, 1988; Carter, 1990], Neill and 
Mengeling [1988] reported the presence of four FCV-specific R N A s  that were 
approximately 8.2 (gemonic RNA), 4.8, 4.2 and 2.4 kb in length. Northern blots of 
d s R N A  showed two double-stranded R N A s  corresponding to the 8.2 kb genomic 
R N A  and the 2.4 kb subgenomic R N A .  Mapping experiments by Northern blot using 
c D N A  probes derived from various locations within the F C V  genome indicated the 
approximate regions from which the subgenomic R N A s  were derived. The study 
indicated that the viral R N A s  were nested, co-terminal transcripts with c o m m o n  3 ’ 
termini. Carter [1990], reported the presence of eight F C V ( F 9  strain) -specific R N A s  
of 7.1, 5.3, 4.3, and 3.6 kb for genomic R N A  and 2.7, 1.9, 1.5 and 0.55 kb for 
subgenomic R N A .  Depending upon the time after infection the relative amounts of 
these subgenomic R N A s  varied. In addition, negative strands of all the genomic-size 
R N A s  and the 2.7 kb subgenomic R N A  [Carter, 1990] and the 2.4 kb subgenomic 
R N A  [Neill &  Mengeling, 1988] were present, suggesting their role as templates in 
the synthesis of their positive-stranded R N A  counterparts. The findings of Neill and 
Mengeling [1988] and Carter [1990] suggested that caliciviruses use transcription and 
translation of subgenomic R N A s  for gene expression, in contrast to picornaviruses, 
which contain only genome-sized R N A  that is translated into one large polyprotein. 
The discrepancies observed for the number of FCV-specific R N A  species were 
largely resolved by Herbert et al., [1996] w h o  extracted 32P-labelled polyadenylated
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R N A  from FCV-infected C R F K  cells and separated them by denaturing P A G E ,  to 
reveal only two R N A  species of 7.6 and 2.4 kb.
1.4.2 Lagovims R N A
In an attempt to identify and characterize the virus causing rabbit hemorrhagic 
disease, Ohlinger et al. [1990] isolated highly pure R N A  of about 8 kb from virions 
present in liver tissue from infected animals. Labelled c D N A  synthesized from virion 
R N A  detected two R N A s  of 8 and 2 kb in Northern blots. The two R N A  molecule 
sizes corresponded to genomic and subgenomic R N A s  respectively. The studies of 
Meyers et al. [1991b] on RHDV-infected rabbit livers also showed the presence of 
two abundant R N A  species of 7.5 and 2.2 kb. Similar sized R N A  molecules were 
observed in purified R H D V  virions indicating that the subgenomic R N A  was 
packaged into mature virus particles. After isolation from liver tissue, viral genomic 
and subgenomic R N A s  were found to be resistant to RNase degradation. The 
researchers suggested that such protection was due to the R N A  being packaged into 
particles. Separation of R H D V  virions by sucrose density gradient fractionation 
suggested the existence of two separate populations of particles carrying either 
genomic or subgenomic R N A ,  although it has not been unequivocally shown whether 
individual virions carry both R N A  species. The subgenomic R N A  was polyadenylated 
and Northern blot analysis using oligonucleotides confirmed it to be of positive 
polarity.
Similar studies with a Spanish isolate of R H D V  [Boga et al., 1992] and E B H S V  
[Wirblich et al., 1994] showed both genomic and subgenomic R N A s  to be present in 
equimolar amounts in infected liver cells. Another report, based on the detection of a
2.3 kb R N A  molecule in stool samples from a human volunteer infected with N V ,  has
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suggested that Norwalk virus m a y  also encode a subgenomic R N A  [Jiang et ah,
1993].
1.5 5 ’ conserved sequences
Cloning of the major subgenomic R N A  of R H D V ,  which encodes the viral 
capsid protein, revealed that the nucleotide sequence of the 5’ end was identical to the 
O R F 1  3 ’ terminal region of the genomic R N A .  Primer extension, direct R N A  
sequencing, and nuclease SI protection analyses showed that the 5’ end of the 2.2 kb 
R H D V  m R N A  corresponded to position 5296 of the genomic R H D V  sequence 
[Meyers et al., 1991b]. Once the complete nucleotide sequence of F C V  was 
determined, it was also noted that a conserved sequence motif of 16 nucleotides was 
present in the 55 termini of both the genomic and subgenomic m R N A s  of the genome 
[Carter et al., 1992a]. Primer extension analysis and R N A  sequencing mapped the 5 ’ 
terminus of the F C V  2.4 kb subgenomic R N A  to position 5227 on the F C V  viral 
genome [Herbert et al., 1996]. This was in concurrence with the results reported by 
Neill et al. [1991] for the subgenomic R N A  of F C V  strain CF168. It was therefore 
concluded that in infected cells F C V  produces a polyadenylated genomic R N A  and a 
functionally bicistronic subgenomic R N A  encoding O R F s  2 and 3. Figure 1.3 shows 
a simple representation of the F C V  and R H D V  genomes along with the conserved 
sequence motifs at the 5’ termini in the genomic and subgenomic m R N A s .
Similarly, short internal repeated sequences located immediately upstream of O R F 2  
have been demonstrated in both group I and II S R S V s  [Lambden et al, 1995; Dingle 
et al, 1995]. These repeated sequences at the 5 ’ end of both the genomic and 
subgenomic suggest that these structures m a y  have a regulatory role such as providing 
a signal for packaging, replication, transcription or translation of the viral genome
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[Lambden et al., 1995]. H u C V s  are an exception as the characteristic repeated 
sequence motifs were not found at the 5’ terminus of the genome and at the start of 
the capsid gene [Liu et al., 1995].
1.6 The genom e-linked V P g protein
As mentioned in Section 1.3 caliciviruses possess a genome-linked protein, 
VPg, which is encoded in ORF1. Its size varies from 10-15 k D a  depending on the 
virus [Burroughs and Brown, 1978; Clarke &  Lambden 1997; D u n h a m  et al, 1998; 
Sosnovtseva et al, 1999]. V P g  is covalently attached to the 5 ’ end of the genome 
(indicated by denaturing conditions specific for removing non-covalent bonds) of 
m any positive sense, single stranded R N A  viruses, including picornaviruses, 
caliciviruses, and many plant R N A  viruses [Burroughs and Brown, 1978; Schaffer et 
al., 1980; Meyers et al., 1991b; Carter et al., 1992; Wirblich et al., 1996; D u n h a m  et 
al, 1998; Leonard et al. 2000; Sosnovtsev &  Green, 2000]. Calicivirus VPgs are 
significantly larger (14-15 kDa) than picornavirus V Pgs (approx. 2.4 kDa) [Burroughs 
and Brown, 1978; D u n h a m  et al, 1998; Cann, 1997] (Figure 1.2).
1.6.1 Picornavirus V P g
In picornaviruses, the V P g  is covalently attached by a tyrosine residue to a 
uridine residue on the 5 ’ end of the viral genomic R N A ,  but is not found on viral 
m R N A  [Ambros &  Baltimore, 1978; Rothberg et al., 1978]. Picornavirus genomic 
R N A  is infectious and can be efficiently translated in the presence or absence of V P g  
protein at its 5 ’ end. In picornaviruses V P g  is thought to be involved in the initiation 
of viral R N A  replication and was shown to act as a primer for the viral 3 D  R N A
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polymerase [Nomoto et al, 1977; Paul et al, 1998]. Purified poliovirus 3 D  R N A  
polymerase was able to uridylylate V P g  protein [Paul et al, 1998]. The presence of 
highly conserved stem-loop structures in the 5 ’ and 3 ’ U T R s  in picomavinis genomes 
as well as c/'s-acting R N A  elements (cre) found within the coding sequence of 
picomavirus 2 C  helicase are required for virus replication [McKnight &  Lemon, 
1996; Lobert et al, 1999; Goodfellow et al, 2000; Lyons et al, 2001; Yang et al., 
2002]. It appeared that the cre elements were essential for negative-strand R N A  
synthesis although the mechanism was not known. It was shown that the cre element 
of poliovirus (mapping to position nt 4444 to 4505 of poliovirus type 1 2 C  coding 
sequence) was used as a template for the in vitro uridylylation of VPg, catalysed by 
the virus 3 D  R N A  polymerase [Paul et al., 2000]. Recently, examination of the 
sequential synthesis of poliovirus negative- and positive-strand R N A s  within 
preinitiation R N A  replication complexes showed that mutations that disrupted the 
structure of the cre prevented V P g  uridylylation and positive-strand R N A  synthesis 
but had no effect on the synthesis of negative-strand R N A  [Murray &  Barton, 2003]. 
These latest findings suggest that in poliovirus R N A  replication initiation of negative- 
strand R N A  synthesis is followed by initiation of V P g  uridylylation, termination of 
V P g  uridylylation and finally initiation of positive-strand R N A  synthesis [Murray &  
Barton, 2003],
1.6.2 Plant virus V P g
A s  mentioned above (Section 1.6), V P g  proteins are also found in plant 
viruses. For example, it is present in the mushroom bacilliform virus ( M B V ;  genus 
Barnavirus) [Revill et al, 1998], turnip mosaic virus ( T u M V )  and tobacco etch 
potyvirus (TEV) (genus Potyvirus) [Murphy et al, 1996], tomato ringspot virus
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(ToRSV; genus Nepovirus) [Rott et al, 1995], and pea enation mosaic virus ( P E M V ;  
genus Enamovirus) [Reisman &  de Zoeten, 1982]. The size of the V P g  protein varies 
between aproximatelly 3 k D a  in enamoviruses and nepoviruses [Wobus et al., 1998; 
W a n g  et al., 1999], 15-16 k D a  in barnavirus [Revill et al., 1998], and 22-24 k D a  in 
potyviruses [Riechmann et al., 1992]. Interestingly enough the barnavirus and 
enamoviruses V P g  genes seem to be located between the proteinase and the 
polymerase genes [Revill et al., 1998; W o b u s  et al., 1998] as opposed to animal 
viruses (picornaviruses, caliciviruses), where it is located before the protease gene 
(Section 1.6,6). Although potyvirus and nepovirus V P g  genes are located before the 
protease gene [Laliberte et al, 1992; W a n g  et al., 1999] just like in animal viruses, 
however, there is no amino acid sequence homology between potyvirus and nepovirus 
V P g s  [Mayo &  Fritsch, 1994].
The roles of potyvirus and nepovirus V Pg s  with respect to protein synthesis are not 
clear. Both potyvirus and nepovirus V P g s  bind to eIF(iso)4E [Wittmann et al., 1997; 
Leonard et al., 2000; Leonard et al., 2002], but the consequences of this interaction 
with repsect to translation initiation are suggestive, as elements in the 5’ U T R  of 
potyviral m R N A  direct cap-independent translation [Carrington &  Freed, 1990]. 
Studies performed on T u M V  revealed that its V P g  interacts with the translational 
eukaryotic initiation factor eIF(iso)4E [Wittmann et al., 1997], a factor involved in 
translation of capped m R N A s  (see Section 1.13.2), Initially, the yeast-two-hybrid 
system was used to screen a c D N A  library from Arabidopsis thaliana in order to 
identify proteins that interact with the viral protein genome linked (VPg)-protease 
(VPg-Pro) of T u M V .  The results revealed that VPg-Pro binds to eukaryotic initiation 
factor eIF(iso)4E of A. thaliana. Deletion analysis showed that the interacting domain 
of the T u M V  VPg-Pro resided within the V P g  region and that T u M V  VPg-Pro and
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V P g  had the same binding affinities for eIF(iso)4E. The interaction of V P g  and 
eIF(iso)4E was further confirmed by an ELISA-based binding assay (Section 3.8) 
[Wittmann et al., 1997]. Later studies showed that the ‘cap analogue’ m 7G T P  
inhibited formation of the T u M V  VPg-eIF(iso)4E complex in a competitive manner. 
In brief, ELISA-based binding experiments indicated that eIF(iso)4E from A. thaliana 
could simultaneously bind to both V P g  and m 7G T P  but ligand binding showed 
negative co-operativity. Lower ligand affinity results either from the binding of one 
ligand physically blocking the binding of the second ligand (e.g. binding of viral V P g  
to eIF4E can lower the affinity of eIF4E for the cap structure of host cell m R N A ,  thus 
inhibiting host cell translation) or binding of V P g  to eIF(iso)4E causes conformational 
changes to the factor rendering it incapable of binding to the cap structure and thus 
inhibiting host cell translation [Leonard et al., 2000]. The ELISA-based binding assay 
was also used to test the interaction between VPg-Pro as well as Pro of T o R S V  and 
eIF(iso)4E of A. thaliana [Leonard et al., 2002]. The results indicated that eIF(iso)4E 
interacted with both VPg-Pro and Pro of T o R S V ,  although retention of the factor was 
less for Pro than for VPg-Pro. This suggested that the interacting domain resided 
within Pro but the presence of V P g  conferred increased affinity of the viral protein for 
eIF(iso)4E. N- terminal deletion analysis determined that the major determinant of the 
Pro-eIF(iso)4E interaction resided within the first 93 amino acids of the Pro domain, 
with an additional domain within the C-terminal two-thirds of Pro possibly 
contributing to the binding [Leonard et al., 2002]. Furthermore, it was shown that 
addition of the cap analogue m 7G T P  inhibited formation of both VPg-Pro-eIF(iso)4E 
and Pro-eIF(iso)4E complexes [Leonard et al., 2002], but to a lesser extent than 
previously described for T u M V  VPg-Pro [Leonard et al., 2000]. Based on the results 
of the T o R S V  Pro-eIF(iso)4E interaction, the researchers suggested that the nepo virus
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Pro m a y  participate in genome circularization by acting as a bridging element 
between host initiation factors and viral R N A ,  thus promoting the assembly of 
translational complexes. The presence of the V P g  domain of the precursor T o R S V  
Pro possibly enhances its ability to bind eIF(iso)4E.
The importance of the VPg-eIF4E interaction in potyvirus infection has been 
demonstated in studies showing that mutant A. thaliana resistant to potyviral, but not 
nepoviral infection do not express eIF(iso)4E [Lellis et al, 2002; Duprat et al, 2002] 
and that a natural recessive resistance gene against potato Y  virus in pepper 
corresponded to eIF4E [Ruffel et al, 2002].
1.6.3 Rabbit haemmorhagic disease virus V P g
A  V P g  protein of 15 lcDa has been identified in R H D V  by radioiodination of 
R N A  [Meyers et al, 1991b]. In this work the presence of V P g  on both genomic and 
subgenomic R N A s  of R H D V  was proven by gel separation of the iodinated R N A  
species. In addition, protease treatment of R H D V  particles prior to phenol treatment 
allowed recovery of both genomic and subgenomic R N A  in the aqueous phase 
whereas without prior protease addition, these R N A s  partitioned into the organic 
phase suggesting the presence of a genome-linked protein. This treatment, together 
with ribozyme digestion, allowed location of the R H D V  V P g  to the 5’ end of the 
genomic (localized within the first 179 nucleotides) and subgenomic RNAs. 
Furthermore, Machin et al [2001] identified tyrosine-21 as the residue involved in 
uridylylation and therefore linkage between V P g  and the R H D V  w a l  R N A .
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1.6.4 Feline calicivirus V P g
In 1997, Herbert et al demonstrated the presence of F C V  V P g  on both the 
genomic and sub-genomic R N A s  (Figure 1.2). The calculated molecular mass of 
F C V  V P g  by computer analysis is 12.7 kDa. The observed mobility of V P g  expressed 
in bacterial cells or in an in vitro system corresponded to a molecular mass of 
approximately 14 k D a  [Sosnovtseva et al, 1999]. The observed mobility of the V P g  
protein found in virions was approximately 15.5 k D a  [Sosnovtsev &  Green 2000]. 
The 15.5 k D a  V P g  band was detected in polyacrylamide gels after boiling or RNase 
TI treatment of the virion sample. RNase TI cleaves R N A  chains between the 3 ’- 
phosphate group of a guanine ribonucleotide and the 5 ’-hydroxyl of the adjacent 
nucleotide, suggesting that a guanine ribonucleotide might remain associated with the
15.5 k D a  form of the V P g  protein after this treatment [Sosnovtsev &  Green 2000]. 
Immunoprecipitation analysis of radiolabeled virus proteins from FCV-infected 
C R F K  cell lysates using anti-VPg serum revealed a protein of the same mobility as 
the 14 k D a  V P g  protein expressed in bacteria, indicating that the predominant form of 
the V P g  protein in infected cells is different from the V P g  form (15.5 kDa) detected in 
mature virions [Sosnovtsev &  Green 2000]. The presence of different forms of V P g  
m a y  reflect modifications that the V P g  protein undergoes during viral replication.
1.6.5 V P g  sequence conservation a m o n g  caliciviruses
Comparison of the amino acid sequence of the putative F C V  VPg, (12.7 kDa; 
aa position 961 to 1072 of the O R F 1  polyprotein) with those of R H D V  (aa 994 to 
1109), Pan-1 (aa 1072 to 1185), and Southampton virus (aa 962 to 1080) showed 
identities of 58, 69, and 36%, respectively, in this region of the genome. These 
sequences share a c o m m o n  structural feature, with the presence of two hydrophilic
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amino acid clusters at the N-termini that can be detected by amino acid sequence 
analysis. The first cluster consists of basic residues, and the second contains acidic 
residues. The significance of this arrangement is not known. The deduced amino acid 
sequence of the F C V  12.7 k D a  protein does not show significant similarity to 
picomavirus V P g  sequences [Sosnovtseva et al, 1999].
1.6.6 M a p p i n g  of V P g  in the calicivirus g en om e
Genetic mapping of the R H D V  and Pan-1 V P g  from in vitro translation 
studies and proteolytic cleavage of the O R F 1  encoded polyprotein, revealed the 
presence of a 15 k D a  and 16 k D a  V P g  respectively, located between a putative 30 
k D a  nonstructural protein gene and the 3 C  protease gene [Wirblich et al, 1996; 
D u n h a m  et al., 1998]. Following picomavirus nomenclature, this protein corresponds 
to 3 B  (VPg). F C V  V P g  also precedes the protease gene but the gene product upstream 
of the V P g  gene has not been identified in proteolytic cleavage studies [Sosnovtseva 
et al, 1999; Sosnovtsev &  Green, 2000].
1.6.7 Role of V P g  in calicivirus m R N A  translation
Early studies on V E S V ,  S M S V  and Pan-1 have shown that treatment of 
calicivirus virion R N A  with proteinase IC results in loss of infectivity [Black et al. 
1978; Burroughs and Brown, 1978; D u n h a m  et al., 1998]. Herbert et al., [1997] 
showed that removal of V P g  from the full-length m R N A  greatly reduced the level of 
translation and showed that addition of the cap analogue m 7G T P  had no effect on the 
translation of F C V  m R N A .  Studies carried out by Sosnovtsev and Green [1995] 
showed that synthetic transcripts derived from a full length F C V  c D N A  clone did not
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require V P g  for infectivity, but needed to be artificially “capped” to be infectious. 
Studies carried out by Thumfart and Meyers [2002], regarding the recovery of wild 
type and recombinant viruses after transfection of c R N A  and c D N A  clones of F C V  
(strain 2024), were in perfect accordance with the results published by Sosnovtsev 
and Green [1995]. Briefly, upon production of an infectious F C V  c D N A  clone, R N A  
was transcribed and used in two reactions. In the first, a cap structure analogue was 
added during transcription with T 7  R N A  polymerase whereas in the second, no cap 
analogue was added. Analysis of the transcription products showed a small amount of 
full-length R N A  (> 7 kb). Following transfection of C R F K  cells with the in vitro 
transcribed R N A  (with and without the cap analogue) and R N A  derived from F C V -  
infected C R F K  cells, a cytopathic effect (CPE) was detected after cells were 
transfected with either R N A  isolated from FCV-infected cells or in vitro transcribed 
capped R N A .  However, the results indicated a considerable reduced efficiency in the 
generation of infectious virus from the synthetic R N A  compared to that from F C V  
R N A .  Transfection of the R N A  transcript that did not contain the cap analogue 
showed no CPE. The synthetic F C V  c D N A  contained a silent mutation (G instead of 
A  at nt 1309) that allowed for discrimination of the synthetic R N A  from the wild-type 
F C V  R N A .  Further proof for the recovery of infectious F C V  after transfection of the 
synthetic R N A  transcript was provided by analyzing the genome of the recovered 
virus for the presence of this mutation. R T - P C R  was performed with R N A  isolated 
from cells infected with the virus after the first passage posttransfection. Sequencing 
analysis of the R T - P C R  products showed the presence of the mutation in the R N A  of 
the virus derived from the in vitro transcribed R N A  only. The researchers concluded 
that the infectivity of the R N A  was clearly dependent on the presence of a 5’ cap
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structure, which served as a substitute for the V P g  linked to the wild-type F C V  
genome [Thumfart &  Meyers, 2002].
A  recent study that m a y  provide an insight to the role of calicivirus V P g  with respect 
to translation initiation was the finding that Norwalk virus V P g  binds to initiation 
factor eIF3 [Daughenbough et al, 2003]. Norwalk virus V P g  used as bait in a yeast- 
two-hybrid screen of an epithelial cell c D N A  library interacted with a c D N A  clone 
encoding the eIF3d subunit (66 kDa) of translation initiation factor eIF3. A  
glutathione S-transferase (GST) pull d o w n  assay using G S T - V P g  and (i) purified 
eIF3, (ii) in vitro translated radiolabeled eIF3d, and (iii) CaCo-2 cell extract showed 
binding of G S T - V P g  to eIF3d in all cases. Treatment of the CaCo-2 cell lysates with 
S7 nuclease prior to the pull d o w n  assay had no effect on the VPg-eIF3 interaction 
suggesting that R N A  did not mediate binding of V P g  to the factor. The region of N V  
V P g  at which eIF3d bound stronger was located in the C-terminal half of the protein 
(amino acid residues 70 to 138). In was also shown that the S n o w  Mountain strain of 
human calicivirus ( S M V )  V P g  also bound to eIF3 from CaCo-2 extract. Further G ST -  
V P g  pull d o w n  assays using CaCo-2 extracts showed the presence of eIF4GI, S6 
(protein of the 40S ribosomal subunit) and small amounts of eIF4E and eIF2a. The 
extent to which these interactions were direct with V P g  or mediated through eIF3 is 
unknown. The effects of the presence of V P g  on cap-dependent and cap-independent 
translation were also investigated. A  capped reporter m R N A  and an E M C V  IRES 
reporter m R N A  were translated in vitro, in the presence of increasing concentrations 
of GST-VPg. The results showed that translation was inhibited in a dose-dependent 
manner. The experiment was repeated using a reporter m R N A  preceded by the 
intergenic region (IGR)-IRES of cricket paralysis virus (CrPV) (Section 1.13.1), as 
this I G R  is unique in that assembly of the 80S ribosomes is possible in the absence of
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canonical initiation factors [Wilson et al, 2000b]. Complete inhibition of IGR-IRES 
m R N A  translation was achieved at higher concentration of G S T - V P g  than that 
required for inhibition of translation of the E M C V  IRES. The significance of this 
result is not k n o w n  [Daughenbough et al, 2003].
The hypothesis that V P g  m a y  act as a “cap analogue” or a signal for ribosome 
binding and assembly is yet to be proved. A  possible mechanism m a y  be related to 
direct interaction of calicivirus V P g  with ribosomal proteins. In this respect, the 
sequence similarity between calicivirus V P g  and one of the eukaryotic initiation 
factors, elFlA, [Dever et al, 1994] is of interest. The similarity reaches levels of 3 5 %  
between elFlA and Southampton virus sequences and 2 6 %  between elFlA and F C V  
sequences [Sosnovtseva et al, 1999]. elFlA is involved in initiation of translation in 
eukaiyotic cells and is essential for transfer of the initiator Met-tRNAj-eIF2-GTP 
ternary complex to the 40S ribosomal subunit. This factor is also thought to stimulate 
m R N A  binding to the 40S subunits and to be an accessory for other factors in 
dissociating 80S ribosomes [reviewed in Hinnebusch, 2000].
The evidence of the role of V P g  in F C V  translation already existing suggests that 
V P g  m a y  indeed substitute for the conventional ‘cap’ structure rendering calicivirus 
translation independent of the need of the conventional cellular cap-binding complex. 
Finally, the ability of V P g  to inhibit translation of capped m R N A  and m R N A s  that 
contain I RES sequences with different requirements for the eukaryotic initiation 
factors [Daughenbough et al, 2003] suggests that V P g  possibly inhibits translation 
through protein interactions c o m m o n  to both cap-dependent and internal initiation.
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1.7 C alicivirus non-structural proteins
A s  mentioned in Section 1.3.1 calicivirus genomes are organized into either 
two (Lagovirus and Sapovirus) or three (Vesivirus and Norovirus) open reading 
frames (ORFs). F C V  O R F 1  encodes a polyprotein, which is 1763 amino acids long 
(approximately 200 kDa) [Carter et al, 1992a]. The nonstructural proteins, including 
the genome-linked VPg, 2 C  helicase, 3 C  cysteine protease, and 3 D  RNA-dependent 
R N A  polymerase, are encoded in ORF1. These proteins, conserved among the non- 
structural proteins of picornaviruses, have been identified in all calicivirus genomes 
identified thus far [Lambden et al, 1993; Jiang et al., 1993; Meyers et al., 1991a; 
Tohya et al., 1991; Carter et al., 1992a; Neill 1994].
Previous studies have shown the production of several different sized polypeptides 
encoded by O R F 1  in virus-specific infected cells. Black and B r o w n  [1977] 
demonstrated the presence of two stable nonstructural proteins of 100 and 80 kDa, the 
65 k D a  capsid protein and a 120 k D a  short-lived nonstructural polypeptide, in S M S V  
infected cells. Fretz and Schaffer [1978] reported five SMSV-virus specific 
nonstructural proteins of 135, 80, 40, 35, and 29 k D a  in addition to the 60 k D a  capsid 
protein. Also, an 86 k D a  polypeptide was observed in cells grown at 43°C, a 
temperature that blocks post-translational cleavage. Studies by Carter et al. [1989a] in 
FCV-infected cells, also using elevated growth temperature, demonstrated the 
presence of two high molecular weight proteins of 125 and 123 k D a  in addition to 
polypeptides of 96, 84, 75, 70, 39, 36, and 27 detected under normal growth 
conditions. In a similar study, after producing monoclonal antibodies specific to FCV, 
Carter et al. [1989b] showed that FCV-infected cells contained six virus-specific 
proteins of 80, 78, 62 (capsid protein), 41, 35, and 29 kDa. In another study,
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Sosnovtsev and Green [2000] demonstrated the presence of precursor proteins of 120, 
90, 43, and 33 k D a  in FCV-infected cells that cross-reacted with anti-VPg antiserum. 
The above findings suggested that the nonstructural proteins are a result of proteolytic 
processing of a single major polypeptide during calicivirus infection.
1.7.1 Calicivirus 2C-like helicase
Sequence comparisons by Neill [1990] revealed that the F C V  polypeptides 
were similar to several picornavirus polypeptides. These included the 2 C  polypeptide 
(helicase), the 3 C  cysteine protease and the 3 D  RNA-dependent R N A  polymerase. In 
this study, it was demonstrated that the 2C-like region of the F C V  genome encoded a 
G x x G x G K T  nucleotide (NTP) binding motif as well as amino acid sequences that 
were shown to be conserved in the picornavirus 2 C  polypeptides. Molecular cloning 
and nucleotide and amino acid sequence analyses revealed that R H D V  also contains 
the 2C-like polypeptide, 3C-like cysteine protease and 3 D  RNA-dependent R N A  
polymerase motifs found in picornaviruses and F C V  [Neill, 1990; Meyers et al 
1991a]. Alignment of the respective F C V  (nt 1445 to 2101) [Neill, 1990] and R H D V  
(nt 1533 to 2130) [Meyers et al, 1991a] sequences revealed a high degree of 
similarity. As in F C V  [Neill, 1990], the R H D V  sequence for the putative 2C-like 
polypeptide contained the conserved nucleotide-binding motif G x x G x G K T  as well as 
most of the other residues important for the helicase function of the protein [Meyers et 
al., 1991a]. The characteristic nucleotide-binding motif of the 2 C  polypeptide has 
been identified by database searches and alignments with other calici- and 
picornaviruses for both groups of SRSVs, Norwalk virus and Lordsdale virus, 
respectively [Jiang et al., 1993; Dingle et al, 1995].
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The size of the 2 C  polypeptide (or NTPase) as defined by cleavage studies is 38.9 
k D a  for F C V  [Sosnovtsev et al., 2002], 41 k D a  for Southampton h um an  virus [Liu et 
al, 1996] and 37 k D a  for R H D V  [Meyers et al., 2000]. Evidence for NTP-hydrolysis 
activity of this protein has been reported for R H D V  [Marin et al., 2000] and human 
Southampton virus [Pfister &  Wimmer, 2001].
1.7.2 Calicivirus 3C-Iike cysteine protease
The F C V  cysteine protease-like sequences, in comparison to the 2 C  helicase 
and 3 D  RNA-dependent R N A  polymerase, had the lowest degree of similarity with 
the picomavirus cysteine proteases. However, the cysteine and histidine residues 
thought to be in the active site of the protease were present and were surrounded by 
amino acids conserved in the picomavirus cysteine proteases [Neill, 1990]. In 
addition, the presence of an approximately 40 k D a  region between the F C V  2C- and 
3 C  cysteine protease-like polypeptides was not similar to any k n o w n  picomavirus 
protein [Neill, 1990]. Amino acid alignment between the respective region of the 
putative F C V  3C-like cysteine protease [Neill, 1990] and the R H D V  sequence 
[Meyers et al, 1991a] showed a low degree of homology although the conserved 
stretch of amino acids including the predicted active site residues cysteine and 
histidine was identified in the R H D V  sequence [Meyers et al., 1991a]. Bacterial and 
in vitro expression studies led to identification of the R H D V  3 C  protease. The 
protease gene was found to be located in the central part of the R H D V  genome 
preceding the 3 D  RNA-dependent R N A  polymerase gene, similar to the 3 C  proteases 
of picornaviruses [Boniotti et al, 1994], Another study however, based on sequence 
analyses of the protease region of the R H D V  polyprotein, suggested that this protease 
was possibly closer in size to the picornaviral 2A  protease (16-17 kDa) than to the
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picornaviral 3 C  protease [Wirblich et al., 1995]. The size of the 3 C  cysteine protease 
as defined by cleavage studies is 19 k D a  for Southampton h uman virus [Liu et al.,
1999] and 15 k D a  for R H D V  [Wirblich et al., 1995]. In FCV, the 3 C  cysteine 
protease forms an active and stable complex with the 3 D  RNA-dependent R N A  
polymerase of 76 k D a  [Sosnovtsev et al., 2002]. Database alignments with other 
calici- and picornaviruses have identified the 3C-like protease sequence for Norwalk 
virus and Lordsdale virus [Jiang et al., 1993; Dingle et al., 1995].
1.7.3 Calicivirus 3 D  RNA-dependent R N A  polymerase
The order of the polypeptides encoded in the F C V  genome are the same as in 
the picornaviruses, with the RNA-dependent R N A  polymerase being located at the C- 
terminus of the F C V  polyprotein [Neill, 1990]. In addition, it was shown that the F C V  
RNA-dependent R N A  polymerase had regions similar to the picornavirus R N A  
polymerase sequences, including the Y G D D  sequence, which is thought to be in or 
near the active site of the polymerase [Neill, 1990]. The conserved Y G D D  motif has 
also been identified hi sequenes of three other caliciviruses, Norwalk virus [Jiang et 
al., 1990], R H D V  [Meyers et al, 1991a] and Lordsdale virus [Dingle et al, 1995]. 
According to amino acid alignment analyses of the putative polymerase, R H D V  (129 
residues) is most closely related to F C V  (56 identical residues out of 130), followed 
by N V  (30 out of 126), E M C V  (27 out of 124), Hepatitis A  virus (25 out of 127), 
F M D V  (21 out of 120), poliovirus (19 out of 118), and Hepatitis E  virus (19 out of 
120) [Meyers et al., 1991a]. Amino acid alignment analysis of the Norwalk virus 3D- 
RNA-dependent R N A  polymerase with R H D V ,  FCV, F M D V ,  E M C V ,  poliovirus, 
and hepatitis E  virus showed N V  to be more closely related to caliciviruses than 
picornaviruses [Jiang et al, 1993].
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Lopez Vazquez et al. [1998] and Wei et al. [2001] carried out studies that led to the 
purification and characterization of the active forms of R H D V  and F C V  R N A -  
dependent R N A  polymerase, respectively. In the case of R H D V  the active polymerase 
is thought to be a 58 k D a  protein derived from processing of the O R F 1  polyprotein by 
the viral protease between the protease and polymerase domains [Lopez Vazquez et 
al., 1998]. In the case of F CV, it was demonstrated and supported by biochemical 
data, that the active form of the F C V  polymerase is the bifiinctional protease- 
polymerase protein (76 kDa) and that processing between these two domains is not 
necessary for RNA-dependent R N A  polymerase activity [Sosnovtseva et al, 1999; 
Wei et al., 2001]. Cleavage studies defined the size of the R H D V  and Southampton 
human virus polymerase to be 58 k D a  [Wirblich et al., 1995] and 57 k D a  [Liu et al.,
1999], respectively.
1.7.4 F C V  O R F 1  polyprotein processing
In 1998 Sosnovtsev et al. [1998] reported the consistent presence of a virus- 
specific protein of approximately 78 k D a  in FCV-infected cells and in clones 
containing the entire or C-terminal part of ORF1. They proposed that this 78 k D a  
protein was an active proteinase complex that is analogous to the 3 C D  (protease- 
polymerase) protein complex of the picornaviruses. Sosnovtseva et al. [1999] fiirther 
demonstrated that the same proteinase mediated ht least four additional cleavages in 
the F C V  nonstructural polyprotein w hen analyzed in vitro. Expression of the region of 
F C V  O R F 1  encoded by nt 3233 to 4054 in an in vitro rabbit reticulocyte system 
(RRL) led to the synthesis of an active protease that specifically processed the viral 
non-structural polyprotein. The role of this active protease in viral replication was 
established by site-directed mutagenesis of the cysteine (Cys1193) residue in the
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putative active site, as this abolished autocatalytic cleavage of the non-structural 
polyprotein as well as cleavage of the viral precursor protein. Expression of the region 
encoding the C-terminus of F C V  O R F 1  (aa 942 to 1761) in bacteria aided direct N- 
terminal sequence analysis of the virus-specific polypeptides produced. The results of 
these analyses indicated that the protease cleaved at amino acid residues E %0/A961, 
e 1°71/S io72^ gi345/xi346 and £1419/q 1420 varjed cleavage efficiencies. One  of these
cleavage sites (E 1071/S1072) defined the N-terminus of a 692 amino acid protein. This 
protein (designated Pro-Pol), which contained both the protease and polymerase 
motifs, was found to be stable and proteolytically active in vitro and in infected cells. 
In summary, time-course analysis of the in vitro translation products derived from a 
full-length O R F 1  c D N A  clone (Urbana strain) showed the early appearance of a 
diffuse band containing high-molecular-mass precursors ranging from 120 to 140 k D a  
that were immunoprecipitated with antisera specific for the Pro-Pol protein. This 
study provided additional evidence for the identity of this protein as a potential active 
protease-polymerase precursor, indicated by immunoprecipitation analysis with 
region-specific antisera (anti Pro-Pol) and by its direct N-terminal sequence analysis, 
which localized the E/S cleavage site at residues 1071 to 1072 of the F C V  O R F 1  
polyprotein. Cleavage of the native F C V  polyprotein encoded by O R F 1  at tins site 
lead to the release of a stable 75.7 k D a  protein which accumulated with time, as 
demonstrated by time-course experiments in infected cells. However, the researchers 
[Sosnovteva et al., 1999] noted that cleavage of the Pro-Pol at the E 1345/T1346 site 
should lead to the appearance of proteins in infected cells with sizes 29.6 and 46.1 
kDa, with sequences overlapping the protease and polymerase motifs, respectively. 
Cleavage at E 14!9/ G 1420 would result in a putative polymerase lacking the conserved 
K D E L R  sequence characteristic of a number of picomavirus polymerases [Koonin,
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1991]. The E 960/A961 cleavage site defined the N-terminus of the 12.7 lcDa V P g  
protein (14 kDa, according to its moblility in S D S - P A G E )  previously mapped 
upstream of the 3 C  protease gene in R H D V  and Pan-1 calicivirus [Wirblich et al., 
1996; D u n h a m  etal, 1998].
The researchers suggested that the predominance of the Pro-Pol protein in infected 
cells and the inefficient cleavage between 3 C  and 3 D  observed in vitro m a y  reflect a 
mechanism for regulation of the amounts of folly processed proteinase and 
polymerase during viral replication. Alternatively, the stability of the Pro-Pol protein 
is suggestive of a mature protein exhibiting both proteinase and polymerase activities. 
Recently, the complete cleavage m a p  of the F C V  O R F 1  polyprotein essential for virus 
growth was determined [Sosnovtsev et al, 2002]. It was determined that the F C V  SC- 
like protease processes the N-terminal half of the O R F 1  polyprotein at cleavage sites 
E 46/A47, E 33I/D332, and E 685/N686. The proteins resulting from these cleavages had 
calculated masses of 5.6, 32, and 38.9 k D a  (designated as p5.6, p32, and p39 
respectively). In addition, the E 685/N686 cleavage site defined the N-terminus of a 30.1 
lcDa (p30) of unknown function. The studies of Sosnovtseva et al [1999] and 
Sosnovtsev et al. [2002] suggested that the F C V  O R F 1  polyprotein gene order was: 
p5.6-p32-p39 (NTPase)-p30-VPg-Protease-Polymerase (Figure 1.4). In addition, 
mutagenesis studies of an infectious F C V  c D N A  clone demonstrated that cleavage 
between each of these gene products (except the Pro-Pol) was critical for the growth 
of the virus.
1.7.5 O R F 1  polyprotein processing in other caliciviruses
In the case of R H D V  it was demonstrated that the R H D V  protease was 
functional and able to cleave polyprotein substrates in cis as well as in trans [Boniotti
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et al, 1994]. Briefly, full length transcripts were generated encoding a protein of 142 
k D a  that included the putative polymerase and the complete capsid protein (VP60). 
(1,315 amino acid residues starting at amino acid 1030 of the R H D V  ORF1). The 
protein sizes resulting after S D S - P A G E  analysis of the translation products were 60 
(VP60) and 80 k D a  suggesting that cleavage had occurred. In addition, when this 
transcript was split into two, the first encoding the N-terminus of the initial 
polyprotein and the second the polymerase and capsid proteins, no cleavage between 
the polymerase and the capsid occurred. Translation of the first transcript resulted in 
two products of 40 k D a  and 30 kDa. However, w hen the two transcripts were co­
translated a considerable increase in the V P 6 0  protein was observed. Site-directed
1010 i  i - j rmutagenesis studies revealed that the Cys and His residues were crucial for the 
proteolytic activity of the R H D V  protease [Boniotti et al, 1994]. A  complete m a p  of 
the cleavage sites involved in the processing of the R H D V  O R F 1  polyprotein was 
constructed after in vitro translation and transient expression of c D N A  construct 
studies [Wirblich et al., 1995, 1996; Martin Alonso et al, 1996; Meyers et al, 2000; 
Joubert et al, 2000]. Figure 1.4 shows a diagrammatic representation of the R H D V  
O R F 1  polyprotein processing along with the cleavage sites that led to the 
identification of the complete genome organisation of the R H D V  O R F 1  polyprotein. 
3C-cleavage sites in the O R F 1  non-structural polyprotein, have also been mapped as 
well for the Southampton h um an  virus [Liu et al, 1996, 1999b]. Figure 1.4 also 
includes the processing of the Southampton virus by the 3C-like protease as well as 
the specific amino acid cleavage sites.
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1.8 C alic ivirus structural proteins
Caliciviruses possess a single major capsid protein of 58-76 k D a  and a minor 
structural protein of a calculated mass of 12 kDa. Both the capsid and the minor 
structural protein are encoded by the subgenomic R N A .  The capsid protein is encoded 
in ORF2, whereas the minor protein from ORF3.
1.8.1 Feline calicivirus capsid protein
Neill et al. [1991] first demonstrated that the capsid protein of F C V  was 
encoded in the 3 ’ end of the genomic R N A  (ORF2) and therefore the 2.4 kb 
subgenomic R N A .  This region contained two open reading frames of which the larger 
one (ORF2), found in the 5 ’ end of the subgenomic m R N A ,  contained 2,004 bases 
encoding a polypeptide of 73,467 Da. This 73,467 D a  protein, as determined by 
sequence analysis, was in agreement with the size of the 76 k D a  capsid precursor of 
F C V  that was demonstrated by Carter [1989a]. Western blot analysis of FCV-infected 
cell extracts using a feline antiserum showed that the capsid protein was detectable at 
3 h post-infection. This is approximately 1 h after the 2.4 kb subgenomic R N A  is first 
detectable [Neill &  Mengeling, 1988]. The largest apparent 1 h increase in capsid 
protein accumulation occurs between 3 and 4 h post infection, the time at which the
2.4 kb m R N A  is actively being synthesized and reaches steady-state levels [Neill &  
Mengeling, 1988].
Frentz and Schaffer [1978] demonstrated that a 60 k D a  capsid protein was present in 
SMSV-infected cells. They were the first to suggest that the 60 ltDa capsid protein 
was generated from a precursor polypeptide of 86 kDa, a primary translation product 
of the subgenomic m R N A .  Previously, Black and B r o w n  [1977] had already 
demonstrated the presence of the 65 k D a  capsid protein in FCV-infected cells but
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were unable to identify a precursor molecule to the capsid protein. Carter [1989a] was 
the first to demonstrate the production of a 76 k D a  capsid precursor polypeptide in 
FCV-infected cells by Western blot analysis using polyclonal and monoclonal feline 
serum, and the use of methods (increased temperature) and reagents (p- 
fluorophenylalanine) that inhibited proteolytic processing. These findings clearly 
suggested that the mature capsid protein of F C V  is the result of a post-translational 
proteolytic cleavage. Identification and sequence determination of the capsid protein 
gene of F C V  involved the expression of a c D N A  O R F 2  construct (nt 2340 to 4380) in 
E.coli. Sequence analysis confirmed that the O F R 2  construct could encode a protein 
of 73,441 kDa. Monoclonal antibodies raised to an O R F 2  fusion protein ((3- 
galactosidase-ORF2 fusion protein) reacted specifically recognized the O R F 2  protein 
specifically with the mature capsid protein (62 kDa) from FCV-infected cell extracts 
and also with the 76 k D a  capsid precursor protein from FCV-infected cultures 
maintained at elevated temperature (inhibitor of proteolytic cleavage) [Carter et al, 
1992b]. The mature capsid protein resulted from removal of a polypeptide of 
approximately 11 kDa. N-terminal sequence analysis of purified, mature capsid 
protein confirmed and identified the position at which the capsid precursor is cleaved 
at amino acid position 125 [Carter et al, 1992b].
A  few years later, it was shown that cleavage of the F C V  capsid precursor is mediated 
by the 3 C  protease [Sosnovtsev et al, 1998]. Briefly, reticulocyte lysates containing 
the translated capsid protein from a c D N A  clone (containing the F C V  O R F 2  sequence 
nt 5316 through a poly (A) tail from the F C V  Urbana strain) were incubated at 37°C 
for various lengths of time and up to 12 hours showed no autocatalytic cleavage of the 
precursor polyprotein. In addition, no cleavage was observed from incubation of the 
precursor with lysates prepared from non-infected C R F K  cells. However, incubation
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of the precursor with a lysate prepared from FCV-infected cells resulted in the 
appearance of a band corresponding in size to the mature radiolabelled F C V  (Urbana 
strain; U R B )  capsid protein (60 kDa) immunoprecipitated from an FCV-infeeted 
C R F K  cell lysate. Furthermore, incubation of non-radiolabeled O R F 1  translational 
products (derived from a clone containing the U R B  O R F 1  sequence, nt 20-5303) with 
radiolabeled capsid precursor protein (derived from the in vitro translation of the U R B  
O R F 2  clone mentioned above) and subsequent S D S - P A G E  analysis revealed the 
presence of mature, cleaved protein. These results strongly suggested that the pro tease 
in the FCV-infected cells was responsible for the cleavage of the capsid precursor in 
trans [Sosnovtsev et al, 1998].
Expression of recombinant R H D V  capsid protein in insect cells either from an 
individual protein species (from an m R N A  analogous to the viral subgenomic R N A )  
or as part of a polyprotein that included the viral 3C-like protease and the R N A  
polymerase [Sibilia et al, 1995] led to the assembly of virus-like particles (VLPs) that 
were both morphologically and antigenically indistinguishable from wild-type 
purified virions [Laurent et al, 1994; Sibilia et al, 1995; Nagesha et al, 1995]. These 
V L P s  contained no R N A  but immunisations of rabbits with them were protected from 
challenge with wild-type virus [Laurent et al, 1994; Sibilia et al., 1995; Nagesha et 
al, 1995]. In a similar study it was shown that the F C V  capsid protein also assembled 
into V L P s  that were not infectious and contained no R N A ,  however, antigenic 
examination with monoclonal antibodies revealed no substantial differences from 
wild-type F C V  virus particles [Geissler et al., 1999].
Recently it was reported that, dining F C V  infection, the activation of caspases was 
responsible for proteolysis of the viral capsid protein as well as cellular apoptosis. 
Caspase-2 and -6 were shown to cleave the 62 k D a  F C V  capsid protein to a 40 k D a
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product in vitro [Al-Molawi et al., 2003]. The 40 k D a  form of the F C V  capsid protein 
was previously reported to occur during F C V  infection in cell culture at >  24 h  post 
infection [Carter et al., 1989b].
1.8.2 H u m a n  calicivirus capsid proteins
In an attempt to aid the classification of the Norwalk virus, Greenberg et al 
[1981] identified two proteins of 59 and 30 k D a  (a soluble protein) in the stool of N V -  
infected volunteers that were reactive with post-infection antiserum. Later, Jiang et al. 
[1992] produced the N V  capsid protein by expression of O R F 2  (nt 5346 to 6935) in 
insect cells using a recombinant baculovirus. Analysis of the expressed products 
showed that O R F 2  encoded a protein of 58 k D a  that was able to self assemble and 
form empty virus-like particles similar to active capsids in size and appearance. The 
antigenicity of the recombinant capsid proteins, as demonstrated by 
immunoprecipitation and E L I S A  assays of serum samples from NV-infected 
volunteers, was indistiguishable from N V  isolated from clinical samples [Jiang et al,
1992]. In addition a minor 34 k D a  protein was also isolated from infected insect cells. 
Amino acid sequence analysis of the N-terminus of the 34 k D a  protein indicated that 
the first 10 amino acids of the N-terminus of the 34 k D a  protein were identical to the 
10 amino acids between residues 217 and 226 of the 58 k D a  capsid protein, 
suggesting that the 58 k D a  capsid undergoes proteolytic cleavage [Jiang et al, 1992]. 
Hardy et al. [1995] investigated the hypothesis that N V  capsid protein might undergo 
specific proteolytic cleavage by treating recombinant N V  (rNV) particles with trypsin. 
A  predominant band of approximately 32 k D a  was observed w h e n  trypsin-treated 
r N V  was subjected to S D S - P A G E  analysis. Sequence analysis of the first 10 amino 
acids of the N-terminus of the 32 k D a  protein showed a trypsin-specific cleavage at
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the C-terminus of lysine 227 of the r N V  capsid protein [Hardy et al., 1995]. In 
addition, a chemotrypsin-treated r N V  produced a product of 34 lcDa as previously 
described [Jiang et al., 1992; Hardy et al., 1995]. In the same study, it was 
demonstrated that the. 30 k D a  soluble protein found in the stools of NV-infected 
volunteers [Greenberg et al., 1981] was in fact the 32 k D a  r N V  cleavage product. The 
N-terminus of the 30 k D a  protein was identical to that of the 32 k D a  cleavage product 
of the r N V  capsid, suggesting that the 30 k D a  soluble protein found in stool was 
produced by specific cleavage of the N V  capsid protein in vivo [Hardy et al., 1995]. 
As mentioned above (Section 1.8.1), during F C V  infection, the 62 k D a  mature capsid 
protein was also cleaved by caspases to produce a 40 k D a  product, suggesting that a 
similar event occurs during N V  infection.
The 58 k D a  capsid protein of the only S R S V  group II isolate, Lordsdale virus, 
has also been expressed in insect cells using recombinant baculovirus. The 58 k D a  
capsid protein self-assembled into VLPs, which clearly resembled ‘empty’ (no R N A )  
S R S V s  [Dingle et al., 1995].
1.9 C alicivirus O R F3 m inor structural protein
Sequence analysis of the 3’ end of the F C V  genome, revealed the presence of 
a small O R F  (ORF3). F C V  O R F 3  was composed of 318 nucleotides, encoding a 
polypeptide of 12,185 D a  [Neill et al., 1991]. Carter [1990] had previously reported 
the presence of the small O R F 3  at the 3’ terminus of the F C V  genome (F9 strain). 
Another F C V  isolate (Japanese F4 strain) was also shown to contain a small O R F  at 
the 3 ’ end of a c D N A  clone (containing the 3 ’-terminal 3516 nt of the genome which 
included the whole O R F s  2 and 3 and part of ORF1), which had 92.5% amino acid 
homology with the F C V  F9 strain [Tohya et al., 1991].
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The determination of the location of the smallest O R F  (ORF3) at the extreme 3* end 
of the F C V  genome by Neill et al. [1991] was further verified by Herbert et al 
[1996]. These studies demonstrated the presence of an ORF3-encoded polypeptide in 
FCV-infected cells using an antiserum raised against a bacterially expressed 
bacteriophage T 7  gene-ORF3 fusion protein. In vivo 32P  labelling of R N A s  from 
FCV-infected cells provided definitive data that O R F 3  is expressed only by a 2.4 kb 
subgenomic R N A  and not by a potential 0.5 kb m R N A  species [Carter, 1990], In 
addition, in vitt'o translation studies of a synthetic R N A  copy of the 2.4 kb 
subgenomic R N A  of F CV, containing both O R F s  2 and 3 that directed the synthesis 
of both O R F 2  and O R F 3  polypeptides, further contributed to the suggestion that the
2.4 kb m R N A  is functionally bicistronic [Herbert et al, 1996].
The presence of a minor structural protein encoded by the 3’ end of O R F 1  of R H D V  
(10 kDa), Norwalk virus (23 kDa) and F C V  (8.5 kDa) R N A  genomes has been 
demonstrated [Wirblich et al., 1996; Glass et al, 2000; Sosnovtsev &  Green, 2000]. 
Comparative analysis of radioactivity incorporated into virion proteins during in vivo 
labelling studies indicated that the O R F 3  protein is present in one or two copies per 
virion. The mobility of the 8.5 k D a  O R F 3  protein present in virions was similar to 
that of the O R F 3  protein found in FCV-infected cells or expressed in bacteria and was 
consistent with data reported by Herbert et al [1996]. Direct N- and C-terminal 
sequence analysis of the purified O R F 3  protein obtained by expression in bacteria 
demonstrated the presence of intact, uncleaved termini, suggesting that the observed 
difference between the calculated (12 kDa) and the apparent (8.5 kDa) masses in 
S D S - P A G E  was not due to proteolytic processing of the protein [Sosnontsev &  
Green, 2000]. Although the role of the O R F 3  structural protein is not yet known, it is 
proposed it m a y  play a role in the encapsidation of the viral genome into particles
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through interactions with both the capsid protein and the viral R N A  [Neill et al., 
1991; Wirblich et al., 1996; Green et al., 2002a].
1.10 C alic ivirus replication
The replication strategy of caliciviruses has not been characterized as 
extensively as for m any positive-strand R N A  viruses. A n  interesting aspect of the 
replication and genome organization of the caliciviruses is that they appear to have 
traits of picorna-, toga- and coronaviruses. The genome organization and R N A  
replication resembles that of the toga- and coronaviruses. The F C V  non-structural 
polypeptides are encoded near the 5 ’ end of the genomic R N A ,  as are those of the 
toga- and coronaviruses. A n  abundant subgenomic R N A  is produced during infection 
[Ehresmann &  Schaffer, 1977; Black et al., 1978], which is derived from the 3 ’ end of 
the genomic R N A  [Neill &  Mengeling, 1988]. This subgenomic R N A  encodes the 
capsid (structural) protein [Ehresmann &  Schaffer, 1977; Black et al., 1978], as does 
the subgenomic R N A  of the togaviruses, which is also derived from the 3’ end of the 
viral genome [Strauss &  Strauss, 1982]. The non-structural proteins that are encoded 
by F C V  resemble those encoded by (and are translated in the same order as) those of 
the picornaviruses (2C helicase, 3 C  cysteine protease and 3 D  RNA-dependent R N A  
polymerase) [Neill, 1990]. Thus, the caliciviruses m a y  represent an intermediate 
between the picorna- and togaviruses.
A  breakthrough in the effort to enhance the understanding of calicivirus replication 
was the study carried out by Green et al [2002a] in the isolation of enzymatically 
active replication complexes from FCV-infected cells. The researchers demonstrated 
the isolation of a membranous fraction from FCV-infected cells that could synthesize 
viral R N A  in vitro, in the presence of magnesium salt, ribonucleotides, and an A T P -
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regenerating system. The newly synthesized R N A  was characterized by Northern blot 
analysis, which showed the production of both full-length (8.0 kb) and subgenomic- 
length (2.5 kb) R N A  molecules similar to those synthesized in FCV-infected cells. 
The viral structural proteins associated with the fraction included both the 60 k D a  
major capsid protein, which was the most abundant viral protein detected, and the 12 
k D a  minor structural protein encoded by ORF3. Nonstructural proteins associated 
with the fraction included the precursor polypeptides Pro-Pol (76 kDa) and p30-VPg 
(43 kDa), as well as the mature nonstructural proteins p32 (derived from the N- 
terminal region of the O R F 1  polyprotein), p30 (the putative “3A-like” protein), and 
p39 (the putative nucleoside triphosphatase). The presence of the cleaved, mature 
nonstructural proteins within the F C V  replication complexes suggests that nearly all 
of the virus-encoded proteins play a role in R N A  replication.
The isolation of enzymatically active replication complexes containing both 
viral and cellular proteins m a y  elaborate the contributions of the virus and the host to 
F C V  R N A  replication. It is possible that the membranes of the replication complex 
might form a scaffold for packaging of the viral R N A  into assembling capsids. 
Localization of the viral proteins within the replication complexes by immunostaining 
m a y  give insight into this process [Green et al, 2002a].
1.11 Effects on host cell follow ing F C V  infection
Infection of C R F K  cells by F C V  results in the production of F C V  capsid 
protein at approximately 3 h post-infection [Neill and Mengeling, 1988]. C R F K  cells 
appear shrunken and round and are detached from the surface of the flask at 5 to 6 h 
post-infection, an indication of cell lysis and subsequent release of F C V  virions. 
Recently it was shown that F C V  infection triggered apoptosis in the host cell that was
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mediated by caspases. Caspases were responsible for the cleavage of the viral capsid 
protein in infected cells, and in vitro studies with recombinant caspases showed that 
caspase-2 and -6 cleaved the F C V  capsid protein [Al-Molawi et al, 2003].
The mechanism of translation of F C V  or any calicivirus m R N A  is still not understood 
and little is known. T o  date it has been shown that inhibition of host cell protein 
synthesis in FCV-infected cells is accompanied by cleavage of eIF4GI and II 
[Willcocks et al, in preparation]. Interestingly, the cleavage occurs closer to the N- 
terminus of the protein so, unlike cleavage in picornaviruses, the domains for eIF4E 
and eIF3 remain linked in F C V  infection [Willcocks et al, in preparation].
As  this thesis focuses on the mechanism of translation initiation on calicivirus m R N A ,  
here follows a review of the process of protein synthesis that normally occurs in 
eukaryotic cells.
1.12 Protein synthesis in eukaryotes
The process of protein synthesis in eukaryotic cells involves the stages of: (i) 
initiation, (ii) elongation, and (iii) termination. Since initiation is believed to be the 
major regulatory step of translation and most of the virus-induced inhibition of host 
cell protein synthesis takes place in the initiation step (for example the well studied 
and defined examples of picornaviruses), this review will describe the process of 
initiation of translation.
1.12.1 Initiation
Protein synthesis occurs in the cytoplasm of eukaryotic cells following the 
transcription of the D N A  to m R N A  and some post-transcriptional modifications (e.g.
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splicing) of the messenger molecule that occur in the nucleus. The process of 
initiation of translation has been reviewed extensively [Pain 1996; Hershey &  
Merrick, 2000; Pestova &  Hellen, 2000].
Initiation of translation involves the sequential binding of a 40S ribosomal 
subunit to m R N A  and eventually the binding of the 60S ribosomal subunit. The 
process itself can be divided into four steps, which are summarized below and in 
Figure 1.5:
(i) Establishment of the 40S ribosomal subunit pool by dissociation of 80S 
ribosomes into 40S and 60S subunits
(ii) Formation of the 43 S pre-initiation complex
(iii) Binding of the 43 S pre-initiation complex to m R N A  and migration to the
correct initiation codon and
(iv) Binding of the 60S ribosomal subunit to form an 80S ribosome at the 
initiation codon to commence translation.
(i) Dissociation of 80S ribosomes
Generation of the 40S ribosomal subunits, necessary for the formation of
the pre-initiation complex, is achieved by binding of eukaryotic initiation factors
(elFs) to both the 60S and the 40S subunits, in an environment where the 80S 
inactive form is the most prominent species under normal physiological 
conditions. Binding of the initiation factors results in the dissociation of the 80S 
ribosome to its 60S and 40S subunits. The two initiation factors that bind 
exclusively to 40S subunits are eIF3 and elFlA, preventing association with the 
60S subunit [reviewed in Hershey &  Merrick, 2000; Pestova &  Hellen, 2000]. The
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Figure 1.5 : Diagrammatic representation of the mechanism of initiation of protein 
synthesis.
Adapted from an illustration by Pain [1996]. The four stages (i-iv) outlined in Section 1.12.1 
are positioned to the left of the diagram.
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mechanism by which this dissociation is achieved has not been clearly defined 
although studies suggest that it could be due to an allosteric effect (i.e. a change in 
the structure of the 40S subunit upon eIF3 binding) [Srivastava et al., 1992]. 
Another factor, eIF6, has been shown to bind to the 60S subunit, preventing its 
association with the 40S subunit [Raychaudhuri et al, 1984], although the role of 
eIF6 as a translation initiation factor has been questioned [Si &  Maitra, 1999].
(ii) Formation of the 43S pre-initiation complex
The next step is the assembly of the so-called ‘ternary complex’ 
comprising the initiator methionyl-tRNAj molecule (which is required for the 
identification of the initiator A U G ) ,  a protein factor eIF2, and a molecule of GTP. 
eIF2 is actually found as a binary complex with G T P  (eIF2-GTP), which 
distinguishes the initiator tRNAj from elongator t R N A s  by recognizing the 
methionyl residue and the A - U  base pair (A1-U72) at the end of the acceptor stem 
[Wagner et al., 1984; Farrugio et al, 1996]. The ternary complex binds to the 40S 
ribosomal subunit to form the 43S pre-initiation complex. Stability of the complex 
is aided by the presence of eIF3 and elFlA [Chaudhuri et al, 1997; 1999]. 
Eventually, eIF2-GTP is released from the 43S pre-initiation complex as eIF2- 
G D P .  Recycling of n e w  eIF2-GTP ready to bind n e w  tRNAj is achieved in the 
presence of eIF2B (or GEF; guanine nucleotide exchange factor) [reviewed in 
Hershey &  Merrick, 2000].
(iii) Binding of the 43S pre-initiation complex to m R N A
The characteristic feature at the 5 ’ end of eukaryotic m R N A s ,  the cap 
structure ( m 7G pp pN )  is the target region at which the cap-binding protein eIF4E
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(part of the eIF4F complex along with eIF4A and eIF4G) binds the m R N A  
molecule. eIF4F binding to the m R N A  has been shown to be necessary for 
optimal binding of the 43 S pre-initiation complex to the m R N A .  The affinity of 
the eIF4F complex for capped m R N A s  depends on accessibility of the cap 
structure (e.g presence of stable secondary structures close to the cap) [Kozak, 
1989b; 1991] and the presence of eIF4E-binding proteins (4E-BP) [Pause et al, 
1994; Haghighat et al., 1995; Altmann et al., 1997]. Indeed, it appeal's that an 
unstructured m R N A  region is of significant importance for the binding of the 43 S 
pre-initiation complex to the 5 ’ end of the m R N A .  This is achieved with the aid of 
the eIF4A subunit of the eIF4F complex, eIF4B, and A T P  [Rozen et al, 1990]. 
eIF4A assumes an ATP-dependent R N A  helicase activity which is stronger in the 
presence of eIF4F (i.e. as part of eIF4F rather than free), eIF4B (an RNA-binding 
protein which greatly stimulates the R N A  helicase activities of eIF4A and eIF4F) 
and also eIF4H (same properties as eIF4B indicated by its homology with the N- 
terminal region of eIF4B) [Lawson et al., 1989; Rozen et al., 1990; Jaramillo et 
al, 1991; Pause &  Sonenberg, 1992; Methot et al, 1994; Lorsch &  Herschlag, 
1998a; Richter-Cook et al, 1998; Rogers et al., 1999]. Another factor, eIF4G (the 
largest subunit of eIF4F) acts as a scaffold protein bringing together all the 
essential factors necessary for the binding of the 43 S pre-initiation complex to the 
m R N A .  Indeed, it has been shown that eIF4G has domains which bind to eIF4E 
(N-terminus domain) [Lamphear et al., 1995; Mader et al., 1995], eIF3 (central 
domain), and eIF4A (central and C-terminus domains) [Imataka &  Sonenberg, 
1997]. The co-operative action of eIF4A, eIF4B and/or eIF4H, eIF4E and eIF4G 
leads to unwinding of any secondary structure present in the vicinity of the 5’ end 
of the m R N A ,  thus allowing attachment of the 43S pre-initiation complex to the
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m R N A .  The initiation complex then migrates along the m R N A  molecule in search 
of the A U G  initiation codon. Recognition of the initiator A U G  by the scanning of 
the 43 S pre-initiation complex is based in the codon-anticodon interaction. It has 
been shown that mutation of the Met-tRNAj anticodon leads to recognition of a 
cognate codon (not A U G )  [Cigan et al., 1988]. The initiation factor eIF2 has also 
been implicated in the recognition of the A U G  codon [Donahue et al., 1988], as 
has elFl and eIF5 [reviewed in Donahue, 2000].
For most cellular m R N A s ,  selection of the initiator A U G  and subsequent joining 
of the 60S subunit is preceded by a process described by Kozak as the “scanning 
model”. According to this model, the 40S ribosomal subunit carrying Met-tRNAj 
and various initiation factors binds initially at the 5 ’end of the m R N A  and then 
migrates, stopping at the first A U G  codon in a favourable context for initiating 
translation. The process requires energy in the form of A T P  [reviewed in Kozak, 
1989a]. The scanning model predicts that proximity to the 5 ’ end in 90-95% of the 
cases determines which A U G  codon will function as the initiator codon. The 
initiator A U G  must be in a good context, which is defined by the presence of 
purines at positions -  3 and +  4 (usually G); the A  of A U G  is considered as +  1. 
The importance of the purine (usuahy A) in position -  3 is manifested by its 
universal conservation amongst vertebrate, fungal, and plant m R N A s  and the fact 
that mutation at this site affects translation more than any point mutation in a 
different site of the consensus sequence. In the absence of a purine in position -  3, 
a G  in position +  4 is then essential for efficient translation. The first A U G  m a y  be 
bypassed if it is in a poor context resulting in the migration and subsequent 
binding of the 43 S initiation complex to the next A U G  codon (leaky scanning) 
[reviewed in Kozak, 1989a].
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(iv) Binding of the 60S ribosomal subunit
Binding of the 60S ribosomal subunit requires the previous dissociation of the 
participating factors. At this point, the 43 S pre-initiation complex contains eIF2, 
eIF3 and possibly eIF5 (GTPase), which binds both of these factors [Chaudhuri et 
al., 1994]. A s  the complex is arrested at the initiator A U G  (by its codon/anticodon 
base pairing), eIF5 hydrolyzes eIF2-GTP so eIF2-GDP and Pi are released from 
the 40S subunit, leaving the initiator t R N A  at position P. Since eIF5 also binds 
eIF3, subsequent release of that factor from the ribosomal complex occurs as well. 
Another factor, eIF5B has been shown to participate in this process. eIF5B is a 
ribosome-dependent GTPase and its presence seems to greatly assist the function 
of eIF5 [Pestova et al, 2000]. G T P  hydrolysis by eIF5B is not required for 80S 
ribosome formation but causes rapid dissociation of Met-tRNAj w h e n  added to 
43 S initiation complexes. The actual mechanism of the 60S ribosomal subunit 
joining to the 40S subunit is still not clear but it appears to be a rather slow 
process. This is indicated by the observation that occasionally half-mers 
(polysome +  40S ribosomal subunit not joined with 60S subunit) are present along 
with polysomes. Once the 80S ribosome is formed elongation of the protein 
commences [reviewed in Heshey &  Merrick, 2000; Pestova &  Hellen, 2000].
1,12.2 Elongation
Once the initiator A U G  is firmly placed in the P  site of the 80S ribosome, the 
elongation step of protein synthesis commences. The process requires the presence of 
factors called eukaryotic elongation factors (eEFs) and GTP, and the addition of 
aminoacyl-tRNAs to the A  site of the ribosome is repeated in a cyclic manner. Firstly, 
the aminoacyl-tRNA, eEFl and G T P  form a complex prior to binding to the A  site of
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the ribosome and this process is codon-dependent (i.e. correct match between codon 
and anticodon). Then, the G T P  hydrolyzes, releasing eEFl and G DP .  Formation of 
the peptide bond between neighbouring codons is catalyzed by the peptidyl 
transferase centre of the 60S ribosomal subunit. Finally, translocation, the movement 
of m R N A  by three nucleotides so a n e w  codon is placed in the A  site, occurs and 
requires eEF2 and GTP. At this point the ribosome begins the next cycle of elongation 
[reviewed in Merrick &  Nyborg, 2000].
1,12.3 Termination
Once the peptide chain has been completed, the ribosome has reached the stop 
codon (UAA, U G A  or UAG). The process requires G T P  bound to a factor termed 
release factor (RF), which recognizes the stop codon and induces the hydrolysis of the 
aminoacyl linkage releasing the peptide and RF-GDP. Efficient termination leads to 
recycling of the ribosomes and m R N A  for another round of translation. Occasionally, 
a small percentage of the 40S subunits m a y  remain attached to the m R N A ,  therefore 
allowing for reinitiation [reviewed in Welch et al, 2000].
1.13 A ltern ative  translational mechanisms
The scanning model described in Section 1.12.1 is a mechanism which relies 
on the presence of a cap structure at the 5 ’ end of cellular m R N A s  (cap-dependent 
translation) and the encounter of the Hist A U G  initiaton codon. However, there are 
deviations from this translational mechanism, most of which emerged mainly from the 
study of viral systems. Several examples of these exist, suggesting that viruses have
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acquired these translational mechanisms from cellular systems, and manipulated them 
to suit their survival and existence.
1.13.1 Internal initiation
As mentioned in Section 1.12.1, most eukaryotic m R N A s  possess a cap 
structure (m7GpppNp) to which eIF4E binds, together with the 43S pre-initiation 
complex. A n  exception to this is the initiation of translation in picornaviruses. 
Picornavirus m R N A  is uncapped and the 5 5 U T R s  are several hundred nucleotides 
long and include regions of secondary structure so stable that it can prevent scanning 
of the 40S subunit from the 5 ’end. Most interestingly, the 5’ U T R  of these m R N A s  
contain A U G  codons in good context that would be difficult to by-pass if actually 
encountered by scanning 40S subunits. However, these A U G  codons in picornavirus 
5’ U T R s  are not conserved, even between strains of the same species, and there is no 
conservation of the length of the reading frames either. Therefore it is unlikely that 
these A U G s  are functional initiation sites that could support ribosome scanning 
[Jackson et al, 1994; reviewed in Belsham and Jackson, 2000]. In this cap- 
independent translation, the 43 S pre-initiation complex binds directly to an internal 
site, either very close to the authentic A U G  initiation codon or up to 160 nucleotides 
upstream of it, depending on the virus and the species concerned [reviewed in Jackson 
et al, 1994]. Studies demonstrated the ability of the 5’U T R  of poliovirus to direct 
internal initiation of eukaryotic m R N A s  by placing it between two cistrons in a 
dicistronic construct. It appeared that active translation of the downstream cistron was 
promoted even under conditions which prevent cap-dependent translation of the 
upstream cistron [Pelletier &  Sonenberg, 1988]. Other studies examined the effect of 
progressive deletions in the 5 ’ U T R  of picornaviruses and concluded that a minimum
52
Chapter 1 Introduction
region is required to direct internal initiation of the downstream cistron. These 
regions, approximately 450 nucleotides long, are n o w  k n o w n  are Internal Ribosome 
Entry Site elements or I RES elements [Pelletier and Sonenberg, 1988; Jackson et al.,
1994]. Another study demonstrated that the encephalomyo carditis virus ( E M C V )  
I RES could direct ribosomes to translate artificial circular m R N A s ,  further enhancing 
the notion of internal initiation [Chen &  Sarnow, 1995].
Apart from picornaviruses (e.g. encephalomyocarditis virus, foot-and-mouth disease 
virus, hepatitis A  virus, poliovirus), which were the first group of viruses in which 
IRES elements were discovered, other groups of viruses such us hepatitis C  virus and 
the closely related pestiviruses (e.g. classical swine fever virus) were found to carry 
such elements in their* 5’ U T R s  [Rijnbrand et al, 1997; Honda et al, 1999]. These 
IRESs are smaller in size (approx 300-330 nucleotides) and their translation 
mechanism appears to be different from that of picornaviruses. Briefly, these IRESs 
seem to promote initiation of protein synthesis independently of the presence and 
participation of eIF4A, eIF4B, and eIF4G or any requirement for A T P  hydrolysis 
[Pestova et al, 1998; Pestova &  Hellen, 1999]. In picornaviruses, almost all of the 
initiation factors participating in the classical cap-dependent translation are required 
since the I RES elements bear domains which specifically bind these factors. The only 
exception is the requirement for eIF4E, a factor that is redundant in cap-independent 
translation of picomavirus IRESs [reviewed in Belsham &  Jackson, 2000].
I RES elements have also been found in insect viruses. Sequence analysis of the viral 
R N A  genomes of cricket paralysis virus (CrPV) showed that its m R N A  is uncapped 
and dicistronic. A n  upstream O R F  encoding the viral nonstructural proteins is 
separated by an intergenic region (IGR) from a downstream O R F  encoding the 
structural proteins. Both the I G R  region and the 5 5 U T R  of C r P V  and Rhopalosiphum
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padi virus (RhPV) have been shown to contain I RE S  elements [Wilson et al, 2000a; 
W oolaway et al, 2001]. However, the I G R  did not contain an A U G  codon 
(methionine) that could be used as the initiator codon for the synthesis of the capsid 
(structural) protein. Instead IGR-IRES initiation of translation was directed by a G C U  
codon (alanine) in the absence of Met-tRNAj and in the ribosomal A  site. The P  site 
(CCU, proline) at the N-terminus of O R F 2  was occupied by a G G A  triplet (glycine) 
present in a stem-loop of the I G R  element, thus forming a pseudoknot structure. This 
pseudoknot structure is thought to aid positioning of the ribosome on the m R N A  for 
subsequent translation of the capsid protein [Wilson et al, 2000b]. The mechanism of 
methionine-independent initiation of capsid protein synthesis has been demonstrated 
in a number of other insect viruses, including Drosophila C  virus (DCV), R h P V  and 
Himetobi P  virus (HiPV). Except from alanine ( G C U  or G C A )  as the initiation codon 
(which is the case in all the above insect viruses), glutamine (CCA) acts as the 
irritation codon in translation of the capsid protein of another insect virus, Plautia stali 
intestine virus (PSIV) [reviewed in RajBhandary, 2000; McCarthy, 2000].
Since the discoveiy of cap-independent translation and the IRES, several 
cellular m R N A s  have been reported to utilize this mechanism [reviewed in Carter et 
al, 2000]. However, caution is required since the features of longer than usual 5’ 
UTRs, A U G  codons not participating in initiation of translation, or a high G C  content 
indicative of secondary structure, that m a y  be observed in a number of cellular 
m R N A s  and are characteristics of viral IRESs, do not necessarily imply the presence 
of an IRES. The first cellular IRES-containing m R N A  to be identified was that 
encoding the immunoglobulin heavy chain binding protein (BiP) [Macejak &  Sarnow,
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1991]. It was identified because of its ability to be translated in polio virus-infected 
cells, whe n  translation of the host cell m R N A  was inhibited [Sarnow, 1989],
Other cellular m R N A s  that have been found to contain an I RES include the 
Antennapedia and Ultrabithorax m R N A s  of Drosophila melanogaster involved in 
development, mammalian fibroblast growth factor 2 m R N A  (FGF2), insulin-like 
growth factor II (IGF2), and c-myc involved in growth/cancer, death-associated 
protein 5 (DAP5) and X-linked inhibitor of apoptosis (XIAP), involved in 
programmed cell death (apoptosis), vascular endothelial growth factor (VEGF) 
involved in stress, platelet-derived growth factor B  (PDGF/c-sw), involved in 
differentiation [reviewed in Carter et al, 2000].
1.13.2 Leaky scanning
This mechanism is usually employed w h e n  the first A U G  is in poor context so 
the 40S subunit bypasses it until it encounters an initiation codon in good context. 
This is seen in some viruses that encode two products from one m R N A .  If both A U G  
codons are in the same open reading frame, with no termination codon in between, the 
result is two products, with the longer having an N-terminal extension. If the A U G s  
are in different open reading frames, two distinct proteins are translated. A n  example 
is the envelope protein (Env) of H I V - 1 which is translated from an m R N A  which also 
encodes the V p u  protein but in a different frame [reviewed in Pain, 1996; P e ’eiy &  
Mathews, 2000].
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1.13.3 Reinitiation
Reinitiation accounts for those m R N A s  that have one or more A U G  codons 
upstream of the authentic initiation codon. If that upstream codon is in a good context, 
it will inhibit translation by intercepting the 40S scanning subunit. Usually, these 
upstream A U G s  are followed closely by an in-frame termination codon, therefore a 
short peptide is encoded. After translation of some such minicistrons, some of the 
40S subunits remain associated with the m R N A  and continue scanning until they 
finally encounter the authentic initiation codon and translation is initiated. Reinitiation 
is most c o m m o n  in prokaryotes and occurs rarely in eukaryotes. O ne  example of 
reinitiation in eukaryotes is that of the Saccharomyces cerevisiae transcription factor 
G C N 4  m R N A .  The reasons for the existence of this mechanism are not yet clear but 
could be involved in translational control [reviewed in Hershey, 1991; Kozak, 1991],
1.13.4 Ribosome shunting
The mechanism of ribosome shunting involves the loading of the 40S 
ribosomal subunit to the 5 ’ end of the m R N A ,  initially it m a y  scan, but then it 
translocates to the downstream initiation codon, directed by ‘shunting elements’ such 
as a hairpin structure. 40S ribosome shunting is thought to decrease the requirement 
of m R N A s  for eIF4F during initiation by reducing the need for m R N A  unwinding 
activity (through the eIF4A subunit of eIF4F). It was first characterized in cauliflower 
mosaic virus ( C a M V )  m R N A  and related pararetroviruses, and was also observed in 
Sendai virus, papillomaviruses and in adenovirus late m R N A s  [reviewed in Pe’ery &  
Mathews, 2000]. For example in adenovirus late m R N A s ,  ribosomal subunits appear 
to scan through the 5 ’ end of the tripartite leader, skip a region of secondary structure, 
and finally land and continue scanning for a short distance [reviewed in Schneider,
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2000]. Although there are many examples of viral m R N A s  that employ ribosome 
shunting, the mechanism is very poorly understood.
1.13.5 Frameshifting
S o m e  viral m R N A s  have sequences that predispose ribosomes to shift reading 
frames. These sites shift reading one base in either the 5’ direction (-1 frameshifting) 
or in the 3’ direction (+1 frameshifting). The mechanisms underlying the two types of 
events appear to be different both structurally and mechanistically, suggesting that 
they control different aspects of proper frame maintenance. Retroviruses, a number of 
positive-strand R N A  viruses amongst those caliciviruses (see Section 1.3), and some 
plant R N A  viruses to name a few, use -1 frameshifting to express a defined ratio of a 
long fusion protein to a shorter protein, thus differing in their C-terminus. 
Frameshifting is usually involved in the expression of replicases such as reverse 
transcriptase in retroviruses or RNA-dependent-RNA polymerases in most other 
viruses. Frameshifting occurs at a ‘slippery sequence’ (usually a heptamer) and is 
enhanced by the presence of a stimulator in the form of a downstream pseudoknot, 
which m a y  act to pause ribosomes [reviewed in Brierley, 1995; Farabaugh et al., 
2000].
1.13.6 Roles of untranslated regions in translation
Translation initiation facilitated primarily by the 3 ’ U T R  of the m R N A  has 
been demonstrated in plant viruses such as satellite tobacco necrosis virus (STNV) 
and barley yellow dwarf virus ( B Y D V )  [Timmer et al., 1993; W a n g  et al., 1997]. 
S T N V  R N A  is naturally uncapped and has a short 5’ U T R  (29 nt) and a long 3 ’ U T R
57
Chapter 1 Introduction
(619 nt) that play a critical role in the translation of viral m R N A .  Deletions and 
mutations introduced in the 5 ’ U T R  and the 3 ’ U T R  reduced the efficiency of 
translation by 3-fold and 20-fold respectively, but this decrease was reversed by 
‘capping’ in both cases. In vitro translation of chimeric m R N A s  comprising the 
coding region of rabbit a-globin and either the 5 ’ U T R ,  3 ’ U T R  or both the 5’ and 3 ’ 
U T R s  of S T N V  m R N A  indicated that both the 5’ and 3 ’ U T R s  were necessary for 
cap-independent translation [Timmer et al, 1993], Similar results were obtained from 
studies with B Y D V  in which a ‘translational enhancer’ sequence (TE) located in the 
3 ’ U T R  of B Y D V  was described [Wang et al, 1997]. However, w h e n  the 3’ T E  
element was moved to the 5 ’ U T R ,  it alone sufficiently promoted translation 
initiation, suggesting that the 5 ’ U T R  m a y  play a role only for the long distance 3 ’-5’ 
communication. Translation of both uncapped m R N A  containing the 3’ T E  element in 
cis and capped m R N A  lacking the 3 ’ U T R  was inhibited by addition of 3 ’ T E  in 
trans. This inhibition was reversed by addition of the initiation factor eIF4F, 
suggesting that the 3 ’ TE, like the 5 ’ cap structure, requires eIF4F for translation 
initiation [Wang et al 1997]. In a yeast-three-hybrid assay, the 3 ’ T E  element of 
S T V R  was found to bind eIF4E, and in a UV-cross linking assay with eIF4F, the 3’ 
T E  element cross-linked only with the eIF4E component of eIF4F (see Section 1.14). 
It is yet unclear whether the eIF4F remains bound to the 3’ T E  element or it is 
transferred from the 3 ’ U T R  to the 5 ’ U T R ,  although the three-dimensional geometiy 
is appropriate for the eIF4G component to position the 40S ribosomal subunit at or 
near the 5’ end of the m R N A  [reviewed in Jackson, 2000].
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1.14 The e IF 4 F  complex
Below follows a brief description of the three canonical eukaryotic initiation 
factors, eIF4A, eIF4E, and eIF4G, which bind to the m R N A  molecule and are 
necessary for protein synthesis. These three factors are subunits of the initiation factor 
4F (eIF4F), which in mammalian and yeast cells play an important role in translation 
in terms of ribosome alignment on the m R N A  molecule to be translated and 
recognition of the correct A U G  initiation codon. The presence of these factors is 
essential for translation of viral proteins in the host cell and it m a y  be logical to 
assume a role in calicivirus protein synthesis.
1.14.1 eIF4A
eIF4A is an ATP-dependent R N A  binding protein (ATPase), and R N A  
helicase [Rozen et al, 1990; Jaramillo et al, 1991; Lorsch &  Herschlag 1998a; 
Rogers et al, 1999]. It is the prototypic member of the D E A D  box family of proteins, 
a family of helicases named alter the eight conserved motifs of the family [Linder et 
al, 1989; Gorbalenya &  Koonin, 1993], It is thought to disrupt secondary and tertiary 
structure in the 5’ U T R  of capped m R N A s  to facilitate ribosomal attachment and 
permit scanning to the correct A U G  initiation codon. eIF4A is the only one of the 
three initiation factors of the eIF4F complex (Section 1.14) that is found to participate 
in translation both as an individual protein and as a component of eIF4F [Conroy et 
al, 1990]. However, eIF4A is likely to gain access to the m R N A  only as part of eIF4F 
and recycle through it [Yoder-Hill et al, 1993; Pause et al, 1994], as eIF4A in the 
eIF4F complex exhibits approximately 20-fold more efficient R N A  helicase activity 
than free eIF4A [Ray et al, 1985; Rozen et al, 1990]. O f  the three factors of the 
eIF4F complex, eIF4A is the most abundant in cells, although its content varies
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between different cell lysates. Its function as a helicase allows the bidirectional 
unwinding of R N A  duplexes, in the presence of A T P  to which eIF4A also binds. 
However, eIF4A alone was shown to unwind only 3-5 base pairs, and this is 
sometimes insufficient to destabilize the duplex [Lorsch &  Herschlag, 1998a,b; 
Rogers et al., 1999]. It was further demonstrated that the presence and association of 
eIF4B and eIF4H with eIF4A prevents reassociation of single stranded R N A ,  leading 
to unwinding of larger duplexes [Rozen et al, 1990; Pause &  Sonenberg, 1992; 
Methot et al, 1994; Lorsch &  Herschlag, 1998a; Rogers et al, 1999]. 
eIF4A was found to be present in mammalian, yeast and plant cells. There are several 
isoforms of eIF4A isolated from the different sources. In yeast the two isoforms of 
eIF4A (TIF1 and TIF2) are very similar [Linder &  Slonimski, 1988]. In mammals, 
eIF4A has three isoforms; eIF4AI (44.4 kDa), eIF4AII (46.3 kDa) and eIF4AIII 
(approximately 45 kDa), all sharing similar characteristics, but only the first two 
appear to function in vivo in protein synthesis [Li et al, 1999]. In an attempt to 
biochemically characterise h um an  eIF4AIII, Li et al. [1999] demonstrated that while 
eIF4AIII exhibited RNA-dependent ATPase activity and ATP-dependent R N A  
helicase activity, it failed to substitute for eIF4AI in an in vitro reconstituted 40S 
ribosome binding assay. eIF4AIII inhibited translation in a reticulocyte lysate system. 
In addition it was shown that eIF4AIII binds only to the central region of eIF4G, as 
opposed to eIF4AI which binds both to the central and carboxy-terminal domains of 
eIF4G (see Figure 1.6) [Li et al, 1999].
eIF4A is required for both cap-dependent and cap-independent translation [Pause et 
al, 1994; Pestova et al., 1996a]. Its essential function has been established from 
studies demonstrating that translation of all m R N A s  is abolished in yeast extracts in
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which the eIF4A gene is disrupted [Blum et al., 1992] and that mutants of mammalian 
eIF4A act as dominant negative inhibitors of translation [Pause et al, 1994].
U p o n  infection of mammalian cells with F M D V ,  eIF4A is cleaved to produce a 
smaller but stable C-terminal product by the F M D V  3 C  protease [Belsham et al,
2000]. A  further study revealed that only eIF4AI (i.e. not eIF4AII) is cleaved in vitro 
by the F M D V  3 C  protease [Li et al, 2001]. Cleavage of eIF4A is unique to F M D V  
and does not occur in poliovirus or E M C V  infection. A n y  role in calicivirus 
translation, apart from its function as an ATP-dependent R N A  polymerase and R N A  
helicase, has not yet been established.
1.14.2 eIF4E
eIF4E is the cap-binding subunit of the trimeric factor eIF4F. It is an 
approximately 25 k D a  molecule, conserved from yeast to man. Several isoforms exist 
in almost all eukaryotic cells, with humans having two (eIF4E and eIF(iso)4E) [ R o m  
et al, 1998]. As opposed to eIF4A which is abundant, eIF4E is thought to be limiting 
in cells [Hiremath et al, 1985; R a u  et al., 1996].
eIF4E alone binds to the cap structure at the 5 ’ end of the m R N A  molecule with high 
specificity and moderate affinity. Several studies have demonstrated that w h e n  eIF4G 
binds to eIF4E (see Figure 1.6) the binding affinity between the protein complex and 
the capped m R N A  increases ten-fold versus eIF4E alone [Haghighat &  Sonenberg,
1997]. Substitution of interacting residues in either eIF4G or eIF4E impairs or 
abolishes their association [Mader et al, 1995; Tarun &  Sachs, 1997; Ptushkina et al, 
1998; Pyronnet et al, 1999]. This reduced affinity of eIF4E for eIF4G presumably 
favours cap-independent translation. Indeed, it has been demonstrated both in 
mammalian and yeast cells, that a family of proteins binding to eIF4E (4E-BPs)
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inhibit cap-dependent translation by binding to eIF4E and thus hindering its 
interaction with eIF4G, in a competitive manner [Pause et al1994; Haghighat et al, 
1995; Altmann et al, 1997].
The role of eIF4E as a cap binding protein assumes that it is not involved in cap- 
independent translation. In picomavirus infection (with the exception of hepatitis A  
virus) eIF4E seems to be redimtant as a consequence of cleavage of eIF4G of the 
domain (amino terminal) that binds eIF4E [Krausslich et al, 1987; Devaney et al, 
1988; Medina et al, 1993; Belsham et al, 2000]. In contrast, a number of studies 
showing that the uncapped satellite tobacco necrosis virus ( ST NV )  bears a motif at its 
3 ’ U T R  that binds eIF4E [reviewed in Jackson, 2000], mutant A. thaliana plants 
resistant to potyvirus infection do not express eIF(iso)4E [Lellis et al., 2002] and that 
a natural recessive resistance gene which corresponds to eIF4E confers protection to 
pepper plants against potato Y  virus infection [Ruffel et al., 2002], suggest that cap- 
independent translation m a y  not be necessarily eIF4E-independent. Indeed, the 
demonstration of the binding between eIF(iso)4E and the V P g  of T u M V ,  also an 
uncapped virus, [Wittmann et al, 1997; Leonard et al., 2000] (see Section 1.6.2) 
strongly supports the notion of alternative binding sites of eIF4E and a role in cap- 
independent translation.
1.14.3 eIF4G
eIF4G is the third subunit of the heterotrimeric eIF4F initiation complex. 
Mammalian, yeast and plant cells all contain two eIF4G isoforms differing from each 
other significantly in size, sequence and activities. Mammalian eIF4GI and eIF4GII 
share 4 6 %  identity at the amino acid level and have a molecular mass of 171.6 and
176.5 kDa, respectively [Yan et al, 1992; Gradi et al., 1998; Imataka et al, 1998].
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Several studies have concluded that eIF4G plays an important role in coordinating and 
enhancing the activities of factors involved in initiation of translation, including the 
cap-binding activity of eIF4E and the poly-(A) binding activity of P A B P  (located at 
the N-terminal third; amino acid residues 1 to 634) [Lamphear et al., 1995; Mader et 
al., 1995; Imataka et al., 1998], the R N A  helicase activity of eIF4A and the 40S 
ribosomal subunit and m R N A  binding activities of eIF3 (central domain; amino acid 
residues 635 to 1039) [Imataka &  Sonenberg, 1997]. The C-terminal third contains a 
second eIF4A-binding site [Imataka &  Sonenberg, 1997] and a binding-site for the 
protein kinase M n k l  [Pyronnet et al., 1999] (Figure 1.6). These findings, together 
with the observation that eIF4G binds directly, and in some cases specifically, to 
m R N A  through a putative R N A  recognition motif (RRM)-like domain [Pestova et al, 
1996b; Kolupaeva et al, 1998], suggest that eIF4G serves as a scaffolding protein by 
bringing together various components of the initiation pathway.
Picornaviruses induce host cell shut-off of protein synthesis by cleaving the amino- 
terminal one third of eIF4G, thus depriving the host cell of eIF4E (Figure 1.6) 
[Lamphear et al, 1993]. Host cell shut-off due to cleavage of eIF4G also occurs 
during h um an  immunodeficiency virus type 1 (HIV-1) [Ventoso et al., 2001] and 
indeed in FCV-infected cells [Willcocks et al, in preparation -  Section 1.12].
1.15 The role o f cellu lar proteins in  translation
Along with the canonical initiation factors, other cellular proteins have been 
identified in playing a role in viral protein synthesis. These include the La 
autoantigen, the polypyrimidine tract binding protein (PTB), the unr protein, the 
poly(A)-binding protein (PABP), and the poly(rC)-binding protein-2 (PCBP-2). 
Below follows a brief description of those which participate in virus translation.
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1.15.1 Role of L a  autoantigen in translation
The La protein is a human antigen (also called SS-B and p52) that is 
recognized by antibodies from patients with autoimmune disorders such as Sjogren’s 
syndrome and systemic lupus erythematosus [reviewed in Tan, 1989]. It belongs to 
the R N A  recognition motif ( R R M )  superfamily of R N A  binding proteins [Chambers 
et al., 1988]. L a  was the first cellular protein identified by a functional assay, to bind 
the region of the poliovirus IRES representing the putative ribosome entiy site. 
Addition of La to rabbit reticulocyte lysates proved to stimulate poliovirus m R N A  
translation and to improve the accuracy of selection of the correct initiation site 
[Meerovitch et al., 1989; 1993]. The L a  autoantigen was also found to greatly 
stimulate in vitro translation of H I V - 1 m R N A  in a R R L  system. It was demonstrated 
that only L a  and not any other initiation factor could stimulate translation of the HIV- 
1 m R N A  containing the /ram-activation response element (TAR) which is found at 
the 5 ’ end of the viral m R N A  [Svitkin et ah, 1994b]. It is n o w  k n o w n  that deletion of 
the C-terminal half of L a  abolishes the ability of the protein to enhance translation of 
both the poliovirus and HIV-1 m R N A s  and that La exists as a dimer under native 
conditions [Svitkin et al, 1994b; Craig et al, 1997]. The E M C V  IRES was also found 
to cross-link L a  (or at least a protein of 52 kDa). The 52 k D a  protein bound to several 
fragments of the E M C V  IRE S  provided that another protein, p57 (or P TB )  did not 
cross-link strongly to the same IRE S  fragment, suggesting that the binding sites of the 
52 and 57 k D a  proteins overlap [Witherell &  Wimmer, 1994]. Later it was 
demonstrated that translational suppression of the E M C V  IRES by surplus P T B  was 
relieved by addition of purified L a  in PTB-depleted rabbit reticulocyte lysates [Kim &  
Jang, 1999].
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The only evidence that L a  binds calicivirus m R N A  comes from studies with the 
Norwalk virus. Binding of L a  to the 5 ’ U T R  of N V  was demonstrated by U V  cross- 
linking, mobility supershift and immunoprecipitation assays. It was also shown that 
binding of L a  and other cellular proteins (see Sections 1.15.2 & 1.15.3) occurs within 
the first 110 nucleotides of the 5’ U T R  of N V  m R N A  [Gutierrez-Escolano et al,
2000]. These results indicate the binding of L a  to the 5’ U T R  of calicivirus m R N A  
but further studies including other members of the Caliciviridae, as well as functional 
assays, need to be conducted before establishing a role for La in calicivirus m R N A  
translation.
1.15.2 Role of poly(rC)-binding proteins -1 and -2 in translation
Cellular proteins PCBP-1 (-38 kDa) and P CB P- 2  (-39 kDa) (also referred to 
as h n R N P s  El and 2 or aCPl and aCP2) are two nucleic acid-binding proteins, that 
together with the heterogeneous ribonucleopartite (hnRNP)-K, correspond to the 
major cellular poly(rC)-binding proteins. Both proteins contain three K-homologous 
(KH) domains which share similarity with other K H  domain proteins (e.g. fragile-X 
protein F M R 1 )  and have more than 8 0 %  amino acid identity. Then m R N A s  are 
widely expressed and have been localised both in the cytoplasm and the nucleus 
[Assheim et al, 1994; Leffers et al, 1995].
Roles attributed to P C B P s  include their functional associations with the 5’ U T R  of the 
a-globin and the tyrosine hydroxylase m R N A s  in complexes that impart stability 
[Kiledjian et al, 1995; W a n g  et al, 1995; Paulding & Czyzyk-Krzeska, 1999]. In 
addition, a number of functions relating to viral infection have been ascribed to the 
proteins. It has been shown that the interaction of P CB P- 2  with the polio virus 5 ’ U T R  
performs dual functions in the life cycle of the virus by facilitating the initiation of
66
Chapter 1 Introduction
both viral protein synthesis and viral RNA synthesis [Blyn et a l ,  1997; Parsley et a l ,
1997]. These findings were further confirmed by Garmanic and Andino who proposed 
that PCBP could also function in a mechanism involving accessory proteins o f viral 
origin to regulate the processes o f translation and replication [Gamarnik & Andino, 
1997; 1998].
PCBPs facilitate viral translation through the interaction with both the first stem-loop 
domain (which folds into a cloverleaf-like structure) and stem-loop IV o f the 
poliovirus 5’ UTR [Blyn et a l  1995; 1996; 1997; Gamarnik & Andino, 1997; Parsley 
et a l ,  1997]. Both PCBP-1 and PCBP-2 form a low affinity complex with the 
cloverleaf RNA, but together with viral protease 3 CD they are incorporated into a 
high affinity ternary ribonucleoprotein (RNP) complex [Andino et a l ,  1990; 1993]. 
Ternary complex formation is required for positive strand RNA synthesis [Andino et 
a l  1990]. Moreover, the interactions o f  the PCBPs and 3 CD with the cloverleaf RNA 
seem to determine whether the genomic RNA is used as a template for protein 
synthesis or RNA replication. Binding PCBPs to the cloverleaf stimulates viral 
translation, whereas binding o f 3CD down-regulates translation [Gamarnik & Andino,
1998].
Walter et a l  [1999] provided evidence for the existence o f distinct 
mechanisms for the internal initiation o f translation between type I (enterovirus and 
rhinovirus) and type II (cardiovirus and aphthovirus) picornavirus IRES elements. In 
vitro translation reactions conducted in HeLa cell extracts that were depleted o f 
PCBP-2, showed a significant diminished capacity to translate reporter RNAs 
containing the type I elements o f poliovirus, coxsackievirus, or human rhinovirus 
linked to a luciferase ORF. However, the addition o f recombinant PCBP-2 restored 
translation. In addition, RNA electrophoretic mobility-shift analysis demonstrated
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specific interactions between PCBP-2 and both type I and type II picornavirus IRES 
elements. However, the translation o f reporter RNAs containing type II IRES 
elements o f  EMCV and FMDV was not PCBP-2 dependent. These data demonstrated 
that PCBP-2 was essential for the internal initiation o f translation on picornavirus type 
I IRES elements but was dispensable for translation directed by the structurally 
distinct type II elements [Walter et a l , 1999].
In addition to its documented functions in the poliovirus life cycle, PCBP-2 was also 
shown to play a role in the translation o f HAV mRNA [Graff et a l ,  1998]. 
Furthermore, human papillomavirus type 16 (HPV16), a member o f the 
Papovaviridae, has evolved a mechanism to utilize PCBP-2 as a regulator o f late gene 
expression [Collier et a l ,  1998]. In caliciviruses, no functional role for PCBP-2 has 
been established, although binding to the first 110 o f  the 5’ end o f the NV genome has 
been demonstrated by a supershift-mobility assay [Gutierrez-Escolano et a l ,  2000].
1.15.3 Role of PTB in translation
The polypyrimidine tract binding protein (PTB), also known as heterogeneous 
nuclear ribonucleoprotein I (hnRNP-I) has roles both in pre-mRNA splicing and in 
initiation o f  cap-independent translation. Initially it was identified as a 57 kDa (p57) 
protein involved in translation o f poliovirus mRNA by mobility shift electrophoresis 
assays [Del Angel et a l ,  1989]. Later, UV cross-linking studies demonstrated that a 
ribosome-associated 57 kDa protein from rabbit reticulocytes was linked to two 
distinct sites o f the FMDV IRES. The first binding site consists o f a conserved hairpin 
structure, whereas the second binding site contains an essential pyrimidine-rich region 
without obvious secondary structure. Competition experiments indicated that the
68
Chapter 1 Introduction
complexes with the two binding sites were formed by a single 57 kDa species [Luz & 
Beck, 1990; 1991].
A polypyrimidine tract o f around 12 to 15 nucleotides in length is found at the 3 ’ end 
o f all picomavirus IRES elements [Kuhn et al., 1990, Nicholson et al., 1991; Pestova 
et al., 1991]. Many studies have investigated the requirement o f this tract for IRES 
function, primarily determining if the sequence or length are o f importance in 
picomavirus mRNA translation. In the case o f  the PV IRES a sequence o f UUUC(C) 
at the 3 ’ end o f the tract was critical for translation whereas other mutations were 
tolerated [Iizuka et al., 1989; Nicholson et al., 1991; Pestova et a l ,  1991; Belsham & 
Sonenberg, 1996]. Mutation o f  this pyrimidine-rich region in FMDV to G residues 
had a negative effect on translational efficiency o f the IRES, although this could have 
been due to creation o f a secondary structure that interfered with IRES activity. Other 
studies in EMCV and Theiler’s murine encephalomyelitis virus (TMEV) have shown 
that complete substitution o f the pyrimidines to purines led to a reduction o f 
translational activity by approximately 30% [Kaminski et al., 1994; Pilipenko et al., 
1994]. These findings suggest that the requirement for the polypirimidine tract differs 
between differenct IRESs.
A cellular 57 kDa protein has been shown to interact with the 5’ UTR o f EMCV 
mRNA [Jang & Wimmer, 1990]. Systematic mutation studies o f the conserved 
oligopyrimidine tract by Pestova et al. [1991] revealed that it was essential for in vitro 
translation o f  poliovirus and EMCV. The function o f this element is related to its 
position relative to other m -acting domains. A 57 kDa protein from the ribosomal salt 
wash fraction o f HeLa cells was found to bind upstream o f the oligopyrimidine tract. 
Translation o f polio vims mRNA in vitro was strongly and specifically inhibited by 
competition with the p57-binding domain o f  the EMCV 5’ UTR indicating a probable
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role for p57 in poliovirus mRNA translation. These results led to the suggestion that 
the oligopyrimidine tract plays an important role in translation o f poliovirus mRNA 
[Pestova et al., 1991]. Further studies showed that both the EMCV and HRV 5’ UTRs 
could be cross-linked to a 58-60 lcDa protein doublet present in HeLa cell extracts in 
higher amounts than in reticulocyte lysates. In the same study it was shown that 
p58/60 is very closely related to PTB [Borman et a l ,  1993]. Hellen et al. [1993] 
demonstrated that the 57 kDa protein shares physical, biochemical and antigenic 
properties with PTB. In addition it was shown that immunodepletion o f PTB from 
HeLa cell extracts inhibited translation o f  poliovirus and EMCV mRNAs but retained 
activity for translation o f capped mRNAs. Additional studies confirmed binding o f 
PTB to multiple sites in the PV and EMCV 5’ UTRs [Hellen et a l ,  1994; Witherell et 
a l ,  1993; Witherell & Wimmer, 1994], Borovjagin et al. [1994] showed that PTB 
played an essential role in EMCV IRES translation after demonstrating that addition 
o f purified recombinant PTB to ascites cells extracts depleted o f endogenous PTB 
exerted a strong enhancing effect on the activity o f the EMCV IRES. It was further 
demonstrated that this enhancing effect was at the level o f pre-initiation complex 
formation. When various PTB deletion mutants were tested, it was found that 
initiation o f translation on the EMCV IRES required the full-length protein. However, 
the PTB-depleted lysate retained the capacity for internal initiation promoted by the 5’ 
UTR o f TMEV and o f hepatitis C vims, and in neither case did addition o f 
recombinant PTB stimulate internal initiation, suggesting there could be a difference 
within the picornavirus (and non-picornavirus) IRES elements for their PTB 
requirement. Truncated versions o f PTB comprising the C-terminus UV cross-linked 
with the EMCV IRES with a lower affinity than full-length PTB but stronger than 
when only the N-terminus was tested. In fact, binding affinities o f  truncated PTB
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were abolished when the C-terminus was deleted. Activity o f the IRES was retained 
with fiill-length PTB and was abrogated when either the C- or N-termini were deleted 
[Kaminski el a l ,  1995]. The findings o f  these binding experiments are consistent with 
results from Conte et al. [2000]. In this study it was demonstrated that PTB has four 
RNA recognition motifs (RRMs) o f  which RRM-3 and RRM-4, found in the C- 
terminus, contribute to RNA binding specificity as demonstrated by mutational 
analyses. Truncation o f  PTB to the C-terminus 3 and 4 RRM domains reduced 
binding to both the EMCV IRES domain 1 and FMDV IRES, although the loss of 
affinity was somewhat less for the FMDV IRES [Conte et a l ,  2000]. It was 
previously demonstrated that PTB was a component o f the 48S and 80S ribosomal 
initiation complexes formed with FMDV IRES-containing RNA in RRL. It was 
suggested that PTB first binds to the IRES and then the small ribosomal subunit joins 
this PTB-IRES complex. In addition, it was demonstrated that mutations in the major 
PTB-binding site o f the FMDV IRES (stemloop H) interfered with the formation o f 
initiation complexes, translation efficiency and PTB cross-linking in RRL, suggesting 
an important function o f PTB in FMDV IRES-directed initiation o f translation 
[Niepmann et a l ,  1997].
As mentioned in Section 1.15.1 the only calicivirus studies that confirm binding o f 
cellular proteins have been carried out on Norwalk virus mRNA. In addition to La, it 
was demonstrated that PTB also binds to the 5’ UTR o f NV and binding was also 
confined to the first 110 nucleotides [Gutierrez-Escolano et a l,  2000]. The potential 
role o f  PTB in FCV translation still remains to be assayed and determined.
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1.16 Thesis aims
The objective o f this project was to conduct studies to aid the understanding o f 
the mechanism o f translation initiation 011 FCV mRNA, thus establishing a model for 
initiation o f translation in caliciviruses. In order to do so, the project had the following 
aims:
(i) Expression and purification o f  FCV VPg and production o f antiserum
(ii) Analysis o f the purified FCV VPg from FCV-infected CRFK cells in order 
to establish specific reactivity with the anti-VPg antibodies and possible 
interactions with other viral proteins
(iii) Analysis o f potential interactions between FCV VPg and the components 
o f the eIF4F complex
(iv) Analysis o f potential interactions between cellular proteins (including the 
canonical initiation factors, eIF4A, eIF4E, and eIF4G) and the 5’ and 3 ’ 
ends o f the FCV genome.
Chapter 1_________________________________________________________Introduction
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Chapter 2
General Materials and Methods
Specific methods used in a particular study are outlined in the appropriate 
results chapters. Details o f  common solutions and buffers used are found in appendix 
4. Standard methods were used [Sambrook et a l , 1989] for DNA manipulations 
unless otherwise stated.
2.1 Restriction enzyme digestion
For analytical digests 1 pg o f plasmid DNA was digested in a 20 pi volume 
reaction containing 2 pi lOx restriction enzyme buffer (supplied), 18 pi sterile 
distilled water (dELO) and 2 units o f restriction enzyme (Promega or New England 
Biolabs). Reactions were incubated at 37°C for 2 h, analysed by agarose gel 
electrophoresis and visualised using a UV transilluminator (UVI tec). Larger scale 
digests for preparation o f fragments for ligation were also performed, using 10 pg o f 
DNA (unless otherwise stated) in a 50 pi volume. Five pi were analyzed by agarose 
gel electrophoresis and results were visualised using a UV transilluminator.
2.2 Agarose gel electrophoresis
Agarose (GibcoBRL) gels (1% or 2% (w/v)) containing 0.5 pg/ml ethidium 
bromide (Sigma) were made with 1 x TAE buffer (A ppendix  4). Gels were run at 150
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V in 1 x TAE buffer. For RNA analysis, 1% (w/v) agarose gels containing 0.5 pg/ml 
ethidium bromide made with 1 x TBE buffer (Appendix 4) were used. Gels were run 
a t l 5 0 V i n l x  TBE buffer. Results were visualised using a UV transilluminator.
2.3 Purification of DNA by gel extraction
Gel extractions (from 1% agarose gels) were performed using the QIAquick 
gel extraction kit (Qiagen) as described in the manufacturer’s protocol.
2.4 Ligations
DNA ligations were performed in a 20 pi reaction volume containing 100 ng 
o f the digested and purified “vector”, 200 ng o f  the fragment to be inserted, 2 pi 10 x 
T4 DNA ligase buffer (Promega), 2 units o f T4 DNA ligase (Promega), to 20 pi with 
sterile dIUO. The ligation mixture was incubated at 16°C o/n. The following day, 
competent bacterial cells were transformed with 5 pi o f the ligation reaction as 
outlined in Section 2.6.
2.5 Preparation of competent bacteria for transformation
Glycerol or commercial (Promega) stocks o f  E.coli cells (DH5a, JM109, 
BL21(DE3) pLysS) were grown in 25 ml LB broth (Appendix 4) o/n in a 37°C 
shaker. From this culture, 50 pi were added to another 25 ml LB broth and grown at 
37°C for approximately 3 h or until the OD6oo reached 0.4-0.6. Cells were pelleted at 
5000 rpm for 5 min. The pellet was resuspended in 20 ml cold lOOmM CaCfe/lO mM
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Tris pH 7.5 (Appendix 4) and placed on ice for 20 min. Cells were spun again and the 
pellet resuspended in 1 ml cold 100 mM CaCh/10 mM Tris pH 7.5.
2.6 Transformation of competent E.coli cells
Competent E.coli cells (100 pi) were added to 0.5 pg plasmid DNA or 5 pi 
ligation mixture and incubated for 10 min on ice. Cells were heat shocked at 37°C for 
5 min. LB broth (1 ml) was added and the mixture incubated at 37°C for another hour. 
Cells were pelleted at 8000 lpm  for 1 min and 1 ml supernatant removed. The pellet 
was resuspended in the remaining supernatant and spread onto LB agar (Appendix 4) 
plates containing selection antibiotic(s) (see Appendix 4 for appropriate selection 
antibiotic) and grown overnight at 37°C. Several colonies were picked the following 
day and minipreps performed to screen for correct constructs. Alternatively, following 
transformation, cells were added to 200 ml LB broth plus antibiotic and grown 
overnight at 37°C for maxipreps the next day.
2.7 Small scale plasmid purification (plasmid minipreps)
Single colonies (between 6-12) were picked from transformation plates 
(Section 2.6) and grown overnight at 37°C in 5 ml LB broth plus antibiotic(s). Cells 
(1.5 ml) were pelleted at 8,000 rpm for 1 min. The pellets were resuspended in 100 pi 
Resuspension solution (Appendix 4), and mixed by vortexing. Cells were lysed with 
200 pi Lysis solution (Appendix 4). Neutralisation solution (150 pi) (Appendix 4) 
was added, and the mixture placed on ice for 5 min. Samples were centrifuged at
14,000 rpm for 5 min. The plasmid-containing supernatants were transferred to new 
sterile eppendorfs, phenol/chloroform extracted and ethanol precipitated. Pellets were
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resuspended in 20 pi TE/RNase A mixture (20:1, using 2 mg/ml RNase A stock; 
Sigma; A ppendix  4). Restriction enzyme digests were performed to identify correct 
constructs.
2.7a Plasmid minipreps for use in TnT reactions
Cells (1.5 ml) were minipreped using the Qiagen plasmid miniprep kit as 
described in the manufacturer’s protocol.
2.8 Large scale plasmid purification (plasmid maxipreps)
Plasmid DNA was purified on a large scale using the Qiagen Hispeed™ 
plasmid maxi kit as described in the manufacturer’s protocol. The concentration o f 
plasmids was assessed using a spectrophotometer (UV1101 Biotech photometer; 
WPA).
2.9 Production of 32P- labelled RNA transcripts
The general method outlined in Sambrook et al. (1989) was used. Linearized 
plasmid DNA (with a T7 promoter) was phenol/chloroform extracted, ethanol 
precipitated and the pellet resuspended in 20 pi sterile dH^O. Transcription reactions 
were carried out in 20 pi volumes and contained 4 pi 5x transcription buffer 
(Promega), 4 pi rNTP minus CTP mix (2.5 mM stock, Promega), 2 pi CTP (0.5 mM 
stock, Promega), 1 pi RNasin (Promega), 0.5 pi BSA (10 mg/ml stock, Promega), 0.5 
pi 1M DTT (GibcoBRL), 1 pi [32P] a-CTP (0.37 MBq; Amersham Pharmacia Biotech 
UK Ltd), 500 ng linearized DNA and 2 pi T7 RNA polymerase (Promega). The
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mixtures were incubated at 37°C for 1 h. Following phenol/chloroform extraction, the 
RNA was precipitated o/n at -20°C in 50 pi 2M ammonium acetate (Sigma), 500 pi 
ethanol and 5 pi tRNA (as an inert carrier; 2mg/ml stock, Sigma). The samples were 
centrifuged at 14,000 rpm for 15 min at 4°C. Pellets were washed in 75% ethanol and 
resuspended in 20 pi RNase-free H2O (Sigma).
2.10 Production of RNA transcripts using the Megascript SP6 kit
Linearized pSP64poly(A) plasmid DNA with SP6 promoter (2 pg; Ambion) 
was transcribed using the Megascript SP6 kit (Ambion) with SP6 RNA polymerase 
(Ambion) at 37°C for 4h (see Section 5.2). Methods and reagents were as described in 
the manufacturer’s protocol.
2.11 Coupled transcription and translation (TnT) reactions
The Promega TNT T7 Quick coupled transcription and translation kit based on 
rabbit reticulocyte lysate was used as outlined in the manufacturer’s protocol. 
Reactions (25 pi) were performed using 0.5 pg o f plasmid DNA and 1 pi [3;>S]- 
methionine (0.37 MBq Redivue™ L-[35S] methionine; Amersham Pharmacia Biotech 
UK Ltd). Samples were analysed by SDS-PAGE (Section 2.20) and autoradiography 
or used in subsequent RNA-binding assays (Section 5.4).
2.12 Tissue culture
Crandell Rees feline kidney cells (CRFK) were grown in Eagle’s Minimum 
Essential Medium (MEM) with Earles salts, supplemented with 10% foetal calf serum
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(FCS), penicillin / streptomycin (1%) and non specific amino acids (1%) (all from 
GibcoBRL). Cells were grown at 37°C with 5% C 02 (Incubator Galaxy S; Wolf 
laboratories). Confluent monolayers were prepared as follows: the media were 
removed and the cells were washed with 3ml 1:10 trypsin/versene (GibcoBRL). The 
trypsin/versene solution was removed and detachment o f the cells was achieved by 
addition o f 2 ml trypsin/versene. Five ml o f 10% FCS-Eagle’s MEM were added and 
the cells centrifuged at 2,500 rpm for 3 min. The medium was removed and the pellet 
was resuspended in 4 ml 10% FCS-Eagle’s MEM. Cells (2 ml, i,e, 1:2) were placed in 
a 75 cm2 flask containing 10 ml 10% FCS Eagle’s MEM.
2.13 Production of FCV stock
A confluent (approx. 80%) 75 cm2 flask o f  CRFK cells was infected with 500 
pi FCV seed stock in 4 ml 2% FCS Eagle’s MEM and rocked for 1 h. Another 8 ml o f 
10% FCS Eagle’s MEM were added to the flask and incubated at 37°C o/n. Cells were 
frozen at -20°C o/n. Cells were subjected to one round o f freeze thawing and aliquots 
were stored at -20°C. The titre o f the virus was determined by plaque assay (Section 
2.14).
2.14 Plaque assay for FCV stock
Plaque assays were performed in 6-well plates (35 mm). The 6-well plate was 
seeded with CRFK cells (an 80% confluent 75 cm2 flask per ten well plates). The well 
plates were rocked gently to ensure even distribution o f the cells, and incubated at 
37°C o/n. Confluent CRFK cells were washed with 1 ml PBSa (Appendix 4). 
Dilutions o f 10'2, 1 O'4, 10'5, 10'6, and 10'7 o f  the stock virus were prepared in complete
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PBSa. The virus was plaqued by adding 0.2 ml o f each o f the above dilutions in the 
appropriate well plates. A negative control well plate contained 0.2 ml PBSa only. 
The well plates were allowed to stand at RT for 1 h with occasional rocking to prevent 
drying o f the cells. Whilst the virus was adsorbing to the cells, molten agar (0.8% 
agarose in H 2O) and double strength medium (A ppendix  4) were placed at 42°C. 
After 1 h the virus was removed and equal volumes o f molten agar and double 
strength medium were mixed and 2 ml o f the mixture was added to each well plate. 
The agar was allowed to set and the well plates incubated at 37°C o/n. Formal-saline 
(3 ml; 10 ml formaldehyde plus 90 ml 0.89% saline) was added to each well plate for 
10 min at RT to fix the cells. The agar plugs were flushed out using MQ H2O. Plaques 
were visualised by staining with crystal violet. Crystal-violet stain (0.5 ml; 0.1% 
ciystal violet in 20% ethanol; Sigma) was added to each well plate, and incubated for 
30 min at RT. The stain was gently washed off with water and the well plates were 
allowed to drain and dry. Plaques appeared as clear circular holes in the cell 
monolayer (crystal-violet is a general protein stain and will stain any adherent cells 
purple). The titre o f the virus was calculated as follows: well plates (in a duplicate 
assay) containing between 20 and 100 plaques were considered. The average number 
value o f  plaques was taken and multiplied by 5 (because only 0.2 ml o f each dilution 
was plated). This gives the number o f  plaques present in each ml o f  the dilution that 
was counted. The result was then multiplied by the dilution factor (e.g. 10'6) to 
calculate the plaque forming units (pfu) o f  the initial virus stock. The result was 
expressed as the number o f pfu per ml.
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2.15 RNA extraction from FCV-infected cells
A confluent 75 cm2 flask o f CRFK cells was infected with 500 pi FCV (F9 
strain) seed stock (approx. 100 pfu/cell) in 4 ml 2% FCS Eagle’s MEM and rocked for 
1 h. Another 8 ml o f 10% FCS Eagle’s MEM were added to the flask and incubated at 
37°C for 5 h. The medium was removed, 1.5 ml cold PBS (GibcoBRL; Appendix 4) 
were added, the cells were scraped off, placed in a cold eppendorf tube and 
centrifuged at 5,000 lpm  for 2 min. The supernatant was removed and the pellet 
resuspended in 1 ml cold RNAzol B (AMS Biotechnology). Cold chloroform (100 pi) 
was added and the mixture shaken vigorously for 15 sec and placed on ice for 5 min. 
Following centrifugation o f the mixture at 12,000 rpm for 15 min, the upper phase 
was transferred to an eppendorf and an equal volume o f cold iso-propanol was added. 
The mixture was stored at 4°C for 15 min and centrifuged at 12,000 rpm for 15 min. 
The supernatant was discarded and 0.5 ml 75% ethanol was added to the pellet. After 
vortexing, the mixture was further centrifuged at 12,000 rpm for 10 min. The 
supernatant was discarded and the pellet was resuspended in 20 pi o f RNase-free
h 2o .
2.16 Reverse transcription of RNA from infected cells
To 5 pi o f RNA sample (Section 2.16) were added 1.5 pi random primers 
(500 pg/ml stock, Promega), 1 pi RNase inhibitor (40,595 U/ml stock, Pharmacia 
Biotech), and 5.5 pi RNase-free H20 . The mixture was placed at 70°C for 5 min 
followed by incubation at RT for 10 min. During the primer-annealing step, a mixture 
comprising 4 pi 5x 1st strand buffer (GibcoBRL), 0.5 pi BSA (10 mg/ml stock, 
GibcoBRL), 1 pi dNTP mix (10 mM each, Promega), 2 pi DTT (0.1 M  stock,
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GibcoBRL), and 1 pi M-MLV reverse transcriptase (200 u/ml stock, GibcoBRL) was 
prepared. This mix was added to the primer annealing mix and incubated at RT for 5 
min, followed by incubation at 37°C for 45 min. Samples were stored at -20°C or 
used directly in PCR reactions.
2.17 Polymerase Chain Reaction (PCR)
A 100 pi PCR reaction mixture was prepared comprising 10 pi lOx PCR 
buffer (with MgCl2; Promega), 2 pi dNTPs mix (10 mM each; Promega), 2 pi cDNA 
(produced by reverse transcription, Section 2.16), 1 pi each o f  the forward (1 pg/pl) 
and the reverse (1 pg/pl) primers (see relevant chapters and Appendix 1), 1 pi Taq 
DNA polymerase (5 U/pl; Promega), and 83 pi sterile dH20 . Cycles were performed 
using the protocols described in specific results chapters.
2.18 Purification of PCR products
PCR products were purified using the Wizard PCR preps DNA purification 
system (Promega) as described in the manufacturer’s protocol.
2.19 SDS-PAGE
SDS-PAGE was carried out using different percentage acrylamide gels as 
described in subsequent chapters (Laemmli 1970, and Appendix 4). Mini gels 
(Biorad) were run at 100 V, large (30 ml) gels were run at 250 V. Gels were either 
stained with Coomasie brilliant blue stain (Biorad; Appendix 4), destained in 20%
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methanol / 7.5% glacial acetic acid (Appendix 4) and dried or used in Western blots 
as described in Section 2.20.
2.20 Western blots
Cell extracts and VPg-containing samples (Chapter 3) were analysed by SDS- 
PAGE as outlined above. Proteins were transferred onto Immobilon-P membranes 
(Millipore Corp) at 100 V/400 mA for 90 min in Tris/glycine/methanol buffer 
(Western blot transfer buffer; Appendix 4). Membranes were blocked overnight in 
5% Marvel (w/v) (blocking solution; Appendix 4) in 1% TBS+0.1% Tween 
(Appendix 4). Proteins were detected using anti-eIF4A (1:2000), anti-eIF4E (1:2000), 
anti-eIF4G (1:1000) antisera (all antibodies were gifts from Dr S. Morley, University 
o f Sussex) or anti-VPg (1:500, raised in rabbit after VPg expression and purification) 
primary rabbit antibodies. Membranes were incubated with primary antibody for 1 h 
with continuous shaking. The antibody was removed with washes in 1% TBS+0.1% 
Tween (2 x 30 sec and 2 x 10 min). This was followed by 1 h incubation with 
peroxidase linked donkey anti-rabbit IgG (1:2500; Amersham), or peroxidase-linked 
goat anti-rabbit IgG (1:2000; Dako) as stated. Washes were repeated and detection 
achieved using chemiluminescence reagents as outlined in the manufacturer’s 
protocol (SuperSignal West Pico chemiluminescent substrate, Pierce). Other proteins 
were detected as specified in the appropriate results section.
2.21 Sequencing
Samples contained 800 ng DNA plasmid and 3.2 pmol universal forward 
primer in a final volume o f 20 pi. Samples were sequenced using the School’s
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sequencing facility (Applied Biosystems 373A DNA sequencer) by Roy Jadubansa 
(SBLS, University o f Surrey).
2.22 Determination of protein concentration
Determination o f the protein concentration in a spectophotometer (UV1101 
Biotech photometer, WPA) was carried out using the BIO-RAD ‘DC protein assay’ as 
described in the manufacturer’s protocol.
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Chapter 3
Interaction of FCV VPg protein with cellular proteins
3.1 INTRODUCTION
The role o f the viral genome-linked protein, VPg, in FCV translation is still 
speculative. To date, it has been shown that it is present on the 5’ ends o f both 
genomic and subgenomic RNAs o f caliciviruses such as FCV [Herbert et a l ,  1996] 
and RHDV [Meyers et a l ,  1991b]. In the case o f FCV, it was shown that removal o f 
VPg from the genomic RNA reduced the levels o f  translation, but addition o f a cap 
analogue had no effect on the translation o f  the major species derived from total 
mRNA isolated from FCV-infected cells [Herbert et a l ,  1996]. In addition, it has been 
demonstrated that synthetic transcripts derived from full-length FCV cDNA did not 
require VPg for infectivity but the transcripts had to be artificially capped to be 
infectious [Sosnovtsev & Green, 1995; Thumfart & Meyers, 2002]
The aims o f  these studies were to express and purify FCV VPg and to produce 
antisera for use in assays for interactions with the canonical initiation factors and 
other cellular proteins. Turnip mosaic potyvirus VPg has been demonstrated to 
interact with initiation factor eIF4E [Wittmann et al. 1997] and Leonard et al. [2000] 
showed that addition o f a cap analogue inhibited the formation o f the VPg-eIF4E 
complex in a competitive manner. Translation initiation factor eIF3 subunit d (66 
kDa) was shown to bind Norwalk virus VPg by yeast two-hybrid and GST pull-down 
assay studies. Also, GST-VPg pull down assays using CaCo-2 extracts showed the 
presence o f  eIF4GI, S6 and small amounts o f eIF4E and eIF2a. The extent to which
84
Chapter 3 Interaction o f FCV VPg protein with cellular proteins
these interactions were direct with VPg or mediated through eIF3 is still unknown. 
[Daughenbaugh et al., 2003].
I f  FCV VPg is acting as a ‘cap substitute’ then analysis o f binding to initiation factors 
may help our understanding o f  its role in FCV mRNA translation.
METHODS
3.2 Plasmid construction
For the expression and subsequent purification o f the FCV VPg protein for the 
purpose o f raising antibodies, the FCV VPg cDNA was isolated and cloned into 
pET28a expression vector. CRFK cells were infected with FCV F9 strain and the 
RNA was isolated as described in Section 2.15. The RNA was reverse transcribed 
(using random primers, Section 2.16) to produce a cDNA template for PCR (Section
2.17). PCR was carried out to isolate the VPg sequence [amino acid sequence o f the 
putative calicivirus VPg was taken from Dunham et al., 1998; nucleotide sequence 
taken from Carter et al., 1992a] using the primers:
(5’) ACGGATCCGAAGCAAAAGGAAAA (designated VPGFOR for forward) and 
(5’) ACAAGCTTTGATTCCTCAGCAAAG (designated VPGREV for reverse). The 
VPg sequence is 338 bp long (see Appendix 2) at position 2897-3235nt o f  the FCV 
genome. The forward and reverse primer sequences (see Appendix 1) included the 
BamHl and H indlll restriction enzyme sites for ease o f  cloning.
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3.2.1 Amplification of the VPg sequence by PCR
A 100 pi PCR reaction mixture was prepared as described in Section 2.17. 
cDNA (2 pi) and 1 pi each o f  the forward (1 pg) and the reverse (1 pg) primers 
(VPGFOR, VPGREV, Section 3.2) were used. The PCR cycle parameters used to 
successfully clone the VPg sequence are shown in Table 3.1. The PCR product was 
purified using the Wizard PCR Preps DNA Purification System (Promega; Section
2.18).
1. Initial denaturation at 94°C for 5 min x l
2. Main Cycle x 25: (a) Denaturation: 94°C, 30 sec
(b) Annealing: 55°C, 1 min
(c) Amplification: 72°C, 1 min
3. Cooling at 72°C for 10 min xl
Table 3.1: PCR cycle details for the amplification of the 338 bp FCV VPg 
sequence
3.2.2 Cloning of the VPg sequence into pGEM-Teasy
The PCR product (VPg fragment) was cloned into pGEM-Teasy (Promega; 
Section 2.4). Following ligation, transformation o f the pGEM-Teasy + VPg plasmid 
into competent E.coli D H 5a cells (Sections 2.5 & 2.6) was carried out. Following 
transformation, at least six o f  the colonies were minipreped (Section 2.7), 
phenol/chloroform extracted and ethanol precipitated.
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3.2.3 Subcloning of the VPg fragment into pET28a expression vector
The VPg sequence was released from pGEM-Teasy by restriction enzyme 
digestion with BamHl and Hincllll (Section 2.1). Following enzyme digestion, the 
samples were run on a 1 % agarose gel, the VPg fragment was excised and extracted 
using the QIAquick Gel Extraction kit (Section 2.3). The VPg fragment was ligated 
into pET28a expression vector (Novagen; previously digested with BaniHl and 
HindlH), as described in Section 2.4. Following ligation o f the VPg fragment into this 
vector, transformation into competent E.coli D H 5a cells (Section 2.5 & 2.6) was 
carried out. Following transformation, at least six o f the colonies were minipreped 
(Section 2.7), phenol/chloroform extracted and ethanol precipitated. The samples 
were digested with BamHl and H indlll (Section 2.1) to check presence o f the VPg 
fragment. Samples were subsequently sequenced as described in Section 2.21 using a 
T7 primer. Maxipreps o f the pET28a + VPg plasmid were performed using the 
Hispeed™ plasmid maxi kit (Qiagen; Section 2.8). The DNA was further purified by 
ethanol/salt precipitation, and the concentration and purity were assayed using a 
spectrophotometer (UV1101 Biotech Photometer; WPA).
3.3 Expression of VPg in E. coli
Expression o f the VPg protein (cloned into the expression vector pET28a) 
required the production and use o f BL21 (DB3) pLysS E.coli competent cells 
(Promega). Production o f competent BL21 (DE3) pLysS E.coli cells was performed 
as described in Section 2.5. Transformation o f  the pETVPg plasmid was carried out 
according to the protocol described in Section 2.6. Transformants were plated out on 
LB agar plates containing kanamycin (30 flg/ml) and chloramphenicol (34 jag/ml)
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(Appendix 4). At least two colonies were picked the following day and grown in 5 ml 
LB broth containing kanamycin and chloramphenicol. The cultures were incubated at 
37°C in a shaker-incubator for 4 h. Following overnight refrigeration at 4°C the 
cultures were centrifuged at 3,000 rpm for 5 min. The supernatant was discarded and 
the pellet was resuspended in 5 ml LB broth containing kanamycin and 
chloramphenicol. Two ml o f the culture was added to 50 ml LB broth, again 
containing kanamycin and chloramphenicol, placed in a shaker-incubator at 37°C and 
left to grow until the OD600 (referenced against LB broth) reached 0.6 (for 
approximately 3 h). At this stage, 100 pi o f culture were removed, centrifuged at
8,000 rpm for 1 min and the pellet was resuspended in 20 pi sterile dH20 . This served 
as a negative control prior to isopropyl thiogalactoside (IPTG) addition.
In order to induce VPg expression, IPTG (1 mM final concentration) was added to the 
50 ml culture, and the cultures were incubated at 37°C in a shaker-incubator for 
another 3 h. At the end o f the 3 h, 100 pi o f culture was removed, centrifuged at 8,000 
rpm for 1 min and the pellet resuspended in 20 pi sterile dH20 . This served as the 
positive control after IPTG addition.
The rest o f  the 50 ml culture was placed on ice for 5 min and centrifuged at 5,000 rpm 
for 5 min. After discarding the supernatant, the pellet was stored at -20°C (BL21 
pLysS E.coli cells lyse by the ‘freeze-thaw’ method). The VPg protein was isolated 
from the pellet as described below. The process was repeated several times for the 
production o f stock E. coli lysate with expressed VPg.
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3.4 Large scale VPg purification
Several small-scale VPg purification experiments were performed in order to 
optimize the conditions o f  the purification. For protein purification the Qiagen Ni- 
NTA Agarose slurry was used, and below is the modified protocol developed to 
achieve maximum yield and purity. The lysate subjected to purification comprised the 
pellet (Section 3.3.1), which was resuspended in 10 ml o f 20 mM Tris-HCL, pH 7.5.
To 2.5 ml o f Ni-NTA Agarose solution (slurry; Qiagen), 2.5 ml o f  equilibrium 
buffer (1 x sodium phosphate [NaPiJ buffer, 5 mM imidazole [PharMingen], 300 mM 
NaCl [Sigma]; Appendix 4) was added and the mixture centrifuged at 2,900 rpm at 
4°C for 1 min. The supernatant was discarded and another 2.5 ml o f  equilibrium 
buffer was added and centrifuged as above. The supernatant was discarded again and
2.5 ml o f equilibrium buffer was added. This step was performed in order to 
equilibrate the slurry before the addition o f  the lysate. To the above mixture, 10 ml o f 
E.coli lysate were added and the mixture left at 4°C for 1 h on a rotary mixer. The 
mixture was centrifuged at 2,900 rpm at 4°C for 4 min, the supernatant removed (PPI) 
and kept for SDS-PAGE analysis. To the pellet, 10 ml o f wash buffer (1 x NaPi 
buffer, 5 mM imidazole, 300 mM NaCl, 1.8 mg/ml aprotinin [Sigma]; Appendix 4) 
was added and the mixture left on a rotary mixer at 4°C for 2 min. Following 
centrifugation at 2,900 rpm at 4°C for 2 min the supernatant was removed (PPWI) and 
kept for SDS-PAGE analysis. The wash step was repeated three more times and each 
time the supernatants (PPWII-IV) were kept for SDS-PAGE analysis. After four 
washes, 1.25 ml o f elution buffer (1 x NaPi buffer, 250 mM imidazole, 300 mM 
NaCl; Appendix 4) was added to the slurry, and the mixture was left at 4°C for 10 
min on a rotary mixer. This was centrifuged at 2,900 rpm at 4°C for 4 min and the 
supernatant (PPELI) was placed in a sterile eppendorf (20 pi o f  which were used for
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SDS-PAGE analysis). The elution step was repeated once (PPELII). All samples (20 
pi) were subjected to SDS-PAGE analysis to verify VPg purification. In addition the 
samples were subjected to SDS-PAGE analysis and Western blotting and challenged 
with anti-His-Peroxidase antibody (1:500, Roche) to verify purified His-tagged VPg 
had been expressed.
3.5 Production of anti-VPg antiserum
Prior to injection into the rabbit, determination o f the concentration o f the 
purified VPg was carried out using the BIO-RAD DC protein assay (Section 2.22). A 
standard curve was constructed using Bovine Serum Albumin (BSA) and absorption 
was read at OD750. Elution buffer (Appendix 4) was used as a blank.
3.5.1 Injection of purified VPg into rabbits
In order to raise antisera to FCV VPg, the purified protein was injected into a rabbit 
(conducted by Peter Scobie-Trumper, University o f  Surrey). The first injection 
comprised 1 ml (approx. 0.74 mg) o f  purified VPg in elution buffer. The first boost 
comprised 0.5 ml VPg (approx. 0.37 mg) and 0.5 ml adjuvant (Freunds complete 
adjuvant), and was injected two weeks after the initial dose. Two weeks later the 
second boost (Freunds incomplete adjuvant) was injected. The ‘test bleed’ (10 ml) 
was collected two weeks after the second boost.
The test bleed was left at room temperature on the day o f collection and placed at 4°C 
overnight, and this caused the blood to clot in the surrounding serum. On the 
following day, the serum was collected and transferred to a centrifuge tube after 
‘rimming’ the clot. The serum was centrifuged at 1337 rpm for 5 min in order to
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separate it from remaining red blood cells. The serum was aliquoted to sterile 
eppendorfs and stored at -20°C. The antiserum was analyzed for specificity and 
reactivity by Western blot on infected cell extracts and purified VPg.
3.6 Analysis of VPg from FCV-infected cells
Analysis o f VPg from infected cell extracts was performed by SDS-PAGE 
analysis followed by Western blotting. Blots were challenged with the VPg antiserum 
(1: 500) produced in rabbits. The aim o f this study was to determine whether the VPg 
antiserum raised in rabbits reacted with VPg produced in FCV-infected cell extracts. 
Prior to that, it was necessary to establish whether the anti-VPg antiserum reacted 
specifically with the recombinant VPg (Section 3.4.1),
3.6.1 Analysis of anti-VPg antisera with recombinant His-tagged VPg
Three different concentrations o f recombinant VPg, neat (0.72 mg/ml or 14.4 
mg in 20 pi sample), 1:10, and 1:100, were subjected to 10% SDS-PAGE analysis and 
Western blotting, and challenged with anti-VPg antisera (1:500) followed by 
peroxidase-linked donkey anti-rabbit conjugate (1:2500). Detection was achieved by 
addition o f chemiluminescence reagents as described in Section 2.20.
3.6.2 Analysis of VPg from FCV-infected CRFK cells
A 75 cm2 flask o f CRFK cells was infected with 500 pi FCV F9 strain 
(approx. 100 pfu/cell) as described in Section 2.13, for 6  h. Another flask o f CRFK 
cells was mock-infected to act as the negative control. Both infected and uninfected
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CRFK cells were harvested in 400 pi cold buffer C. The samples were left on ice for 5 
min and centrifuged at 14,000 ipm  for another 5 min. The supernatant was removed 
and kept for analysis. O f each sample, 20 pi were subjected to SDS-PAGE (10%) 
analysis, followed by Western blotting and probed with anti-VPg antiserum (1:500) 
and peroxidase-linked donkey anti-rabbit conjugate (1:2500). The results were viewed 
as before by addition o f chemiluminescence reagents as described in Section 2.20.
3.7 Interaction of recombinant FCV VPg with eIF4E, eIF4A and 
eIF4G (Pull down assay)
To 50 pi o f Ni-NTA Agarose solution (slurry), 50 pi o f equilibrium buffer was 
added and the mixture was equilibrated as described in Section 3.4. To the above 
mixture, 1 pi recombinant His-tagged VPg (approximately 700 ng) were added and 
the new mixture left at 4°C for 1 h on a rotary mixer. The mixture was centrifuged at 
2,900 rpm at 4°C for 1 min and the supernatant was removed and retained 
(NiNTA+VPg). To the pellet, 200 pi o f wash buffer (1 x NaPi buffer, 40 mM 
imidazole, 300 mM NaCl, 1.8 mg/ml aprotinin; Appendix 4) was added and the 
mixture was left on a rotary mixer at 4°C for 1 min. Following centrifugation at 2,900 
rpm at 4°C for 1 min, the supernatant was removed. The wash step was repeated once. 
After two washes, 10 pi HeLa S10 cell extract (kindly provided by Dr Ken Mellits, 
University o f  Nottingham) in 190 pi wash buffer were added to the slurry and left at 
4°C for 1 h  on a rotary mixer. The mixture was centrifuged at 2,900 rpm at 4°C for 1 
min and the supernatant was removed and retained (Unbound HeLa proteins). Each 
pull down assay was performed three times in order to assay binding o f eIF4E, eIF4A 
and eIF4G. The slimy was resuspended in 20 pi sterile dH20  (HeLa proteins bound to
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VPg). To 20 pi o f each sample (NiNTA+VPg, unbound HeLa proteins and HeLa 
proteins boimd to VPg), 10 pi SDS sample buffer, and 1 pi DTT were added prior to 
SDS-PAGE analysis. Following 10% (for eIF4E and eIF4A) and 7.5% (for eIF4G) 
SDS-PAGE analysis, Western blotting (Sections 2.19 and 2.20) was performed. The 
nitrocellulose membranes were challenged with anti-eIF4E, anti-eIF4A and anti- 
eIF4G antisera respectively and goat-anti-rabbit conjugate HRP as described in 
Section 2.20. A positive control containing HeLa S10 extract was used. The results 
were visualised after addition o f chemiluminescence reagents as described in Section
2.20. The principle o f the pull down assay is summarised in Figure 3,1.
3.8 Interaction of recombinant FCV VPg with eIF4E, eIF4A and 
eIF4G (ELISA-based binding assay)
These experiments were carried out in collaboration with Professor Jean- 
Francois Laliberte’s group (INRS-Institut Armand-Frappier, Quebeq, Canada) using 
the FCV VPg generated above (Sections 3.3 & 3.4). The clones and the antibodies 
were kindly provided by Professor Nahum Sonenberg (McGill University, Montreal, 
Canada).
Initially recombinant FCV VPg (His-tagged) was adsorbed to the wells o f  an ELISA 
plate (1 pg/well) by overnight incubation at 4°C and the wells were blocked with 5% 
BLOTTO in phosphate-buffered saline (PBS). E.coli lysates expressing murine GST- 
tagged eIF4E, GST-tagged eIF4G and eIF4A were diluted in 1% BLOTTO in PBS 
with 0.2% Tween and were incubated for I h at 4°C with the previously coated wells.
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Figure 3.1 : Schematic representation of the principle of the pull down assay 
(Section 3.7)
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Detection o f bound initiation factor was achieved as in ELISA assays with an anti- 
GST antibody (in the case o f  eIF4E and eIF4G) or anti-eIF4A antibody followed, by 
peroxidase-labeled goat anti-rabbit immunoglobulin G (KPL). Wells were washed 
three times with 0.05% Tween between incubations [as in Leonard et a l., 2000]. The 
results (OD values) were read at X — 492 nm.
Once interaction between eIF4E and VPg was established (Section 3.16; Figure 3.11) 
the assay was repeated with E.coli eIF4E lysate only including two controls. These 
were TuMV VPg interacting with eIF(iso)4E from Arabidopsis thaliana [as described 
in Leonard et a l ,  2000] and recombinant FCV VPg with no tag (obtained from a 
collaboration with Dr Stephen Curry, Imperial College London) interacting with 
murine eIF4E. The latter control was performed to ensure eIF4E was binding to the 
VPg and not the His-tag. The results (OD values) were read at X = 492 nm.
RESULTS
3.9 Cloning of FCV VPg sequence into pET28a expression vector
The 338 bp VPg fragment [Dunham et al. 1998, Carter et a l  1992a] was 
successfully amplified by PCR, at an annealing temperature o f  55°C for 1 min 
(Section 3.2.1). Figure 3.2 shows the production o f an approximately 340 bp band, 
indicating the presence o f the VPg sequence. Following ligation o f the amplified VPg 
fragment into pGEM-Teasy (Section 3.2.2), the VPg fragment was digested from the 
pGEM-Teasy + VPg plasmid, ligated into pET28a and transformed into competent 
E.coli D H 5a cells for plasmid propagation (Section 3.2.3). After DNA purification, 
restriction enzyme digestion was performed in order to ensure the VPg sequence was
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Figure 3.2: Amplification of the FCV VPg fragment by PCR
RNA from FCV-infected cells was reverse transcribed and the cDNA was 
subjected to PCR to isolate the VPg sequence. The 338 bp VPg fragment was 
amplified by PCR at an annealing temperature o f 55°C for 1 min. The PCR 
product was analysed on a 1.5% agarose gel and visualised by ethidium 
bromide staining.
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incorporated into the expression vector. Agarose gel electrophoresis (not shown) 
verified the presence o f the VPg fragment (approx. 340 bp). DNA sequencing was 
performed to verify the sequence (Appendix 3). Although at some points the 
determination o f the base was not achieved (designated as N), the peaks produced 
(different colours correspond to different bases) assume the base content o f the VPg 
sequence. Impurities in the sample subjected to sequencing might be the cause o f the 
appearance o f the ‘N ’ bases.
3.10 Expression of VPg protein in E.coli
Following transformation o f the pETVPg plasmid (maxiprep) into competent 
BL21 (DE3) pLysS E.coli cells, four colonies were picked in order to induce VPg 
expression (Section 3,3.1). Induction o f  VPg was achieved by addition o f  ImM IPTG. 
SDS-PAGE (10 %) analysis was performed to demonstrate absence and presence o f 
VPg prior to and after addition o f  IPTG. Figure 3.3 shows that in all four selected 
colonies induction o f VPg expression after IPTG addition was successful.
3.11 Purification of the VPg protein
The samples retrieved from incubation o f the E. coll lysate (containing 
expressed VPg) with Ni-NTA agarose (Section 3.4) were subjected to 10 % SDS- 
PAGE analysis to verify purification. Figure 3.4 demonstrates that purification o f the 
VPg protein was successful. The exact concentration o f  the protein purified in both 
elution steps was determined prior to injection into the rabbit. Determination o f the 
VPg concentration was achieved using the BIO-RAD ‘DC Protein Assay’ (Section 
2.22).
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Figure 3.3: VPg expression in E. co/i
E. coli BL21 (DE3) pLysS competent cells were transformed with the pETVPg 
plasmid and were induced with ImM IPTG. Fractions o f the bacterial products 
were subjected to SDS-PAGE and visualized with Coomassie blue stain. (A) 
Culture samples prior to IPTG addition. (B) Culture samples after ImM IPTG 
addition. (C) Positive control from previous large scale VPg expression.
kDa
u
Jgto
03
Cu
Cm
£
CU
0 m
£
cu
t i
£
Cu
Cu
>—
>
CU
Dm
—1
t i
t i
Cu
cu
t i
t i
Cu
cu
Figure 3.4: Purification of FCV VPg expressed in E. coli by Ni-NTA 
agarose
VPg expressed in E. coli, purified using Ni-NTA agarose. Samples PPI (E. coli 
lysate containing VPg and equilibrium buffer); PPWI-IV (samples treated with 
wash buffer for removal o f unbound protein); PPELI (elution I, VPg eluted 
protein, 0.950 mg/ml); PPELII (elution II, 0.840 mg/ml) were subjected to 
SDS-PAGE and visualised with Coomassie blue stain. Purified VPg was eluted 
as a His tagged protein.
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A calibration curve was constructed using BSA as the standard and adsorption was 
read at 750 nm. From the calibration curve (graph not shown) it was deduced that the 
PPELI sample was approximately 0.95 mg/ml, whereas the PPELII sample had a 
concentration o f 0.84 mg/ml (Figure 3.4). It was essential for the purification process 
to be repeated several times since purified VPg was used in several other studies. 
Thus, different amounts o f pure VPg were retrieved. The concentration o f the purified 
VPg protein which was used to inject the rabbit for production o f  antiserum was 
approximately 0.74 mg/ml (Section 3.5.1).
3.12 Characterization of recombinant His-tagged VPg with anti-His 
antibody
As mentioned in Section 3.4, after VPg purification all the samples (PPI, 
PPWI-IV, PPELI and PPELII) were subjected to SDS-PAGE analysis and Western 
blotting and probed with anti-His-peroxidase antibody (1:500), to verify the purified 
protein was VPg (since it was flanked with His residues when expressed in pET28a, 
see Appendix 2). Figure 3.5 shows the amount present (band intensity) o f His-tagged 
VPg in all samples, with the highest amount present in the two elution samples 
(PPELI & II).
3.13 Anti-VPg antiserum reacts with recombinant His-tagged VPg
The optimum dilution o f the anti-VPg antiserum reacting with VPg extracted 
from FCV-infected CRFK cells, was determined to be 1:500. SDS-PAGE analysis o f 
samples containing different dilutions o f recombinant VPg followed by Western
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Figure 3.5: Detection of recombinant His-tagged VPg by anti-His-peroxidase 
antibody
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blotting and probing with anti-VPg antisera (Section 3.6.1) demonstrated that the 
antisera bind specifically to purified VPg. Figure 3.6 shows the results obtained in 
which the neat and 1:10 dilution samples o f  VPg produced three bands o f 
approximately 20 kDa, 16.5 kDa and <16.5 kDa. In the neat sample the intensity of 
the bands is stronger than the 1:10 dilution sample. The 1:100 dilution sample 
produced a single band o f 20 kDa, which is considered to be the VPg protein. The 
appearance o f the 16.5 and <16.6 kDa bands suggest the presence o f degradation 
products.
3.14 Detection of VPg-containing polypeptides in FCV-infected cells
Mock and FCV-infected CRFK cell extracts were subjected to SDS-PAGE 
and Western blot analysis and probed with anti-VPg antiserum as described in 
Section 3.6.2, The results obtained, shown in Figure 3.7, revealed the presence of 
three bands in the infected cell extract. Their sizes were approximately 88 kDa, 45 
kDa and 20kDa. Figure 3.13 (Section 3.17) depicts a diagrammatic representation o f 
the sizes o f the products which may have been detected. As expected, no bands were 
observed in the uninfected CRFK cell extracts. The results suggest the presence o f 
uncleaved polyprotein products. Intermediate sized polyprotein products have been 
described for FCV by Carter [1989a], Sosnovtseva et a l  [1999] and Sosnovstev et al. 
[2002].
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Different concentrations (neat, 1:10 & 1:100) o f recombinant VPg (His-tagged VPg, 
Figure 3.3) were subjected to SDS-PAGE followed by immunoblotting and 
detection with rabbit anti-VPg (Section 3.5.1) and peroxidase-linked donkey anti­
rabbit IgG (Section 3.4) using chemiluminescence reagents as described in Section
2.20. Neat sample contained 0.72 mg/ml purified His-tagged VPg.
Figure 3.6: Analysis of anti-VPg antisera with recombinant VPg
Figure 3.7: VPg antiserum specifically reacts with proteins from FCV-infected 
C R F K  cells.
Mock and FCV-infected CRFK cell extracts were subjected to SDS-PAGE and 
Western blot analysis. The blot was probed with anti-VPg antiserum followed by 
peroxidase-linked donkey anti-rabbit IgG and visualised using chemiluminescence 
reagents as described in Section 2.20.
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3.15 FCV VPg interacts with eIF4E but not eIF4A and eIF4G
Interaction o f VPg with eIF4E was firstly established using a pull down assay 
as described in Section 3,7. Recombinant VPg was bound to Ni-NTA agarose 
(Sections 3.4 & 3.11) and allowed to interact with proteins in a HeLa SIO cell extract. 
Samples containing VPg only (NiNTA+VPg), unbound HeLa proteins (wash step) 
and HeLa proteins bound to VPg were subjected to SDS-PAGE and Western blot 
analysis, followed by probing with anti-eIF4E antibody. Figures 3.8, 3.9 & 3.10 show 
the results o f the pull down assays. The sample that contained only the purified VPg 
protein (NiNTA+VPg) did not react with any anti-elF (eIF4E, eIF4A or eIF4G) 
antibody as expected. The sample with the unbound HeLa proteins (wash step) 
produced a band o f  high intensity in all three blots suggesting that eIF4A, eIF4G and 
some eIF4E wash away. The sample that contained HeLa proteins bound to VPg 
produced no bands in the eIF4A and eIF4G blots (Figures 3.8 & 3.9). However, in 
the eIF4E blot in the same sample (HeLa proteins bound to VPg) (Figure 3.10) a
band corresponding to eIF4E was observed suggesting that some eIF4E was also
\
retained due to its interaction with VPg. This suggested an interaction between VPg 
and eIF4E.
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Figure 3.8: Interaction of FCV VPg with eIF4E .
FC V VPg interacts with mammalian eIF4E as demonstrated by pull down assay. 
Recombinant VPg (Section 3.3) was immobilised to N i-N T A  agarose. Following 
washes to remove any unbound protein, 10 pi o f  HeLa cell extract and 190 pi 
wash buffer were added and incubated at 4°C to allow binding o f HeLa cell 
proteins to FC V  VPg. Any HeLa unbound proteins were isolated by 
centrifugation o f  the mixture and subsequent removal o f  the supernatant. HeLa 
proteins bound to VPg were isolated by resuspension o f the slurry in 20 pi sterile 
dH20  and SDS sample buffer. The samples were subjected to SDS-PAGE and 
Western blot analyses with anti-eIF4E antiserum followed by goat-anti-rabbit 
conjugate HRP and visualised using chemiluminescence reagents. HeLa cell 
extract (2 pi) served as a positive control.
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Figure 3.9: eIF4A does not bind to FCV VPg.
Recombinant VPg (Section 3.3) was immobilised to Ni-NTA agarose. Following 
washes to remove any unbound protein, 10 pi o f HeLa cell extract and 190 pi 
wash buffer were added and incubated at 4°C to allow binding o f HeLa cell 
proteins to FCV VPg. Any HeLa unbound proteins were isolated by centrifugation 
o f the mixture and subsequent removal o f  the supernatant. HeLa proteins bound to 
VPg were isolated by resuspension o f  the slurry in 20 pi sterile dH20  and SDS 
sample buffer. The samples were subjected to SDS-PAGE and Western blot 
analyses with anti-eIF4A antiserum followed by goat-anti-rabbit conjugate HRP 
and visualised using chemiluminescence reagents. HeLa cell extract (2 pi) served 
as a positive control.
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Figure 3.10: eIF4G does not bind to FCV VPg.
Recombinant VPg (Section 3.3) was immobilised to Ni-NTA agarose. Following washes 
to remove any unbound protein, 10 pi o f HeLa cell extract and 190 pi wash buffer were 
added and incubated at 4°C to allow binding o f  HeLa cell proteins to FCV VPg. Any 
HeLa unbound proteins were isolated by centrifugation o f the mixture and subsequent 
removal o f  the supernatant. HeLa proteins bound to VPg were isolated by resuspension 
o f the slurry in 20 pi sterile dH20  and SDS sample buffer. The samples were subjected 
to SDS-PAGE and Western blot analyses with anti-eIF4G antiserum followed by goat- 
anti-rabbit conjugate HRP and visualised using chemiluminescence reagents. HeLa cell 
extract (2 pi) served as a positive control.
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3.16 VPg protein interacts with eIF4E but not eIF4A and eIF4G as 
demonstrated by ELISA-based binding assay
Following the pull down results presented in Figures 3.8, 3.9 and 3.10 
suggesting an interaction between FCV VPg and eIF4E but not eIF4A and eIF4G, the 
interactions were assayed using a different method, an ELISA-based binding assay 
(Section 3.9) [Leonard et a l ,  2000]. In this assay recombinant His-tagged VPg (1 pg) 
was absorbed to the wells o f an ELISA plate. E.coli lysates expressing murine GST- 
tagged eIF4E, eIF4A and GST-tagged eIF4G were separately incubated with the His- 
tagged VPg coated wells. Detection o f bound initiation factors was achieved with an 
anti-GST antibody in the case o f  eIF4E and eIF4G, and anti-eIF4A. Figure 3.11 
shows the results o f  the binding assay. For eIF4A and eIF4G only the values 
corresponding to 10 pi lysate were plotted since the OD492 readings were veiy low for 
lysate less than 10  pi.
The second ELISA-based binding assay was performed using recombinant FCV His- 
tagged VPg and eIF4E against two controls. The controls used included TuMV VPg 
incubated with eIF(iso)4E from Arabidopsis thaliana [Leonard et a l ,  2000] and 
recombinant FCV VPg with no tag. TuMV VPg acted as a positive control for 
demonstrating binding between a VPg protein and initiation factor 4E [Leonard et al., 
2000] whereas purified FCV VPg with no tag acted as a control against binding 
between eIF4E and the His- or T7-tag, both present in the original FCV VPg sample 
(Appendix 2). The results presented in Figure 3.12 demonstrate an interaction 
between FCV His-tagged VPg and mammalian eIF4E. The interaction between the 
FCV VPg with no tag and eIF4E was also demonstrated although binding was slightly 
lower than with the His-tagged VPg. The results suggest binding between FCV VPg 
and eIF4E.
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3.17 DISCUSSION
In order to understand any role for FCV VPg in translation any possible 
interactions with the canonical initiation factors and other cellular proteins have been 
investigated. Evidence o f such interactions may consequenty lead to a model for FCV 
translation being proposed.
The first step in this study was the expression and purification o f recombinant FCV 
VPg. The identification and alignment o f  the genomic region which encodes FCV 
VPg by Dunham et al. [1998] and Carter et al. [1992a] enabled the design o f PCR 
primers to isolate the VPg sequence. The results presented in Figure 3,2 show a 340 
bp product, the size o f the VPg nucleotide sequence. Ligation o f the VPg fragment 
into pET28 expression vector and subsequent sequencing (Section 3,2.3) verified the 
correct base content o f the putative VPg fragment isolated by PCR. The purified VPg 
was subjected to SDS-PAGE and Western blot analysis (Section 3.6) to further verify 
the presence o f the His-tagged VPg (as expressed in the pET28a vector). The results 
obtained (Figure 3.5) verified the presence o f VPg (approx. 20 lcDa as migrated in 
SDS-PAGE). The anti-His-peroxidase antibody reacted stronger with the last two 
elution samples. This was expected as the bulk o f the His-tagged VPg was contained 
(eluted) in these samples. From the SDS-PAGE analysis o f the protein purification 
(Section 3.11, Figure 3.4), it can be seen that the amount o f VPg present in the 
samples PPI and PPWI-IV was negligible. The strong band formation in Figure 3.5 
may be due to high concentration o f  the anti-His-peroxidase antibody, thus resulting 
in strong cross-reactivity even with small amounts o f the VPg protein present. 
Recombinant His-tagged VPg was injected into a rabbit for the purpose o f raising 
antisera (Section 3.5.1). The results presented in Figure 3.6 (Section 3.13) revealed 
that the anti-VPg antiserum reacts specifically with recombinat FCV VPg producing
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bands (in the neat and 1:10 VPg concentrations) o f 20 kDa as well as 16.5 and <16.5 
kDa. The 16.5 and <16.5 kDa bands are thought to be degraded products o f the 
recombinant His-tagged VPg since the approximately 20 kDa protein is considered to 
be the full-length recombinant VPg (cloning o f the sequence downstream o f the T7 
promoter o f  the pET28a expression vector, plus the histidine residues result in His- 
tagged VPg o f approximately 20 kDa).
Once reactivity between the VPg antiserum and the recombinant VPg was 
verified, the next step was to assay the reactivity and specificity o f the anti-VPg 
antiserum with FCV-infected cell extracts (Section 3.6.2), SDS-PAGE and Western 
blot analysis o f FCV- and mock-infected CRFK cells revealed bands o f approximately 
88, 45, and 20 kDa (Figure 3.7). Since in FCV infection the VPg protein forms part 
o f a 200 kDa precursor polyprotein that is cleaved to produce the individual proteins 
(helicase, VPg, cysteine proteinase and polymerase [Neill, 1990]) encoded in ORF 1 
[Carter, 1989a; Sosnovtseva et al., 1999] the results were suggestive o f the presence 
o f uncleaved polyprotein products. Intermediate sized polyprotein products have been 
described for FCV by Carter [1989a] Sosnovtseva et al. [1999] and Sosnovtsev et al. 
[2002]; RHDV by Wirblich et al. [1995 & 1996] and Alonso et al. [1996]; and SV by 
Liu et al. [1996]. Most o f these studies have determined the exact cleavage sites that 
result in the production o f cleaved polyprotein products and are depicted in Figure 
1.4 (Sections 1.7.4 & 1.7.5).
Previous studies in FCV-infected cells have demonstrated the presence o f several 
precursor proteins (incomplete cleavage o f  the FCV polyprotein) o f 120, 90, 43, and 
33 kDa that cross-reacted with anti-VPg antiserum [Sosnovtsev & Green, 2000]. 
Studies by Sosnovtseva et a l  [1999] have identified four cleavage sites mapped to the 
FCV genome (Urbana strain). Cleavage at E 960/A961 and E 10?1/S 1072 defined a 12.7
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kDa protein corrsponding to the FCV VPg protein although it appeared as a 14 kDa 
product in SDS-PAGE analysis. Cleavage at E 107,/S 1072 defined the N-terminal border 
o f the 3CD-like 78 kDa Proteinase-polymerase (Pro-Pol) previously mapped to the C- 
terminus o f  a VPg-Protemase-Polymerase-encoded sequence. An additional cleavage 
site (E1345/T 1346 and E 1419/G I42°) mapped inside the Pro-Pol was predicted to inactivate 
the polymerase by truncation o f functional domains [Sosnovtseva et a l ,  1999; Wei et 
a l,  2001]. Recently Sosnovtsev et a l  [2002] presented a completed processing map 
with the essential cleavage sites and size products o f the nonstructural polyprotein 
encoded by ORF1 o f the FCV genome (Urbana strain). They reported that the N- 
terminal half o f the FCV ORF1 polyprotein processed by the FCV 3C-like proteinase 
at cleavage sites E46/A47, E331/D332 and E685/N686 produced proteins with calculated 
molecular weights o f 5.6, 32, and 38.9 kDa (designated 5.2, 32 and 39 kDa as 
depicted in Figure 1.4, Section 1.7.4). The latter cleavage site (E685/N686) also defined 
the N-terminal border o f a 30 kDa protein. These studies together with the cleavage 
sites determined by Sosnovtseva et a l  [1999], suggests that the FCV ORF1 gene 
order is p5.6-p32-p39 (NTPase) - p30 - VPg - Pro - Pol. Figure 3.13 shows a 
diagrammatic representation o f  the results described in Section 3.14 (Figure 3.7) in 
alignment with the FCV polyprotein gene order as defined by Sosnovtsev et a l  
[2002]. The approximately 88 kDa protein detected by the VPg antisera is thought to 
be a cleaved product containing VPg and the protease and polymerase (VPg-Pro-Pol) 
proteins. The approximately 45 kDa protein detected suggests a product containing 
the 30 kDa protein proceeding VPg (p30) and the VPg protein (p30-VPg). The 20 kDa 
protein band is considered to be the fully cleaved VPg. Although the calculated size o f 
the protein o f this strain (FCV F9) is approximately 15 kDa, its mobility in SDS-
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PAGE may have been hindered, resulting in a higher molecular weight band. This is 
not uncommon and has been reported elsewhere [Sosnovtseva et ah, 1999].
Binding o f  canonical initiation factors eIF4A, eIF4G, and eIF4E to 
recombinant FCV VPg were assayed in two different ways. Pull down (described in 
Section 3.7 and Figure 3.1) and ELISA (Section 3.8) assays were performed and all 
the above factors were assayed. eIF4A and eIF4G did not interact with VPg and this 
was demonstrated by both pull down and ELISA-based binding assays (Sections 3.15 
& 3.16; Figures 3.9, 3.10 & 3.11). However, the present studies demonstrated an 
interaction between eIF4E and FCV VPg (Sections 3.15 & 3.16; Figures 3.8, 3.11 & 
3.12). In the pull down assay, samples containing NiNTA+VPg, unbound HeLa 
proteins, and HeLa proteins bound to VPg were subjected to SDS-PAGE and Western 
blotting analysis and were probed with anti-eIF4E antiserum and peroxidase-linked 
goat anti-rabbit IgG. A band was detected in the HeLa protein bound to VPg sample 
(Figure 3.8). However a band o f strong intensity also appeared in the unbound HeLa 
proteins sample. This outcome may be due to low affinity o f the recombinant His- 
tagged VPg for eIF4E as a result o f  the purification state o f the protein. An alternative 
possibility is that the amount o f His-tagged VPg (0.72 pg) present in the Ni-NTA 
agarose was too low to interact with the amount o f eIF4E present in the HeLa SIO 
extract, thus any unbound eIF4E was washed off with other unbound HeLa proteins. 
However, using ten times more VPg did not alter this result. The assay was repeated 
twice as previous pull down assays produced more than one band reacting with anti- 
eIF4E antisera in the HeLa bound sample. This problem was resolved by using 
recombinant VPg instead o f E. coli lysate-containing expressed VPg, and by 
substituting the secondary antibody from peroxidase-linked donkey anti-rabbit IgG
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with peroxidase-linked goat anti-rabbit IgG. It was identified that donkey anti-rabbit 
HRP conjugate cross-reacted with other bacterial proteins, thus producing extra bands 
in the HeLa bound to VPg sample.
The results o f the pull down binding assay were consistent with those seen in 
the ELISA-based binding assay. Figure 3.11 shows a graph with the mean OD492 
values o f mammalian eIF4E bound to recombinant His-tagged VPg-coated wells. This
f
result is supported by a second experiment (Figure 3.12). The adsorbance readings at 
OD492 were slightly different for the corresponding values o f 5 and 10 pi eIF4E lysate 
in the two experiments (Figures 3.11 & 3.12) but this can be attributed to the 
different batches o f  FCV His-tagged VPg. In addition, in the second ELISA-based 
binding assay, eIF4E lysate was also incubated with non-tagged VPg (Figure 3.12), 
The results for both VPg proteins (i.e His- tagged and non-tagged) were suggestive o f 
binding between FCV VPg and eIF4E, although the non-tagged VPg interaction was 
not as strong. These results may well be due to differences in isolation and/or 
purification procedures which may have affected the activity states o f the two 
proteins. Use o f E.coli lysates expressing the two different forms o f the VPgs could be 
assayed in the ELISA-based binding assay as bacterial proteins do not interfere with 
the system [Leonard et a l ,  2000]. The binding affinities between VPg and eIF4E 
could be assayed by addition o f  increasing amounts o f a competitor substance such as 
a cap analogue or use 4E-BP1 [Haghighat et a l ,  1995] to try and inhibit the reaction.
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Chapter 4
UV-cross linking studies with the 5’ and 3’ ends of the FCV 
genome
4.1 INTRODUCTION
It has been known for over 20 years that poliovirus mRNA translation in rabbit 
reticulocyte lysates (RRL) is inefficient and inaccurate (especially at high RNA 
concentrations) but it can be rescued by addition o f HeLa cell extracts [Brown & 
Ehrenfeld 1979; Dorner et al., 1984]. The same is true for other enteroviruses and in 
particular for rhinovirus IRES-containing RNA [Borman et al., 1993]. Furthermore, 
addition o f liver cell but not HeLa cell extracts stimulated the translational efficiency 
o f the hepatitis A virus mRNA in RRL [Glass & Summers, 1993]. It was therefore 
correctly assumed that some IRES elements required additional cellular factors to the 
canonical initiation factors for optimal efficiency. A number o f cellular proteins have 
now been identified as binding to the picornavirus IRES elements with the use o f UV 
cross-linking. These include the autoantigen La, the polypyrimidine tract binding 
protein (PTB), the um- protein, the poly(A)-binding protein (PABP), and the poly(rC)- 
binding protein-2 (PCBP-2) (Sections 1.15.1,1.15.2 & 1.15.3).
Recently, binding o f PTB and La proteins to the 5’ end o f the NV genome was 
demonstrated by UV cross-linking and immimoprecipitation assays. In the same study 
it was also shown that PCBP-2, unr and hnRNP L interact with the 5’ end o f the NV 
genome [Gutierrez-Escolano et a l ,  2000].
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The aim o f these studies was to initially determine which cellular proteins, found 
in HeLa SIO cell extract, bind to the 5’ and the 3 ’ regions o f the FCV genome. After 
observing that PTB binds to the 5’ end o f the FCV genome, further studies were 
performed to determine whether recombinant PTB binds to this region. Positive 
results o f  interaction between recombinant full-length PTB and the 5’ end o f the FCV 
genome led to a final competitive study in order to confirm the interaction.
The FCV genome regions used for these protein-RNA studies comprised the first 
190 nt o f the 5’ end with (nt 1 to 190) and without (nt 20 to 190) the UTR (5’+UTR, 
190 nt and 5’-UTR, 171 nt respectively) and the first 191 nt o f the 3’ end with the 
UTR (3’+UTR, nt 7500 to 7690).
METHODS
4.2 Amplification of the 5’ and 35 ends of the FCV genome
A 100 pi PCR reaction mixture was prepared as described in Section 2.17. 
RNA from FCV-infected cells was reverse transcribed (Sections 2.15 & 2.16) and 2 
pi used in the reaction along with 1 pg o f each o f the forward and the reverse primers. 
The names and sequences o f the primers are listed below in Table 4.1 (also see 
Appendix 1). The underlined sequences in the forward (FOR) and reverse (REV) 
primers are the H m dlll and Pstl restriction sites, respectively, used for ligations into 
the pGEM-4Z vector (Section 4.3).
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Name Sequence Amplicon range
FOR5’+UTR CAAAGCTTCGTAAAAGAAATTTGA nt 1 to 15
REV5’+UTR CACTGCAGACATACGTCGTAACT nt 190 to 176
FOR5’-UTR CAAAGCTTAATGTCTCAAACTCT nt 20 to 34
REV5’-UTR same as REV5’+UTR nt 190 to 176
FOR3’+UTR CAAAGCTT CAAAGGGTACAAGGCC nt 7500 to 7485
REV3’+UTR CACTGCAGCCCTGGGGTTAGGCG nt 7690 to 7676
Table 4.1: Primer sequences used for the production of the FCV genome regions 
5’+UTR (nt 1 to 190), 5’-UTR (nt 20 to 190), and 3’+UTR (nt 7500 to 7690) for 
use in the cross linking studies.
The PCR cycle parameters used to successfully isolate the 5’+UTR and 5’- 
UTR fragments are shown in Table 4.2. The PCR cycle parameters used to 
successfully isolate the 3’+UTR fragment are shown in Table 4.3. All the PCR 
reaction products were assayed by electrophoresis through a 1.2% agarose gel.
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1. Initial denaturation at 94°C for 5 min xl
2. Main Cycle x 25: (a) Denaturation: 94°C, 30 sec
(b) Annealing: 52°C, 30 sec
(c) Amplification: 72°C, 30 sec
3. Cooling at 72°C for 10 min x l
Table 4.2: PCR cyele details for the amplification of the S’+UTR and 5’- 
UTR fragments
1. Initial denaturation at 94°C for 5 min x l
2. Main Cycle x 25: (a) Denaturation: 94°C, 30 sec
(b) Annealing: 65°C, 30 sec
(c) Amplification: 72°C, 30 sec
3. Cooling at 72°C for 10 min x l
Table 4.3: PCR cycle details for the amplification of the 3’+UTR fragment
4.3 Production of pGEM-4Z/5’+UTR, pGEM-4Z/5’-UTR and 
pGEM-4Z/3’+UTR plasmids
The PCR products were purified using Promega’s Wizard PCR preps DNA 
purification system (Section 2.18), Following ligation into the pGEM-Teasy vector 
(Section 2.4) production o f  pGEM-Teasy/5’+UTR, pGEM-Teasy/5’-UTR, and 
pGEM-Teasy/3’+UTR plasmids was achieved. The plasmids were transformed into 
competent E.coli D H 5a cells. Following transformation and overnight growth o f
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colonies in LB medium, the plasmids were subsequently minipreped (Sections 2.5, 
2.6 & 2.7), The plasmids were subjected to restriction enzyme digestion with Hindlll 
and Pstl (Section 2.1) in order to isolate the FCV sequences and run on a 1.2% 
agarose gel (Section 2.2). The fragments were gel excised and purified using the 
QIAquick gel extraction kit (Section 2.3) and finally ligated into pGEM-4Z vector 
(Section 2.4). The pGEM-4Z vector was also previously digested with HindiII and 
Pstl restriction enzymes, run on a 1% agarose gel, gel excised and purified using the 
QIAquick gel extraction kit. Following ligation the three plasmids produced, pGEM- 
4Z/5’+UTR, pGEM-4Z/5’-UTR, and pGEM-4Z/3’+UTR were transformed into 
competent E.coli D H 5a cells (Sections 2.5 & 2.6). The overnight cultures were 
minipreped using the QIAGEN Spin Miniprep kit (Section 2.7a). The minipreps were 
checked on a 1.2% agarose gel against X markers and a spectrophotometer (at X = 260 
nm) to determine the concentration o f plasmid DNA present. DNA sequencing 
(Section 2,21) was also performed to verify that plasmids contained the correct 
sequence (Appendix 3).
4.4 Production of [32P]-labelled RNA transcripts
Linearization o f plasmids downstream o f  the FCV sequences was achieved by 
restriction enzyme digestion with BamHL (Section 2.1). Plasmid pD 1+2+3, which 
contains the EMCV 5’ UTR from nt 227 to 838 inserted in pGEM l as an EcoRI- 
BamHY fragment [Kaminski et al., 1995] was used as a positive control (plasmid 
kindly provided by Dr Ann Kaminski, University o f  Cambridge). Plasmid pD 1+2+3 
was also checked on a 1.2% agarose gel against X markers and a spectrophotometer 
(at X = 260 nm) to determine the concentration o f plasmid DNA present, and
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linearized with BamHl. The linearized plasmids (pGEM-4Z/5’+UTR, pGEM-4Z/5’- 
UTR, pGEM-4Z/3’+UTR and pDl+2+3) were subjected to phenol / chloroform 
extraction and ethanol precipitation. Each pellet was resuspended in 20 pi RNase-free 
H20  and used for the production o f  [32P]-labelled RNA transcripts (Section 2.9). One 
pi from each sample was checked on a TBE gel to ensure that equal amounts were 
used in subsequent cross linking studies.
4.5 UV cross-linking of HeLa SIO cell extract to the 55 and 3’ ends 
of the FCV genome
A 96 well round bottom well plate was used for all the cross-linking 
experiments. The reactions contained pGEM-4Z/5 ’+UTR, pGEM-4Z/5’-UTR, 
pGEM-4Z/3’+UTR, and pD 1+2+3 (positive control) RNA transcripts. In addition two 
negative controls were prepared; one contained HeLa SIO lysate and instead o f RNA, 
RNase-free water was used and UV cross-linked (in order to treat the protein content 
o f the HeLa cell extracts the same). The second negative control sample was the same 
but it was not subjected to UV cross-linking.
UV cross-linking reactions contained: 1 pi [32P]-labelled RNA transcript, 0.5 
pi tRNA (2 mg/ml), 1 pi KC1 (1 M), 3.5 pi RNase-free H20 , 2 pi 5x binding buffer 
(A ppendix 4), and 1 pi HeLa SIO extract (provided by Dr Ken Mellits, University o f 
Nottingham). The samples were covered with the lid and left at room temperature for 
15 min. The plate was placed on ice and after removing the lid the samples were 
irradiated three times at 8,000 (x 100 pJ/cm2) in the UV Stratalinker 1800 device. 
Following cross-linking, 4 pi RNase mix (100 pi 5 mg/ml RNase ONE™, Promega; 
50 pi lOx dilution buffer; 350 pi RNase-free H20 )  was added to each well. The plate
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was sealed with the lid and Nescofilm and was incubated at 37°C for 15 min. Finally, 
10 pi sample buffer and 1 pi DTT were added and the mixtures were transferred to 
sterile eppendorfs. 10% SDS-PAGE analysis was carried out according to the protocol 
described in general methods (Section 2.20). Gels were stained, destained, dried and 
exposed to X-ray film. The results were visualised by autoradiography.
4.6 UV cross-linking of recombinant PTB to recombinant FCV 
sequences
The protocol followed was the same as in Section 4.5 but instead o f HeLa SIO 
extract, 2 pg o f recombinant human PTB protein (531 aa) were used. The transcripts 
5’+UTR, 5’-UTR, 3’+UTR (negative control) and pD 1+2+3 (EMCV IRES; positive 
control) were UV cross-linked with recombinant fall length PTB [hisPTB, 1-531 aa; 
Conte et al. , 2000] which was kindly provided by Dr Stephen Curry (Imperial 
College, London).
4.7 Competitive binding study
Transcripts (5’+UTR) labelled with [32P] a-CTP (Section 2.9) and non­
labelled 5’+UTR transcript (1 pi 10 mM rCTP was used) were produced as described 
in Section 4.4. Reactions contained 500 ng o f [32P]-labelled pGEM-4Z/5’+UTR 
transcript and increasing amounts (0, 0.01 pg, 0.1 pg, 1 pg and 2 pg) o f non-labelled 
pGEM-4Z/ S’+UTR. Full length PTB (1 pg) was added to each sample and the 
reactions were UV cross-linked.
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RESULTS
4.8 PTB binds to the 5’ end of the FCV genome
RNA transcripts containing nt 1 to 190 (5’+UTR), nt 20 to 190 (5’-UTR), nt 
7500 to 7690 (3’+UTR) o f the FCV genome and nt 227 to 838 o f  the EMCV 5’ UTR 
and were cross-linked with HeLa S10 extract. The samples were subjected to 10% 
SDS-PAGE analysis and results were visualised by autoradiography.
The results obtained and presented in Figure 4.1 show the binding o f several proteins 
in samples 5’+UTR, 5’-UTR, and EMCV IRES. Sample 3’+UTR produced only one 
band, which was also present in the other three samples, suggesting that most o f the 
protein binding occurs at the 5’ end o f the FCV genome.
O f particular interest was the presence o f  two bands migrating between 47.5 and 62 
kDa in samples 5’+UTR, 5’-UTR, and EMCV IRES. Their sizes were suggestive o f 
the presence o f the La (52 kDa) and PTB (57 kDa) proteins and are indicated by 
arrows in Figure 4.1. The 57 kDa protein was o f  very strong intensity in the EMCV 
IRES sample, compared with samples 5’+UTR and 5’-UTR, whereas the intensity o f 
the 52 kDa protein was stronger in the FCV 5’ end samples.
Bands o f approximately 120, 95 and 10 kDa were also present in samples containing 
the 5’ end o f the FCV genome (plus or minus the UTR) and the EMCV IRES. 
Another band o f  approximately 45 kDa is present in the 5’+UTR and EMCV IRES 
samples but is extremely faint in the 5’-UTR sample. The band that is present in all 
four samples is approximately 75 kDa. Proteins such as um- and hRNP L, which are 
97 and 68 kDa respectively, could well represent the 95 and 75 kDa bands. No bands 
were observed in either negative control.
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Figure 4.1: UV cross-linking of HeLa cell extract proteins to FCV RNA.
Regions o f the 5’ (plus or minus the UTR; nt lto  190 and nt 20 to 190, respectively) and 3’ 
(nt 7500 to 7690) ends o f  the FCV genome were incubated with HeLa cell extracts as 
indicated, UV irradiated, RNase digested, analysed by SDS-PAGE and visualised by 
autoradiography. The EMCV IRES acted as a positive control. The two negative controls 
comprised o f HeLa S10 extract and no RNA; one sample was subjected to cross-linking 
whereas the other was not.
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4.9 Recombinant full-length PTB binds to the 5’ end of the FCV 
genome
As the results presented in Figure 4.1 (Section 4.8) suggested PTB may bind 
to the FCV genome, recombinant fiill-length PTB was incubated with [32P]-labelled 
pGEM-4Z /5NTJTR, pGEM-4Z /5’-UTR, pGEM-4Z /3’+UTR and pDl+2+3 RNA 
transcripts produced as described in Section 4.4. The 3’+UTR transcript o f the FCV 
genome and the EMCV IRES transcript (pD 1+2+3 plasmid) o f  the EMCV genome 
served as negative and positive controls respectively. The results shown in Figure 4.2 
were visualised by autoradiography. These results confirmed that PTB does interact 
with the 5’ end o f  the FCV genome irrespective o f the presence o f  the 5’ UTR 
sequence. This suggests that PTB may bind to the 5’ end o f the FCV coding region.
4.10 Recombinant full-length PTB binds specifically to the 5’ end of 
the FCV genome
After establishing that recombinant fiill-length PTB binds to the 5’ end o f the 
FCV genome (Section 4.8, Figure 4.2) another UV cross-linking study was 
performed using an unlabelled 5’ end RNA transcript (5’+UTR) as competitor, to 
further verify the specific binding o f PTB with the 5’ end o f the FCV genome. The 
amount o f the 32P-labelled transcript was 500 ng in all samples and unlabelled 
transcripts (0.01 pg, 0.1 pg, 1 pg, and 2 pg) were added. The amount o f  recombinant 
fiill-length PTB was 1 pg in all samples. The samples were analysed by 10% SDS- 
PAGE and visualised by phosphoimager analysis (Molecular Imager R FX, Biorad). 
Figure 4.3 shows a decrease o f  the signal o f [32P]-labelled 5’ end RNA transcript with 
increasing amounts o f unlabelled 5’ end RNA transcript.
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Figure 4.2: Recombinant full length PTB binds to the 5’ end of the FCV genome.
Transcripts containing the 5’ end (plus or minus the UTR; nt lto 190 and nt 20 to 190, 
respectively) o f the FCV genome were incubated with 2 pg o f recombinant full-length 
PTB protein, UV irradiated and RNase treated. The 3’+UTR FCV transcript served as 
negative control (see Figure 4.1) and the EMCV IRES transcript as positive control. 
The samples were analysed by SDS-PAGE and visualised by autoradiography.
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Figure 4.3: Recombinant full length PTB binds the 5’+UTR of the FCV genome.
The first 190 nucleotides of the 5’ end of the FCV genome bind to recombinant full 
length PTB (Figure 4.1). FCV 32P-labelled 5’+UTR RNA transcripts (500 ng) were 
incubated with various amounts of unlabelled 5’+UTR RNA transcripts and 1 pg full 
length PTB as indicated, UV irradiated and RNase digested. The samples were subjected 
to SDS-PAGE analysis and visualised by phosphoimager analysis.
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The results show that the 5’+UTR-PTB binding can be competed effectively with 0.5 
pg of unlabelled transcript (decrease in the band intensity is evident after addition of 1 
pg unlabelled competitor RNA transcript). The radioactive signal was further reduced 
after addition of 2 pg of competitor 5’+UTR verifying that PTB binds to the 5’ end of 
the FCV genome.
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4 . 1 1  D is c u s s io n
As mentioned in Section 4.1 the aim of this study was to initially identify the 
interaction of cellular proteins, other than the canonical intiation factors to the 5’ 
and/or 3’ ends of the FCV genome. The RNA transcripts used contained sequences 
from the 5’ end (nt 1 to 190 and nt 20 to 190) and 3’ end (nt 7500 to 7690) of the FCV 
genome and the 5’ UTR (nt 277 to 838) of the EMCV genome. The results, shown in 
Figure 4.1 (Section 4.8) indicated the presence of proteins of approximately 120, 95, 
57, 52 and 10 kDa in samples containing the 5’+UTR, 5’-UTR, and EMCV IRES 
transcripts only. A band corresponding to approximately 45 kDa was observed in all 
samples, including the 3’+UTR fraction. No bands were observed in either negative 
control.
The observation of the band migrating at about 57 kDa suggested the presence of the 
PTB protein. Indeed the strong intensity of the band in the EMCV IRES (pD 1+2+3 
transcipt) sample, along with information from previous studies [Jang & Wimmer, 
1990; Borovjagin et a l, 1991; Hellen et a l, 1993; Borman et a l, 1993; Borovjagin et 
al, 1994; Kaminski et a l, 1995; Kaminski & Jackson, 1998], strongly suggested that 
the protein band migrating at this position was PTB.
The protein migrating at about 52 kDa was thought to be La. However, it is known 
that EMCV mRNA translates efficiently and accurately in RRL which lack La 
[Jackson, 1986]. Moreover, addition of La to RRL had no effect on translation of the 
EMCV mRNA in contrast to poliovirus RNA [Svitkin et a l, 1994a], whose 5’ UTR is 
known to bind La [Meerovitch et al., 1989]. The same result was confirmed by Kim 
and Jang [1999] although they further demonstrated that the inhibitory effect of 
excess PTB in EMCV mRNA translation is rescued by La. The intensity of the 52 
kDa protein in the EMCV IRES sample however is not as strong as in the FCV 5’ end
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samples. Based on these observations, the interaction of the 5’ and 3’ ends of the FCV 
genome with other cellular proteins was further investigated by another assay as 
presented in Chapter 5.
The observation of the band migrating at 95 kDa and our belief that it might be unr 
(97 kDa) again is not supported by the EMCV IRES positive control as it has been 
shown that a 97 kDa protein does not cross-link with the 55 UTR of EMCV [Borman 
et al., 1993]. The presence of the bands migrating at 120, 45 and 10 kDa cannot be 
accounted for, as there is no literature supporting such findings. Meerovitch et al.
[1989] have reported cross-linking of a minor polypeptide of 100 kDa to the 
polio virus 5’ UTR (nt 559 to 624) but after addition of 100-fold molar excess of RNA 
cross-linking of the 100 kDa protein was increased, indicating that binding was not 
specific.
The only account of binding of cellular proteins to cahcivirus RNA is a report by 
Gutierrez-Escolano et al. [2000] that demonstrated the binding of HeLa and CaCo-2 
proteins to the first 110 nt of the 5’ end of the Norwalk virus genome. The sizes of the 
proteins that cross-linked with the 5’ end of the NV genome were 97, 68, 57/60, 52, 
and 39 kDa. The poliovirus 55 UTR (nt 275 to 628) served as their positive control. 
Further studies identified proteins 57/60 kDa as PTB (by cross-linking), 52 and 68 
kDa as La and hnRNPL, respectively (by immunoprecipitation), and 39 kDa as 
PCBP-2 (by mobility supershift electrophoresis assay). UV cross-linldng of NV RNA 
(nt 1 to 110) with HeLa and CaCo-2 S10 extracts and recombinant PTB produced a 
band of 57/60 kDa but its intensity was stronger in the poliovirus controls. Those 
results along with the ones presented in this study suggest that PTB may bind to the 5’ 
end of the genome of all caliciviruses. The 97 kDa and 52 kDa proteins found to 
cross-link with the 5’ end of the NV genome may correspond to the 95 kDa and 52
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kDa proteins that eross-linked with the 5’ end of the FCV genome. However, cross- 
linking of the 68 kDa and 39 kDa proteins was not seen in these studies. Instead, 
proteins of 120, 45, and 10 kDa were seen to cross-link with the 5’ end of the FCV 
genome as well as with the EMCV IRES (pD 1+2+3 transcript) positive control. The 
75 kDa protein was the only one seen to bind as well to the 35 end of the FCV 
genome. The significance of the interactions of these different sized proteins with the 
FCV and NV genomes is not yet clear and requires further assaying. The results of the 
interactions of La (52 kDa) and PCBP-2 (39 kDa) proteins with the 5’ end of the FCV 
genome will be discussed in Chapter 5. The profile of the proteins that interact with 
the 5’ end of the FCV genome could be further assayed by the production of CRFK 
SIO extracts and their use in cross-linking. These studies would determine whether 
there are any differences in profiles of proteins binding to FCV RNA from the two 
cell lines (i.e. HeLa and CRFK).
The strong indication of the interaction of PTB with the 5’ end of the FCV 
genome led to the next study in which recombinant full length PTB was cross-linked 
to the same RNA transcripts (Section 4.9). This time, the 3’+UTR transcript of the 
FCV genome and the EMCV IRES transcript served as negative and positive controls 
respectively. The results presented in Figure 4.2 supported the suggestion that PTB 
binds to the 5’ end of the FCV genome irrespective of the presence of the 5’ 
untranslated region.
In order to show that binding of PTB to the 5’ end of the FCV genome was 
specific, a competitive binding study was conducted (Section 4,10). Incubation of 500 
ng [32P]-labelled 5’+UTR RNA transcript with 1 pg recombinant full-length PTB and 
increasing amounts of non-labelled 5’+UTR transcript led to a reduction in band 
intensity due to cross-linking with PTB. A reduction in the band intensity was
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observed after addition of 50% excess of non-labelled RNA (1 pg ‘cold’ 5’+UTR 
RNA transcript, Figure 4.3) verifying that binding of PTB to the 5’ end of the FCV 
genome is specific. The reactions also contained 0.5 pg of tRNA which acted as a 
non-specific competitor RNA.
As mentioned in Sections 4.1 & 4.2, the length of the 5’ end used in these 
studies was from nt 1 to 190 (including the UTR) and nt 20 to 190 (without the UTR). 
The results indicated (Figures 4.1 & 4.2, Sections 4.8 & 4.9) that binding of PTB 
occurs irrespectively of the presence of the untranslated region. This suggests that the 
5’UTR is not an essential sequence for specific binding of PTB to the 5’ end of the 
FCV genome. UV cross-linking studies using shorter sequences than 190 nt would 
allow determination of the minimum sequence to which PTB binds. In addition, 
affinity studies of full-length, truncated and mutated versions of PTB using the 
EMCV IRES fragment 1 (domains D, E, F, G and H) as the positive control, as 
described in Conte et al. [2000], would allow determination of the binding affinities 
of PTB and its trimcated or mutated versions to the 5’ end of the FCV genome. 
Alternatively, filter-binding assays [as described in Conte et a l, 2000] could be 
performed to determine the strength of interaction between the full-length and 
truncated / mutant PTBs and the 5’ end of the FCV genome.
The results of this study were confirmed by Dr Michael Niepmann’s group 
[Institute of Biochemistry, Giessen, Germany]. It was shown that nt 1 to 681 
(designated ORFa) and nt 1 to 1012 (ORFb) of the FCV genome cross-link with PTB. 
Plasmids supplied to Dr M. Niepmann contained the FCV sequences inserted into 
pGEM-3Zf vector which were assayed by TnT for protein production. Previously 
these FCV fragments were isolated from pGEM-Teasy vector by EcoRI digestion 
(pGEM-Teasy plasmids were provided by Dr Margaret Willcocks, School of
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Biomedical & Life Sciences, University of Surrey). Dr Niepmann’s group (all 
experiments were performed by Yotong Song) also tested for functional requirement 
of PTB in FCV mRNA translation using both ORFa and ORFb transcripts in PTB- 
depleted RRL. It was concluded that PTB did not stimulate translation of either 
transcript. Insight into the functional requirement of PTB in FCV mRNA translation 
will be hopefully provided by assaying VPg-attached full-length FCV mRNA isolated 
from FCV-infected cells in PTB-depleted RRL (this study is being currently 
performed by Dr Michael Niepmann’s group, Institute of Biochemistry, Giessen, 
Germany).
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C h a p t e r  5
I n t e r a c t i o n  o f  c e l l u l a r  p r o t e in s  w i t h  t h e  5 9 a n d  3 ’ e n d s  o f  t h e
F C V  g e n o m e
5 .1  I N T R O D U C T I O N
A novel protein-RNA binding assay using oligo-dT Dynabeads was developed 
by Stassinopoulos and Belsham [2001]. This assay enabled the study of functional 
interactions of the FMDV IRES with canonical initiation factors and other cellular 
proteins. The concept is diagrammatically depicted in Figure 5.1. Briefly, oligo-dT 
beads immobilise RNA transcipts with a poly(A) tail. Addition of TnT-derived 
proteins or rabbit reticulocyte lysates (RRL) allows binding of proteins to the 
immobilised RNA transcripts. After washing off unbound proteins, SDS-PAGE (in 
the case of TNT-derived proteins) and/or Western blotting (in the case of incubation 
with RRL) analyses determine which proteins bind to the transcripts of interest.
Having established that cellular proteins PTB and possibly La bind to the 5’ end of the 
FCV genome (Chapter 4) further studies were performed to determine whether the 
components of the eIF4F complex, that is, eIF4A, eIF4E, and eIF4G interact with the 
5’ and/or 35 ends of the FCV genome by using the oligo-dT bead binding assay. In 
addition, La, PCBP-1 and PCBP-2 proteins were assayed to determine any interaction 
with the 5’ and/or 3’ ends of the FCV genome. In the case of PCBP-2, the assay was 
carried out to determine whether this protein binds the 5’ end of the FCV genome as 
suggested for the 5’ end of the NV genome [Gutierrez-Escolano et a l, 2000].
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Figure 5.1 : Diagrammatic illustration of the principle of the RNA-protein binding 
assay.
The diagram illustrates the addition of RRL which contains several cellular proteins. In the 
case of TNT-derived proteins, only one protein was present.
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The RNA transcipts used in this assay contained sequences from the 5’ (nt 1 to 190) 
and 3’ ends (nt 7500 to 7690) of the FCV genome and include the untranslated 
regions. FMDV IRES fragment 1 (nt 653 to 803; domains J, K and L) [Stassinopoulos 
& Belsham, 2001] was used as a control.
M E T H O D S
5 .2  P r o d u c t io n  o f  R N A  t r a n s c r ip t s  w i t h  a p o l y ( A )  ta il
The 5’+UTR (nt 1 to 190) and 3’+UTR (nt 7500 to 7690) fragments of the 
FCV genome were excised from pGEM-Teasy (Section 4.2.2) by digestion with Hind 
III and Pstl restriction enzymes. The fragments were subjected to 1% agarose gel 
electrophoresis, gel excised and purified (Section 2.3) and then sub-cloned (Section
2.4) into pSP64poly(A) vector (Ambion), which was previously digested with Hindlll 
and Pstl. The pSP64poly(A) + 5’+UTR and pSP64poly(A) + 3’+UTR plasmids were 
transformed into competent JM109 E.coli cells (Sections 2.5 & 2.6), and plated out 
on LB agar containing ampicillin (Appendix 4) and left to grow o/n at 37°C. At least 
two colonies were picked the following day, and after growing in 5 ml LB broth and 
ampicillin at 37°C o/n they were minipreped as described in Section 2.7. The 
plasmids were re-transformed and grown in 100 ml LB broth and ampicillin at 37°C 
o/n and maxipreped (Section 2.8) the following day.
The plasmids (5 pg) were linearized by digestion with EcoPl and then 
phenol/chloroform extracted and ethanol precipitated at -20°C o/n. The pellet was 
resuspended in 10 pi RNase-free H2O.
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The linearized plasmids (5 pi, approx. 2 pg) were transcribed using the Megascript 
SP6 kit with SP6 RNA polymerase for 4 h at 37°C as described in Section 2.10. They 
were phenol/chloroform extracted and isopropanol precipitated at -20°C o/n. On the 
following day they were centrifuged at 14,000 rpm for 15 min and the pellet was 
resuspended in 20 pi RNase-free FLO. A positive control, pSP64poly(A) + FMDV Fl 
transcript (containing nt 653 to 803; domains J, K, and L) [Stassinopoulos & 
Belsham, 2001] was kindly provided by Dr Graham Belsham (Institute for Animal 
Health, Pirbright, Surrey) and a negative control, 5 pg poly(A) (polyadenylic acid 
[5’], potassium salt; Sigma) were used.
Transcripts (1 pi) were analysed on a TBE agarose gel (Section 2.2) and their 
concentration was determined by reading the OD at 260nm.
5 .3  P r o d u c t io n  o f  p r o te in s  in  c o u p le d  t r a n s c r ip t io n  a n d  t r a n s la tio n  
re a c tio n s
The proteins used in the protein-RNA binding assay (Section 5.4) were the 
three canonical initiation factors eIF4A (sequence cloned into pGEM-3Z; Li et al, 
2001), eIF4E (cloned into pGEM-3Z; by digestion with £coRI and BamHl from pET- 
1 Id + eIF4E; kindly provided by Professor Chris Proud, University of Dundee) and 
eIF4G (cloned into pSK-HFCl; Joshi et a l, 1994), and also the cellular proteins La, 
PCBP-1 and PCBP-2 (all cloned in pCDNA3.1 vectors; kindly provided by Dr Anne 
Willis, University of Leicester). TNT reactions were performed as described in 
Section 2.11. Each reaction contained 0.5 pg of plasmid DNA. Each plasmid was 
checked in a TnT reaction for production of protein of the expected size prior to use in 
the Dynabead RNA-protein binding assay. The reactions were analysed by 10% and
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7.5% (eIF4G) SDS-PAGE (Appendix 4). Gels were stained, destained, dried and 
exposed to X-ray film. The results were visualised by autoradiography.
5 .4  P r o t e i n - R N A  b in d in g  a s s a y
Dynabeads 01igo(dT)25 (500 pi; Dynal) were put on a magnetic stand and left 
for 30 sec to equilibrate. The supernatant was removed and the beads were 
resuspended and washed with 500 pi 0.5x SSC (Appendix 4). The beads were placed 
on the magnetic stand and the supernatant was removed. They were washed with 500 
pi lx bead-binding buffer (Appendix 4), placed on the magnetic stand, the 
supernatant was removed and the pellets were resuspended in 50 pi of lx  bead- 
binding buffer. Poly(A)-tailed RNA transcripts (5 pg) containing the FCV 5’UTR and 
3’UTR, and FMDV IRES FI, or 5pg poly(A) control were added and the samples 
were left to mix on a rotor at 4°C for 30 min. The beads were washed twice in 500 pi 
lx bead-binding buffer as before. Individual TNT reactions (25 pi; Section 5.3) and 5 
pg tRNA (competitor; Sigma) were added and incubated with the immobilized RNA 
transcripts, immobilized poly(A) or dH20  (5 pi) for 60 min at 4°C as before. After the 
incubation the supernatants were removed and the beads washed twice with 500 pi lx 
bead-binding buffer as before. The beads were resuspended in 20 pi sterile dH20 , 10 
pi SDS sample buffer (New England Biolabs) and 1 pi DTT (New England Biolabs). 
All samples were analysed by 10% SDS-PAGE with the exception of the samples 
containing eIF4G which were analysed by 7.5% SDS-PAGE. Gels were stained, 
destained, dried and exposed to X-ray film. Results were visualised by 
autoradiography.
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An additional study was carried out for eIF4G. The protocol is the same as 
above with one exception. Instead of adding TNT-derived eIF4G, 50 pi rabbit 
reticulocyte lysate were added. Distilled H20  served as the negative control. 
Following resuspension of the beads in 20 pi sterile distilled water, 10 pi SDS sample 
buffer and 1 pi DTT, the samples were analysed by 7.5% SDS-PAGE and Western 
blotting. The blot was probed with anti-eIF4G and donkey anti-rabbit HRP conjugate. 
Results were visualised by addition of chemiluminescence reagents as described in 
Section 2.20.
R E S U L T S
5 .5  e I F 4 A  b in d s  to  th e  5 ’  a n d  3 ’  e n d s  o f  th e  F C V  g e n o m e
The 5’ and 3’ ends of the FCV genome and FMDV IRES FI were 
immobilised to oligo(dT) beads as described in Section 5.4. eIF4A was produced in a 
TnT reaction (Section 5.3) and incubated with the RNA transcripts.
Figure 5.2 shows the results obtained. The FMDV IRES FI transcript (positive 
control) produced a strong signal as expected [Stassinopoulos & Belsham, 2001]. The 
two bands produced corresponded to the two eIF4A isoforms (eIF4AI and eIF4AII, 
44.4 kDa and 46.3 kDa, respectively). The 5’ end of the FCV genome (nt 1 to 190) 
produced a strong signal for the two isoforms, as did the 3 ‘ end (nt 7500 to 7690) but 
the bands were of lower intensity. The poly(A) negative control produced two very 
faint bands, probably due to unspecific binding of eIF4A to the beads. The results are 
indicative of binding of both the 55 and 3’ ends of the FCV genome to eIF4A, with the 
former possibly binding better than the latter.
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Figure 5.2: The 5’ end of the FCV genome binds eIF4A stronger than the 3’ end.
RNA transcripts (5 pg) corresponding to the 5’ (nt ltol90) and 3’ (nt 7500 to 7690) ends 
of the FCV genome were bound to oligo dT Dynabeads. The beads-RNA complex was 
incubated with 25 pi of TNT-derived eIF4A. The FMDV IRES fragment 1 RNA 
transcript served as a positive control, whereas polyadenylic acid (poly(A)) served as 
negative control. The samples were analysed by SDS-PAGE and visualised by 
autoradiography.
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5 .6  c I F 4 E  d o e s n o t  b in d  to  th e  5 ’  a n d  3 5 e n d s  o f  th e  F C V  g e n o m e
The poly(A)-tailed RNA transcripts (Section 5.2) were incubated with oligo- 
dT beads and TNT-derived eIF4E (Section 5.3) as described in Section 5.5. The 
results obtained are shown in Figure 5.3. Both the 5’ and 3’ ends of the FCV genome 
produced extremely faint bands, indicative of no significant binding of eIF4E, versus 
the poly(A) negative control. The only strong signal band was produced in the FMDV 
IRES Fl sample. Although it is known that eIF4E is redundant in internal initiation of 
translation, a mechanism that all picornaviruses employ, in this particular study 
(which was repeated twice) the results indicate interaction between eIF4E and the 
FMDV IRES Fl. This finding and possible explanation are discussed later in Section 
5.10.
5 .7  e I F 4 G  d o e s n o t  b i n d  t o  e ith e r  th e  5 9 o r  th e  3 9 e n d s  o f  th e  F C V  
g e n o m e
As mentioned in Section 5.4 the binding of eIF4G to the 5’ and 3’ ends of the 
FCV genome was assayed in two different ways by the bead-binding assay. The first 
experiment was the same as in Section 5.5, i.e. oligo-dT beads were incubated with 
the 5’+UTR (nt 1 to 190), 3’+UTR (nt 7500 to 7690) and FMDV IRES Fl (nt 653 to 
803) poly (A) transcripts (Section 5.2) and TNT-derived eIF4G (Section 5,3). The 
samples were analysed by 7.5% SDS-PAGE and results were visualised by 
autoradiography. In the second experiment the same transcripts, this time including 
the 5’-UTR (nt 20 to 190) transcript, were incubated with the oligo-dT beads and 50 
pi RRL. The samples were analysed by 7.5% SDS-PAGE and Western blotting. The
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Figure 5.3: The 5’ and 3’ ends of the FCV genome do not bind eIF4E.
RNA transcripts (5 pg) corresponding to the 5’ (nt 1 to 190) and 3’ (nt 7500 to 
7690) ends of the FCV genome were bound to oligo dT Dynabeads. The beads- 
RNA complex was incubated with 25 pi of TNT-derived eIF4E. The FMDV IRES 
fragment 1 RNA transcript and polyadenylic acid (poly(A)) served as negative 
controls. The samples were analysed by SDS-PAGE and visualised by 
autoradiography.
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blot was probed with anti-eIF4G antiserum and peroxidase-linked donkey anti-rabbit 
IgG. In both experiments, the negative controls comprised of dFLO.
The results of these studies are shown in Figures 5.4 and 5.5 respectively. No 
interaction of eIF4G with either the 5’ or the 3’ ends of the FCV genome was 
observed using either protocol. The positive control FMDV IRES FI transcript 
produced a band with a size corresponding to eIF4G as expected [Stassinopoulos & 
Belsham, 2001]. In both studies the negative controls produced no bands.
5 .8  L a  a u to a n tig e n  in te r a c ts  w i t h  th e  5 9 e n d  o f  th e  F C V  g e n o m e
RNA transcripts (Section 5.2) corresponding to the 5’ (nt 1 to 190) and 3’ (nt 
7500 to 7690) ends of the FCV genome, along with FMDV IRES FI (nt 653 to 803) 
transcipt and polyadenylic acid were individually incubated with oligo-dT beads and 
TNT-derived La (Section 5.3) as described in Section 5.4. The samples were 
subjected to 10% SDS-PAGE analysis and the results were visualised by 
autoradiography.
Figure 5.6 shows the results obtained. The strongest signal (band intensity) was 
produced for the 5’HTJTR transcript indicating binding between La and the 5’ end of 
the FCV genome. This result is in concurrence with our assumption based on the UV 
cross-linking studies (Section 4.8) that La binds to the 5’ end of the FCV genome. 
Samples containing the 3’+UTR transcript and the polyadenylic acid produced very 
faint bands, indicating that the 3’ end of the FCV genome does not bind La. The 
FMDV IRES FI transcript produced a band of intermediate intensity, i.e. weaker than 
the 5’+UTR transcript but stronger than the 3’+UTR transcript and the polyadenylic 
acid negative control. To date no report has confirmed binding of La to any part of the 
FMDV 5’ UTR. These results are discussed in detail in section 5.10.
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Figure 5.4: The 5’ and 3’ ends of the FCV genome do not bind eIF4G.
RNA transcripts (5 pg) corresponding to the 5’ (nt 1 to 190) and 3’ (nt 7500 to 
7690) ends of the FCV genome were bound to oligo dT Dynabeads. The beads- 
RNA complex was incubated with 25 pi of TNT-derived eIF4G. The FMDV IRES 
fragment 1 RNA transcript served as a positive control, whereas sterile distilled 
H20  served as negative control. The samples were analysed by SDS-PAGE and 
visualised by autoradiography.
Figure 5.5: The 5’ and 3’ ends of the FCV genome do not bind eIF4G.
RNA transcripts (5 pg) corresponding to the 5’ (plus or minus the UTR; nt lto 190 
and nt 20 to 190, respectively) and 3’ (nt 7500 to 7690) ends of the FCV genome were 
bound to oligo dT Dynabeads and incubated with 50 pi RRL. The FMDV IRES 
fragment 1 RNA transcript served as a positive control, whereas sterile distilled H20  
served as negative control. The samples were subjected to SDS-PAGE and Western 
blot analysis. The blot was probed with anti-eIF4G antiserum followed by peroxidase- 
linked donkey anti-rabbit IgG and visualised using chemiluminescence reagents as 
described in Section 2.20.
Figure 5.6: La autoantigen binds to the 5’ end of the FCV genome.
RNA transcripts (5 pg) corresponding to the 5’ (nt Ito 190) and 3’ (nt 7500 to 
7690) ends of the FCV genome were bound to oligo dT Dynabeads. The 
beads-RNA complex was incubated with 25 pi TNT-derived La. The FMDV 
IRES fragment 1 RNA transcript served as a positive control, whereas 
polyadenylic acid (poly(A)) served as negative control. The samples were 
analysed by SDS-PAGE and visualised by autoradiography.
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5 .9  T h e  5 ’  a n d  3 ’  e n d s  o f  th e  F C V  g e n o m e  d o  n o t  in t e r a c t  w it h  
e ith e r  P C B P - 1  o r  P C B P - 2  p r o te in s
RNA transcripts with poly(A) tails (Section 5.2) including the 5’ and 3’ ends 
of the FCV genome, the FMDV IRES Fl and polyadenylic acid were individually 
incubated with oligo-dT beads and TNT-derived PCBP-1 and PCBP-2 (Sections 5.3 &
5.4). The samples were analysed by 10% SDS-PAGE and results were visualised by 
autoradiography.
Figure 5.7 shows the results obtained. For all transcripts, and the polyadenylic acid 
negative control, we saw bands for both PCBP-1 and PCBP-2. These results are 
indicative of non-specific binding of the two proteins with the 5’ and 3’ ends of the 
FCV genome, supported by literature confirming no binding between the FMDV 
IRES Fl transcript and PCBP-2 [Stassinopoulos & Belsham, 2001] and the 
polyadenylic acid negative control results. These results are discussed in detail in 
Section 5.10,
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Figure 5.7: The 5’ and 3’ ends of the FCV genome do not bind PCBP1 or 
PCBP2.
RNA transcripts (5 pg) corresponding to the 5’ (nt lto 190) and 3’ (nt 7500 to 7690) 
ends of the FCV genome were bound to oligo dT Dynabeads. The beads-RNA 
complex was incubated with 25 pi of either TNT-derived PCBP1 or PCBP2. Both the 
FMDV IRES fragment 1 RNA transcript and polyadenylic acid (poly(A)) served as 
negative controls. The samples were analysed by SDS-PAGE and visualised by 
autoradiography.
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5 .1 0  D I S C U S S I O N
There is currently little understanding about the mechanism of initiation of 
translation on FCV mRNA and there is a lack of evidence providing information 
about the interactions between the FCV genome, in particular the 5’ and 3’ ends, with 
canonical initiation factors as well as other /ram-acting factors. The determination of 
any interaction with the eIF4F complex and/or other cellular proteins and the current 
knowledge from other positive-stranded RNA viruses, may allow the generation of a 
hypothesis on the mechanism of FCV mRNA translation.
Gutierrez-Escolano and co-workers [2000] were the first to report interaction of the 5’ 
end of the NV genome (nt 1 to 110) with cellular factors from HeLa and CaCo-2 cell 
extracts. They have demonstrated binding of the 5’ end of the NV RNA with proteins 
unr (97 kDa), hnRNP L (68 kDa), PTB (57/60 kDa), La (52 kDa) and PCBP-2 (39 
kDa). In Chapter 4 it was demonstrated that PTB interacts with the 5’ end (nt 1 to 
190 or nt 20 to 190) of the FCV genome, in a specific manner, and this is in 
agreement with the results obtained from binding studies on NV [Gutierrez-Escolano 
et al ,2000].
The findings from the oligo-dT beads-RNA-protein assay indicated an 
interaction of eIF4A with the 5’ end (nt 1 to 190) of the FCV genome and to a lesser 
extent with the 3’ end (nt 7500 to 7690). These findings were supported by the FMDV 
IRES FI (nt 653 to 803) positive control [Stassinopoulos & Belsham, 2001] which 
produced the strongest signal after incubation of TNT-derived eIF4A with the oligo- 
dT-RNA complex. Both isoforms of eIF4A (eIF4AI and II; 44.4 and 46.3 kDa 
respectively) were seen when the results were visualised by autoradiography. The 
polyadenylic acid negative control produced very faint bands indicative of no
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interaction. It can therefore be suggested that in FCV mRNA translation eIF4A 
assumes its role as an ATP-dependent helicase that unwinds RNA secondary structure 
[Pause & Sonenberg, 1993]. The fact that its helicase activity is enhanced in the 
presence of inflation factor eIF4B [Rozen et al., 1990; Methot et al., 1996] raises the 
question whether eIF4B also interacts with the FCV genome. Interaction of eIF4A 
with the FCV 3’ end may suggest genome circularisation. RNA-protein binding 
assays such as UV cross-linking with recombinant eIF4A could be performed to 
futher establish the interaction with the 5’ and 3’ ends of the FCV genome. A 
competitive binding assay, similar to the one described in Section 4.7 would test 
whether such binding is specific. The functional requirement of eIF4A could be 
assayed by analysing FCV mRNA translation in eIF4A-depleted RRL as described in 
Stassinopoulos and Belsham [2001], or by using dominant negative eIF4A mutants as 
described in Pause et al [1994].
The initiation factor eIF4E was assayed in the same way as eIF4A. The results 
shown in Figure 5.3 showed no interaction between eIF4E and either the 5’ or the 3’ 
ends of the FCV genome. A positive signal, however, was produced for the FMDV 
IRES Fl control. Although this transcript served mostly as a positive control in the 
present study, it is known that eIF4E is redundant in picornavirus internal initiation of 
translation. Indeed it has been shown that the N-terminal domain of eIF4G that 
interacts with eIF4E [Mader et a l , 1995] is cleaved off by the FMDV L protease 
[Lamphear et a l, 1995] strongly suggesting that eIF4E is not required for FMDV 
translation. The contradictive result of this study could be attributed to the strong 
binding of eIF4G to the FMDV IRES Fl fragment. eIF4G, which is present both in 
the TnT Quick master mix (first assay) and the RRL (second assay), binds strongly to
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the FMDV IRES FI, maybe pulling down some eIF4E. eIF4E being radioactively 
labelled (in the first assay) is the only protein to be shown up after autoradiography. 
In the second assay probing with anti-eIF4E antiserum would result in the production 
of a band corresponding to eIF4E. Repetition of the assay with eIF4G-depleted RRL 
would further support the finding that eIF4E does not bind the 5’ and 3’ ends of the 
FCV genome and does not show up in the negative control FMDV IRES FI fragment.
Absence of eIF4E binding to the 5’ end of the FCV genome was not a 
surprise. As shown in Chapter 3 there are strong indications of interaction between 
eIF4E and the genome-linked protein VPg. Thus the role of eIF4E as a cap-binding 
protein may still remain with the suggestion that the VPg protein assumes the role of 
the cap structure. Indeed recent findings that eIF4G is cleaved during FCV infection 
at the N-terminus but, unlike picornaviruses, the eIF4E-binding domain remains intact 
[Willcocks et al., in preparation] strongly supports the hypothesis that eIF4E is 
required in FCV mRNA translation.
Initiation factor eIF4G was assayed in two different ways as described in 
Section 5.3. In the first assay TNT-derived eIF4G was incubated with the immobilised 
oligo-dT-[35S-met]-RNA complex, whereas in the second assay, the immobilised 
RNA transcripts were incubated with RRL. The results shown in Figures 5.4 & 5.5 
are consistent and indicate that neither the 5’ nor the 35 ends of the FCV genome 
interact with eIF4G. These findings were supported in both assays by the positive 
interaction of FMDV IRES FI [Saleh et al., 2001; Stassinopoulos & Belsham, 2001]. 
It is now known that FCV induces inhibition of host-cell protein synthesis in infected 
cells and that this is accompanied by cleavage of both eIF4GI and eIF4GII. This 
cleavage takes place at the N-terminus of the factor but unlike in picornaviruses the
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binding domains for eIF4E and eIF3 remain intact in FCV infection [Willcocks et a l, 
in preparation]. These findings, along with the results shown here, suggest that eIF4G 
may act as a scaffolding factor, recruiting proteins necessary for FCV translation, but 
it does not necessarily interact directly with the FCV genome. Other RNA-protein 
binding assays such as UV cross-linking or electrophoretic mobily shift assays with 
recombinant eIF4G may further support the findings of the present study.
The interaction of La autoantigen with the 5 s end (nt 1 to 190 or 20 to 190] of 
the FCV genome was suggested based on the UV cross-linking studies (Chapter 4, 
Section 4.8, Figure 4.1). This interaction was further assayed by the oligo(dT)-RNA- 
protein assay. The results in Figure 5.6 support the initial hypothesis. Interaction of 
La with the 55 end of a calicivirus RNA was demonstrated by immunoprecipitation 
assays for NV [Gutierrez-Escolano et a l, 2000]. In this study, the 3’ end (nt 7500 to 
7690) of the FCV genome served as a negative control based on previous results 
(Section 4.8, Figure 4.1) and produced a band of very low intensity. The other 
negative control, polyadenylic acid, was included as a means of eliminating any non­
specific binding to the olido-dT beads. Although La has been shown to bind to 
poliovirus and EMCV IRES elements [Meerovitch et a l, 1989; 1993; Witherell & 
Wimmer, 1994], it has not been shown to bind to the FMDV IRES. The findings 
shown in Figure 5.6 indicated a positive interaction between La and the FMDV IRES 
FI fragment. However, the intensity of the band produced was lower than the one 
seen in the FCV 55 end sample.
A positive control for this study could have been an EMCV 5’ UTR (nt 260 to 840) as 
described in Witherell and Wimmer [1994]. The functional role of La in FCV mRNA 
translation is not known but could be assayed in La-depleted RRL with subsequent
154
Chapter 5 Interaction of cellular proteins with the 5’ and 3’ ends of the FCV genome
addition of recombinant La protein, or by using dominant negative La mutants [Craig 
e ta l , 1997].
Interaction of PCBP-2 with the 5’ end (nt 1 to 110) of the NV genome has 
been previously demonstrated by Gutierrez-Escolano et al [2000]. TNT-derived 
PCBP-1 and PCBP-2 proteins were assayed in this study by the oligo-dT-RNA- 
protein assay as before. The results shown in Figure 5.7 show a rather non-specific 
interaction of both proteins for the 5’ and 3’ ends of the FCV genome. Although 
literature supports interaction of PCBP-2 with the FMDV 5’ UTR [Walter et a l ,
1999], localisation studies show this interaction is confined to the region of nt 423 to 
654 of the FMDV IRES and not in the region of the FMDV IRES Fl fragment (nt 
653 to 803) [Stassinopoulos & Belsham, 2001]. Therefore, the appearance of bands in 
the FMDV IRES Fl transcript as well as the polyadenylic acid negative controls 
indicate non-specific binding of PCBP-2 to the 5’ and 3’ ends of the FCV genome. 
The assay could therefore be repeated using the FMDV IRES fragment 3 as a positive 
control.
The findings reported by Gutierrez-Escolano et al. [2000] concerning binding 
of PCBP-2 to the 55 end of the NV genome were determined by supershifl assays after 
incubation of RNA transcripts with anti-PCBP-2 antibodies. Such results could have 
been produced due to interaction of the NV 5’ end with a protein attached to PCBP-2 
in the HeLa cell extract used in the supershift assay.
Binding of PCBP-1 has been demonstrated for the poliovirus 5’ UTR and is 
assumed (together with PCBP-2) to have a role in translation as well as replication 
[Gamarnik & Andino, 1997]. No studies have shown any interaction of PCBP-1 with 
the FMDV 5’ UTR. Therefore, as with PCBP-2, the production of bands appearing in
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all transcripts (55 and 3’ ends of FCV and FMDV IRES FI) as well as the 
polyadenylic acid negative control were likely due to non-specific binding. The assay 
could be repeated using regions of the poliovirus (PV) 5’ UTR (either domain I of the 
PV 5’ UTR,; nt 1-180, or PV IRES stem-loop IV; nt 220-440) as positive controls 
[Gamarnik & Andino, 1997]. Alternatively, UV cross-linking or mobility supershift 
assays could be performed with recombinant PCBP-1 and PCBP-2 proteins and anti- 
PCBP-1 and anti-PCBP-2 antisera respectively.
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C h a p t e r  6
G e n e r a l  D is c u s s io n
The emergence of a new group of viruses causing many diseases in man and 
animals, including the major viral cause of gastroenteritis in humans, led to their 
classification into a new family of viruses, the Caliciviridae. Their division into four 
genera, designated Lagovirus, Vesivirus, Norovirus and Sapovirus has only been 
recently revised by the ICTV [Mayo, 2002]. Our knowledge of these pathogenic 
viruses has expanded with the determination of several complete genome sequences 
[Neill, 1990; Jiang et a l , 1990; Neill et a l, 1991; Meyers et a l , 1991a; Carter et a l, 
1992a; Lambden et a l, 1993; Sosnovtsev & Green, 1995; Dingle et a l, 1995; Hardy 
& Estes, 1996; Liu et a l, 1999b].
Caliciviruses are single-stranded, positive-sense RNA viruses. The viral genome, 7-8 
kb in length, is polyadenylated but bears no ‘cap5 structure. Instead it bears a 10-15 
kDa genome-linked protein, designated VPg [Burroughs and Brown, 1978; Schaffer 
et a l , 1980; Wimmer, 1982; Meyers et a l, 1991]. The replication cycle involves the 
synthesis of at least one 3’ co-terminal subgenomic RNA, which also bears VPg at its 
5’ end [Carter, 1990; Meyers et a l, 1991b; Herbert et a l, 1996]. The lack of a ‘cap’ 
structure suggests that calicivirus mRNA is translated by a cap-independent 
mechanism. However, little is known about the mechanism of calicivirus mRNA 
translation although recently it has been shown that inhibition of host cell protein 
synthesis in FCV-infected cells is accompanied by cleavage of eIF4GI and II. This 
cleavage was shown to occur closer to the N-terminus of the factor thus, unlike
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cleavage in picornaviruses, the domain for eIF4E remains linked in FCV infection 
[Willcocks et al., in preparation].
This research project aimed to give an insight into calicivirus mRNA 
translation by studying virus/host interactions at the molecular' level. Feline calicivirus 
(FCV) was used as it can be propagated in tissue culture. Initially, work was 
performed to investigate interactions between the virus genome-linked protein VPg 
and other cellular proteins. Such interactions would lead to a better understanding of 
the role of VPg in calicivirus mRNA translation and its suggested role as a cap 
analogue. To date it is known that removal of VPg from the full-length mRNA greatly 
reduced the level of translation and that addition of the cap analogue m7GTP to in 
vitro translation reactions had no effect on FCV RNA translation, whereas synthetic 
transcripts derived from frill length FCV cDNA clone did not require VPg for 
infectivity, but needed to be artificially “capped” [Herbert et al., 1997; Sosnovtsev & 
Green, 1995; Thumfart & Meyers, 2002]. In addition, plant virus TuMV VPg was 
shown to form a complex with the translational eukaryotic initiation factor (iso) 4E 
[eIF(iso)4E] with addition of the ‘cap analogue’ m7GTP inhibiting formation of the 
VPg-eIF(iso)4E complex in a competitive manner [Wittmann et al., 1997; Leonard et 
al., 2000]. These studies led to our hypothesis of a role for VPg as a “cap analogue”.
The work presented in Chapter 3 of this thesis focused on the interactions 
between FCV VPg and cellular proteins from FCV-infected CRFK cells and inflation 
factors eIF4E, eIF4A and eIF4G. FCV VPg was successfully expressed in bacteria 
and purified. The recombinant FCV VPg (which bore a His-tag) was injected into a 
rabbit and antisera were raised. The antisera were used to check reactivity and 
specificity with recombinant VPg (Section 3.13) and with proteins from FCV-infected
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CRFK cells (Section 3,14). The antisera specifically reacted with recombinant FCV 
VPg producing bands of 20 kDa, 16.5 kDa and <16.5 kDa in the different 
concentrations (neat, 1:10 & 1:100) tested. The 16.5 and <16.5 kDa bands are 
possibly degraded products of the purified His-tagged VPg whereas the approximately 
20 kDa protein is considered to be the full-length tagged VPg. The results obtained 
from assaying the reactivity and specificity of anti-VPg antiserum with proteins from 
FCV-infected CRFK cells revealed the presence of three bands of approximately 88, 
45, and 20 kDa (Figure 3.7). Previous studies in FCV-infected cells have reported the 
presence of several precursor proteins (incomplete cleavage of the FCV polyprotein) 
of 120, 90, 43, and 33 kDa that specifically cross-reacted with anti-VPg antiserum 
[Sosnovtsev & Green, 2000]. The 20 kDa protein is thought to be the fully cleaved 
VPg, migrating slighter higher in SDS-PAGE, which is not uncommon [Sosnovtseva 
et a l , 1999]. The 88 and 45 kDa proteins may represent uncleaved protein products 
both comprising VPg and neighbouring gene products. Based on the alignment of the 
FCV polyprotein gene order as defined by Sosnovtsev et a l [2002] the approximately 
88 kDa protein is thought to be a cleaved product containing VPg and the protease 
and polymerase (VPg-Pro-Pol) proteins, whereas the approximately 45 kDa protein 
suggests a product containing the 30 kDa protein preceding VPg (p30) and the VPg 
protein (p30-VPg) (see Figure 3.13).
The second part of Chapter 3 was devoted to investigating interactions 
between VPg and the three subunits of initiation factor eIF4F; eIF4E, eIF4A and 
eIF4G. For that purpose, two assays were used. The first was the pull down assay 
(Figure 3.1) in which the previously purified His-tagged VPg, immobilised by Ni- 
NTA agarose, was incubated with HeLa S10 extract. The results (Section 3.15; 
Figures 3.8, 3.9 & 3.10) suggested an interaction between VPg with eIF4E only.
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These findings were supported by the second assay, an ELISA-based binding assay 
(Section 3.16; Figures 3.11 & 3.12) developed by Leonard et al [2000]. These 
experiments were conducted in collaboration with Professor Jean-Francois Laliberte’s 
group [INRS-Institute Armand-Frappier, Quebeq, Canada]. The second assay also 
argued against this being a result of an interaction between the His-tagged VPg and 
eIF4E through the His- or T7-tag (both present in the purified FCV VPg) by including 
a non-tagged VPg control (produced through a collaboration with Dr Stephen Curry, 
Imperial College, London). Binding of TuMV VPg with eIF(iso)4B from Arabidopsis 
thaliana served as a positive control [Wittmann et al, 1997; Leonard et a l , 2000]. The 
binding affinities between VPg and eIF4E could be assayed by addition of increasing 
amounts of a competitor such as a cap analogue or 4E-BP1 in the ELISA-based 
binding assay. The interaction between FCV VPg and eIF4E could be further 
investigated by localising the binding site. To date, the tertiary structure of FCV VPg 
is not known, creating a mystery as to what motif(s) present might be involved in its 
interaction with eIF4E. Expression and purification of a truncated and/or mutated 
version of FCV VPg followed by the ELISA-based binding assay and amino acid 
sequence analysis may reveal which part of FCV VPg is interacting with eIF4E.
Thus, the notion that VPg may act as a cap analogue during FCV mRNA 
translation is further enhanced since eIF4E is the cap-binding factor and is binding to 
VPg. Since it was shown that addition of the cap analogue m7GTP had no effect on 
FCV mRNA translation [Herbert et a l , 1997] it is possible that the cap structure and 
the FCV VPg bind to eIF4E at different sites. However, it was recently reported that 
recombinant Norwalk virus VPg inhibited translation of capped (m7GTP-Luciferase), 
IRES-containing (EMCV IRES-Luciferase) and IGR-IRES-containing (CrPV IGR- 
IRES-Luciferase) reporter mRNAs in RRL [Daughenbaugh et al., 2003]. The
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significance of these findings are not clear and are contradicted by the results from 
Herbert et al [1997]. The same study [Daughenbaugh et a l, 2003] first demonstrated 
binding of recombinant NV VPg to translation initiation factor eIF3 subunit d by both 
yeast-two-hybrid and pull down (using either recombinant eIF3 or CaCo-2 extracts) 
studies. The pull down studies with CaCo-2 extracts also suggested binding of NV 
VPg with factors eIF4G, and to a lesser extent with eIF4E and eIF2a, although they 
argue that these proteins may have been pulled down along with eIF3. Another 
protein, S6 (of the 40S ribosomal subunit) was also pulled down and this was 
attributed to the affinity of VPg for the 40S ribosomal subunit. Again, these findings 
do not support inhibition of CrPV IGR-IRES translation, since CrPV mRNA does not 
require initiation factors for assembly of the 80S ribosomes [Wilson et a l, 2000b].
eIF3 has been implicated in 80S ribosome dissociation, Met-tRNAj and 
mRNA binding to the 40S ribosomal subunit and association with other factors. At 
least four of its subunits, including d bind RNA [reviewed in Hershey & Merrick,
2000]. The interaction of NV VPg with eIF3 and S6 [Daughenbaugh et a l, 2003], as 
well as sequence similarities between calicivirus VPg and initiation factor elFlA (a 
ribosomal protein involved in aiding mRNA binding to the 40S subunits) [Dever et 
a l, 1994], enhances the notion for a role of calicivirus VPg as a signal for ribosome 
binding and assembly.
In order to better understand the mechanism of FCV mRNA translation it was 
necessary to establish any interactions with canonical initiation and other cellular 
factors with regions of the FCV genome. Previous studies by Gutierrez-Escolano et 
al [2000] suggested binding of PTB, La, unr, PCBP-2 and hnRNP L to the 5’ end (nt 
1 to 110) of the Norwalk virus genome. Chapter 4 of this thesis presents UV cross­
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linking studies performed using the 5’ end (nt 1 to 190; nt 20 to 190) and 3’ end (nt 
7500 to 7690) of the FCV genome with HeLa S10 extract. The results showed that 
proteins of approximately 120, 95, 57, 52 and 10 kDa bind to the 5’ end of the FCV 
genome irrespective of the presence of the 20 nt UTR (Figure 4.1). The observation 
of the band migrating at about 57 kDa in both the 5’ end transcripts and the positive 
EMCV IRES (pD 1+2+3) transcript control suggested the presence of the PTB protein, 
whereas the protein migrating at about 52 kDa was thought to be La. Confirmation 
that PTB binds to the coding region of the FCV genome was provided by UV cross- 
linking studies with recombinant full-length PTB (Figure 4.2) and a UV cross-linking 
competitive assay showed that binding of PTB to the FCV 5’ end is specific (Figure 
4.3). Further confirmation was provided by cross-linking studies carried out by Dr 
Michael Niepmann’s group [Institute of Biochemistry, Giessen, Germany] using two 
longer fragments of the FCV genome (nt 1 to 681 and nt 1 to 1012) that cross-link 
with PTB. When these two transcripts were tested for functional requirement of PTB 
in FCV mRNA translation in PTB-depleted RRL it was shown that PTB did not 
stimulate translation. This should be repeated using full-length, VPg-attached mRNA 
from FCV-infected cells. For that purpose a study that is currently being performed in 
Dr Michael Niepmann’s laboratory involves assaying VPg-attached full-length FCV 
mRNA isolated from FCV-infected cells in PTB-depleted RRL. It may be that PTB 
acts as an RNA chaperone maintaining or attaining the appropriate secondary or/and 
tertiary structure of the RNA, as is the case in picornaviruses [reviewed in Belsham & 
Jackson, 2000].
Another important study would be to localise the nucleotide position at which PTB 
binds the 5’ end of the FCV genome. The minimum-length sequence used was the 
first 190 nucleotides. Cross-linking studies using shorter sequences would provide a
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clue as to which regions bind PTB. The first 190 nucleotides of the FCV genome have 
many regions occupied by three (nt 37 to 39 and nt 95 to 97), four (nt 23 to 26, nt 30 
to 33, nt 70 to 73 and nt 79 to 82), five (nt 114 to 116, nt 137 to 138) and eight (nt 163 
to 170) consecutive pyrimidines. Figure 6.1 shows the first 190 nucleotides of the 
FCV genome folded with the aid of an RNA folding software package (Michael 
Zuker: The RNA infold server; www.bioinfo.math.rpi.edu/~zukerir0. The positions of 
the pyrimidines mentioned above are shown as dark green asterisks. One of them (nt 
23 to 26) is immediately downstream of the initiation codon (nt 20 to 22). The two 
regions at which three and five consecutive pyrimidines respectively exist seem to 
occur opposite each other in a loop (nt 37 to 39 and nt 112 to 116). The eight 
consecutive pyrimidine residues lie towards the end of the 190 nt sequence and it is 
the closest to being a polypyrimidine tract. However, in picornaviruses PTB does not 
bind exclusively to the polypyrimidine tract found just downstream of the IRES 
element [reviewed in Belsham & Jackson, 2000]. Affinity or filter-binding studies 
could be used to determine binding affinities between full-length, truncated and/or 
mutated versions of PTB and the 5’ end of the FCV genome. Also, mutations 
substituting the pyrimidines to purines could reveal if binding of PTB is abolished and 
determine the site(s) at which PTB binds to the 5’ end of the FCV genome.
The other feature observed in position nt 63 to 66 is a GNRA tetraloop (Figure 6.1), a 
feature common in picornaviruses and essential for picornavirus translation as 
determined by mutagenesis studies. Although the sequence in picornaviruses is 
GUGA (entero-/rhinoviruses) or GCGA (cardio-/aphthoviruses), the tetraloop in FCV 
RNA is GAAA. However establishing any role for this motif by mutagenesis studies 
is difficult prior to determining the mechanism of FCV mRNA translation and the 
functional roles of the proteins found to interact with its 5’ and 3’ ends.
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Figure 6.1: The 5’ end (nt 1 to 190) folding pattern of the FCV genome
The 5’ end (nt 1 to 190) of the FCV genome used in the cross-linking and oligo(dT) bead 
binding assays. The folding pattern was produced with the aid of an RNA folding software 
package (The RNA mfold server; Michael Zuker). The 5’ UTR comprises mainly A and U 
residues. Nucleotide 63 to 66 form a possible GNRA tetraloop motif. Green asterisks 
denote pyrimidine-rich regions. Initiation codon (AUG) is at position nt 20.
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In Chapter 5 a newly developed assay involving immobilisation of transcripts 
to oligo(dT) beads [Stassinopoulos & Belsham, 2001] was used to assay possible 
interactions between the 5’ (nt 1 to 190) and 3’ (nt 7500 to 7690) ends of the FCV 
genome and cellular proteins present in RRL. The results suggested binding of eIF4A 
to both the 5’ and 3’ ends of the FCV genome (Figures 5.2) and La to the FCV 5s end 
(Figure 5.6). Factors eIF4E (Figure 5.3), eIF4G (Figures 5.4 & 5.5) and PCBP-1 and 
PCBP-2 (Figure 5.7) did not bind to either end of the genome. The functional roles of 
eIF4A and La could be assayed by using the relevant protein depleted-RRL with 
subsequent addition of recombinant proteins, or by using dominant negative eIF4A 
and La mutants [Pause et a t, 1994; Craig et al., 1997]. Binding of eIF4A to the 5’ end 
of the FCV genome was somewhat expected due to its function as a helicase capable 
of unwinding RNA duplexes. Its binding to the 3’ end could be for the same reason 
although functional studies are required. The folding pattern of the last 190 
nucleotides (nt 7500 to 7690) of the 3’ end of the FCV genome used in these studies 
(as produced by the RNA mfold server; Michael Zuker) revealed that apart from two 
A-U rich loops no other striking features exist. As mentioned above for PTB, La is 
also thought to act as an RNA chaperone stabilising a particular secondary or tertiary 
structure within picomavirus IRESs [reviewed in Belsham & Jackson, 2000] and this 
may also be its role in FCV mRNA translation.
The findings presented in this thesis are summarised diagrammatically in 
Figure 6.2, in which a simplistic model of the interactions between features of the 
FCV mRNA (i.e. VPg and the 3’ & 5’ ends) and cellular proteins is proposed. 
Additional information included is the cleavage of eIF4G near the eIF4E-binding 
domain and binding of eIF3 to VPg. Binding of eIF4E to VPg certainly suggests a
165
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role as a cap analogue or 4E-BP. Determination of any interaction between eIF3 and 
FCV VPg would further enhance the suggestion that VPg also acts as a signal for 
ribosome binding and assembly. Indeed the results of this study may be the first 
demonstration of a viral cap analogue or viral 4E-BP. Binding of FCV VPg to eIF4E 
may reduce cap-dependent protein synthesis of the host cell. Since the eIF4E domain 
of eIF4G is not cleaved during FCV infection, it may be that FCV uses VPg to 
deprive the host cell of eIF4E through its interaction with it and this may be the 
mechanism which FCV and possibly other caliciviruses use to shut off host cell 
protein synthesis. Lack of binding between eIF4G and the 5’ end of the FCV genome 
suggests that it assumes its role as a scaffolding protein, bringing together other 
factors necessary for translation without interacting with the coding sequence of FCV 
mRNA.
Elucidating the mechanism of FCV mRNA translation will aid our 
understanding of the calicivirus cytopathogenicity and will provide valuable 
information for production of vaccines and other anti-viral strategies.
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A P P E N D I X  1
P r i m e r  I n f o r m a t i o n
Forw ard prim er o f  the V Pg sequence (V P G FO R )
23nt, Tm: 54°C
BamHl
I
ACGGATCCGAAGCAAAAGGAAAA
R evese prim er o f  the V Pg sequence (V P G R E V )
24nt, Tm: 58°C
Hindlll
I
ACAAGCTTTGATTCCTCAGCAAAG
Both the forward and reverse primers were designed to be flanked by 2 
different restriction sites (BamHl and Hindlll respectively) for the purposes of 
cloning into suitable vectors.
I
5’+UTR fragment of the FCV genome
Forward primer (FOR5’+UTR): 24nts, Tm: 62°C 
HindIII
C AAAGCTT C GT A A A AG A A ATTTG A
Reverse primer (REV59 +UTR): 23nts, Tm: 68°C 
Pstl |
CACTGCAGACATACGTCGTAACT
The 5’+UTR fragment comprised of 190bp.
The forward primer starts from the 5’ end of the FCV genome. The Hindlll restriction 
site and the extra C (in bold, immediately after the Hindlll restriction site) were added 
to recreate a Hindlll recognition site and place the PCR 5’+UTR fragment in frame, 
respectively, in the pGEM-4Z vector (2746bp). The Hindlll restriction site was 
chosen because it was immediately downstream the T7 promoter of the pGEM-4Z 
vector. The reverse primer starts at position 190bp from the 3’end and comprised of 
15nts, preceded by a Pstl restriction site, chosen to linearise the PCR 5’+UTR 
fragment in the pGEM-4Z vector.
5*-U T R  fragm ent o f  the F C V  genom e
Forward primer fFOR5’-UTR): 23nts, Tm: 62°C 
Hindlll
I
CAAAGCTTAATGTCTCAAACTCT
II
Reverse primer (REV5’-UTR): 23nts, Tm: 68°C
Pstl
c a c t g c I g a c a t a c g t c g t a a c t
The 55-UTR comprised of 171bp, lacldng the 19nts UTR. The forward primer 
was designed to fit the same purposes as the 5’+UTR fragment. The reverse primer of 
the 5’-UTR fragment is the same as for the 5’+UTR fragment.
3 ?+U T R  fragm ent o f  th e F C V  genom e
Forward primer (TORS’+UTRf: 24nts, Tm: 72°C 
Hindlll
i
CAAAGCTTCAAAGGGTACAAGGCC
Reverse primer (REV3;+UTR): 23nts, Tm: 78°C 
Pstl
i
C ACT GC AGCCCT GGGGTT AGGCG
The 3’+UTR comprised of 191bp, including the 3’UTR. Both the forward and 
reverse primers were designed to fit the same purposes as the 5’+UTR and 5’-UTR 
fragments.
Melting temperature calculated according to the formula: Tm = [4* (G+C)] + [2* 
(A+T)J
III
A P P E N D I X  2
AGATCTCGATCCCCCGCGAAATTAATACGACTCACTATAGGGGAAT
__________ operator  Xha  I
TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTT 
rbs N co  I H is •  T ag
AAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCA
T 7*Tag
CAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCTAGCATGAC
Bamm
---------------------------------    V Pg
T GGT GGAC AGC A A AT GGGT CGCGGAT CCGAAGC AAAAGGAAAAAC
B g l  II T7 promoter lac
CAAATTGAAGATTGGGACATACAGGGGTCGCGGTGTAGCGCTGAC
TGATGACGAGTACGATGAGTGGCGCGAACACAACGCCTCCAGAAA
ATTGGATTTGTCAGTGGAGGATTTCTTAATGTTGCGCCATCGTGCCG
CTCTAGGAGCCGACGACAATGATGCAGTAAAATTCCGGTCGTGGTG
GAACTCCAGAACCAAAATGGCCAATGATTATGAGGATGTCACCGT
IV
AATTGGCAAAGGTGGCGTCAAACATGAAAAGATCAGAACCAATAC
CCTAAAAGCTGTGGATCGTGGTTATGACGTCAGCTTTGCTGAGGAA 
Hind III Eag I
» Nnn   Xhal
TCAAAGCTTGCGGCCGCACTCGAGCAC
H is*T ag  
 ►
C ACC ACC ACC ACC ACT GAGAT CCGGCT GCTAAC AAAGCCC
pE T 28a+V P g sequence for V P g expression . The VPg sequence is underlined. The 
sequence of the T7 promoter and the six-histidine residues preceding VPg can also be 
seen.
V
A P P E N D I X  3
S e q u e n c in g  D a t a
1. pET+VPG/FOR: DNA sequencing of the pET28a+VPg plasmid (C hapter 3)
2. 4Z5+/FWD: DNA sequencing of the pGEM-4Z/5’+UTR plasmid (C hapter 4)
3. 4Z5-/FWD: DNA sequencing of the pGEM-4Z/5’-UTR plasmid (C h ap ter 4)
4. 4Z/3+UTR/FOR: DNA sequencing of the pGEM-4Z/3’+UTR plasmid 
(C h ap ter 4)
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A P P E N D I X  4
S o lu t io n s
General Solutions
TA E  B uffer (50x): 1 litre
242 g Tris (Sigma)
57 ml glacial acetic acid (Fisher chemicals)
100 ml 0.5 M EDTA (pH 8.0) (Sigma)
Made up to 1 L with sterile dH20. Used inlx concentration as running buffer and as a 
means to dissolve the agarose for analysis of DNA.
T B E  B uffer (lOx): 1 litre
121 g Tris
62 g Boric acid (Sigma)
18.6 g EDTA
Made up to 1 L with sterile dH20. Used inlx concentration as running buffer and as a 
means to dissolve the agarose for analysis of RNA transcripts.
TE Buffer: 500 m l
5 ml 1 M Tris (pH 7.6)
XI
Made up to 500 nil with sterile dH20  
Sterilised by autoclave.
L uria -  B ertan i (L B ) broth: 1 litre
10 g Tryptone (Oxoid)
5 g Yeast extract (Oxoid)
10 g NaCl (Sigma)
Made up to 1L with sterile dH^O 
Adjust pH to 7.5 with 5 M NaOH (Sigma)
Sterilised by autoclave.
L uria -  B ertan i (L B ) agar: 1 litre
Same as LB broth (above) plus 1.5% agar (w/v) (BACTO™Agar; Difco). 
Sterilised by autoclave.
C aC l2 solution (for resuspension  o f  com petent E .co li  cells)
6 g CaCh (Sigma)
4 ml 1 M Tris-HCl (pH 7.5)
Made up to 400 ml with sterile (IH2O.
Filter sterilized with 500 ml Cornish filter unit. Stored at 4°C.
1 m l0.5M EDTA(pH8.0)
XII
PBS
Each 5 g tablet contains 3,000 mg/1 NaCl, 200 mg/1 KC1, 1,150 mg/1 Na2HPC>4 and 
200 mg/1 KH2P 04.
Each tablet was dissolved in 1 litre dH20 , pH 7.45. Stored at 4°C.
PBSa
Same as PBS above with the addition of 132.5 mg/1 CaCl22H20  and 100 mg/1 
MgCl2‘6H20. Aliquots were filtered sterilised before use in plaque assay. Stored at 
4°C.
Plaque assay
D ou b le strength m edium
33 ml sterile dH20
10 ml lOx MEM (Eagle’s modification with Earles salts)
2 ml heat inactivated foetal calf serum 
1 ml penicillin and streptomycin 
1 ml glutamine
1 ml non-essential amino acids 
4-6 ml sodium bicarbonate 
0.5 ml gentamycin
All materials (except dH20) were from GibcoBRL. This made 50 ml double strength 
medium. The medium was mixed and wanned to 42°C in a water bath before use.
PBS tablets (GibcoBRL)
XIII
A d d i t io n  o f  a n t ib io t ic s  f o r  s e le c t iv e  g r o w th
pG E M -T easy+V P g transform ation
Ampicillin (25 mg/ml): 1:500 
20% X-Gal: 75-100 pi in 100 ml 
IPTG (100 mM): 1:400
pG EM -4Zy5’+ U T R /5’-U T R /3 ’+U T R  transform ation
Ampicillin (25 mg/ml): 1:500 
20% X-Gal: 75-100 pi in 100 ml 
IPTG (100 mM): 1:400
pE T +V P g transform ation
Kanamycin 30 pg/ml: 1:500 of 15 mg/ml stock
pE T +V Pg transform ation  for V Pg expression
Kanamycin 30 pg/ml: 1:500 of 15mg/ml stock
Chloramphenicol 34 pg/ml (diluted in ethanol): 1:500 of 17 mg/ml stock 
IPTG 100 mM (2.38 g in 100 ml sterile dt^O, and filter sterilized)
SDS-PAGE Solutions
A X 2 buffer (resolving gel buffer): 500m l
0.75 M Tris (pH 8.8)
XIV
or 45.3 g Tris made up to 500mls with dH20. 
Adjust pH with HCI drops.
B X 2 buffer (stacker gel buffer): 500m l 
0.25 M Tris (pH 6.8)
or 15.12 g Tris made up to 500 ml with dH20. 
Adjust pH with HCI drops.
R esolving G els Stacker Gel
C ontents 7.5% 1 0 % 1 2 % 4%
Sterile dH 20 5.5ml 4.5ml 3.2ml 3.7ml
A X 2 10ml 10ml 10ml -
B X 2 - - - 5ml
A crylam ide:
B is
40%
3.8ml 5 ml 6.3ml 1ml
D e-aerate gel m ixes
10%  SDS 200jll1 200jal 200jal lOOpl
A m m onium
Persulfate
200pl 200pl 200pl lOOpl
T em ed 50pl 50pl 50pl 30j.il
Acrylamide:Bis (Biorad)
XV
Temed (Sigma)
SD S-P A G E  R unning buffer
3 g Tris
14.4 g Glycine (Sigma)
5 ml 20% SDS (Sigma)
Made up to 1 L with dFLO.
C oom assie stain  for protein  gels
1.25 g Coomassie brilliant blue (Coomassie brilliant blue R-250; Biorad) 
125 ml Methanol (Fisher chemicals)
50 ml Acetic acid (Fisher chemicals)
325 ml dFLO
D estain
125 ml Methanol 
50 ml Acetic acid 
325 ml dH20
Western Blot Solutions
W estern B lot T ransfer buffer
Ammonium persulfate (Sigma)
3 g Tris
XVI
Make up to 800 ml with cold dUELO 
Add 200 ml Methanol 
Keep cool at 4°C before use.
10 x TBS -  0.1%  Tween
24.2 g Tris 
80 g NaCl
Dissolve in 800 ml cffi^O 
pH to 7.6 with concentrated HCl 
Add 10ml Tween-20 
Make up to 1 L with (IH2O 
Store at 4°C
B lock ing solution
5% w/v Marvel in 1 x TBS-Tween
Plasmid Miniprep Solutions
R esuspension  solution
50 mM glucose (Sigma)
25 mM Tris (pH 8.0) 
lOmMEDTA
14.4 g Glycine (Sigma)
L ysis solution  
1% SDS 
0.2 M NaOH
N eutralization  solution
120 ml 5 M Potassium acetate (Sigma) 
23 ml Glacial Acetic Acid 
57 ml dH20
T E /R N ase solution
450 jLtl TE buffer
50 pi RNase A (lOmg/ml; Promega)
VPg Purification Solutions
E quilibrium  buffer
lx NaPi (sodium phosphate) solution
5 mM imidazole (PharMingen)
300 mM NaCl
W ash buffer  
lx NaPi solution 
40 mM imidazole 
300 mM NaCl
XVIII
Aprotinin (5.5 pl/ml; Sigma)
E lution  buffer
lx NaPi solution 
250 mM imidazole 
300 mM NaCl
lO xNaPi stock  solution
1 MNaH2P 04
100 mM Tris-HCl pH 8
For 100 ml: 15.6 g NaH2P04 (Sigma); 1.21 g Tris
Dissolve in sterile dH20  and adjust the pH to 8.0 with saturated NaOH solution or 
solid pellets (Sigma).
Cross-linking Solutions
5x B ind ing  buffer
50 mM HEPES (Sigma) pH 7.2 
15 mM MgCl2 (Sigma)
25% glycerol (Fisher chemicals)
5 mMDTT
XIX
100 mM Tris-HCl pH 7.5 
10 mMMgCfe
1 mMKCl
RNase mix
50 pi 1 Ox dilution buffer
100 pi RNase ONE™ (5 mg/ml, Promega)
350 pi RNase-free H2O
Dynabead protein-RNA binding assay solutions
SSC (20x): 1 litre
175.3 gNaCl
88.2 g sodium citrate 
800 ml dll20
Dissolve NaCl and sodium citrate in 800 ml H20. Adjust the pH to 7.0 with a few 
drops of NaOH solution. Sterilize by autoclave. Used in 0.5x concentration in 
Dynabead protein-RNA inding assay.
Bead-binding buffer (lOx)
100 mMICCl 
10 mM Tris, pH 7.5
2 mM MgCl2
lOx Dilution buffer
XX
Make up to the desired volume with dH20. Sterilize by autoclave. Used in lx 
concentration in Dynabead protein-RNA binding assay.
XXI
